| 2024 | 38895069 | 10.1002/jha2.907 | Belantamab mafodotin in triple-refractory multiple myeloma patients: A retro-prospective observational study in Italy. | EJHaem | Fazio F, Petrucci MT, Corvatta L, Piciocchi A, Della Pepa R, Tacchetti P, Musso M, Zambello R, Belotti A, Bringhen S, Antonioli E, Conticello C, Renzo ND, De Stefano V, Musto P, Gamberi B, Derudas D, Boccadoro M, Offidani M, Morè S |
| 2024 | 38633115 | 10.1002/jha2.873 | Unlocking the potential of synthetic patients for accelerating clinical trials: Results of the first GIMEMA experience on acute myeloid leukemia patients. | EJHaem | Piciocchi A, Cipriani M, Messina M, Marconi G, Arena V, Soddu S, Crea E, Feraco MV, Ferrante M, La Sala E, Fazi P, Buccisano F, Voso MT, Martinelli G, Venditti A, Vignetti M |
| 2024 | 38805638 | 10.1182/blood.2024023890 | Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia. | Blood | Koury LCA, Kim HT, Undurraga MS, Navarro-Cabrera JR, Salinas V, Muxi P, Melo RAM, Gloria ABF, Pagnano KBB, Nunes EC, Bittencourt RI, Rojas N, Quintana Truyenque SM, Ayala-Lugo AI, Oliver AC, de Figueiredo-Pontes LL, Traina F, Moreira F, Fagundes EM, Duarte BKL, Mora-Alferez AP, Ortiz P, Untama JL, Tallman MS, Ribeiro RC, Ganser A, Dillon RJ, Valk PJM, Sanz MA, Löwenberg B, Berliner N, Rego EM |
| 2024 | 38424214 | 10.1038/s41591-024-02827-9 | Recommendations to address respondent burden associated with patient-reported outcome assessment. | Nature medicine | Aiyegbusi OL, Cruz Rivera S, Roydhouse J, Kamudoni P, Alder Y, Anderson N, Baldwin RM, Bhatnagar V, Black J, Bottomley A, Brundage M, Cella D, Collis P, Davies EH, Denniston AK, Efficace F, Gardner A, Gnanasakthy A, Golub RM, Hughes SE, Jeyes F, Kern S, King-Kallimanis BL, Martin A, McMullan C, Mercieca-Bebber R, Monteiro J, Peipert JD, Quijano-Campos JC, Quinten C, Rantell KR, Regnault A, Sasseville M, Schougaard LMV, Sherafat-Kazemzadeh R, Snyder C, Stover AM, Verdi R, Wilson R, Calvert MJ |
| 2024 | 38207239 | 10.1200/OP.23.00434 | Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care System. | JCO oncology practice | Sparano F, Giesinger JM, Gaidano G, Anota A, Cavo M, Brini A, Voso MT, Venditti A, Perrone F, Di Maio M, Luppi M, Baron F, Platzbecker U, Fazi P, Vignetti M, Efficace F |
| 2024 | 38174977 | 10.1002/ajh.27196 | Similar efficacy outcomes with peripheral blood stem cell versus bone marrow for autologous stem cell transplantation in acute myeloid leukemia: Long-term follow-up of the EORTC-GIMEMA randomized AML-10 trial. | American journal of hematology | Baron F, Efficace F, Cannella L, Stevens-Kroef M, Amadori S, de Witte T, Lübbert M, Venditti A, Suciu S |
| 2024 | 37801052 | 10.1002/cncr.35021 | Patient-reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemia. | Cancer | Efficace F, Cottone F, Yanez B, Kota V, Castagnetti F, Caocci G, Bonifacio M, Patriarca A, Capodanno I, Miggiano MC, Tiribelli M, Breccia M, Luciano L, Giai V, Iurlo A, Abruzzese E, Fava C, Dinner S, Altman JK, Rosti G, Cortes J, Vignetti M, Cella D |
| 2024 | 37847211 | 10.2450/BloodTransfus.464 | Donor specific anti-HLA antibodies in hematopoietic stem cell transplantation. Single Center prospective evaluation and desensitization strategies employed. | Blood transfusion = Trasfusione del sangue | La Rocca U, Perrone MP, Piciocchi A, Barberi W, Gesuiti P, Laurenti L, Cinti P, Gozzer M, Bafti MS, Carmini D, Cinelli N, Cavallari C, Giovannetti G, Ricci R, Girelli G, Foà R, Martelli M, Coluzzi S, Iori AP |
| 2024 | 38882459 | 10.4084/MJHID.2024.041 | Impact of Daratumumab on Stem Cell Mobilization and Transplant in Patient with Newly Diagnosed Multiple Myeloma: A Real Word Single-Centre Study. | Mediterranean journal of hematology and infectious diseases | Passucci M, Fazio F, Micozzi J, Bafti MS, Assanto G, Piciocchi A, Martelli M, Petrucci MT |
| 2024 | 38113467 | 10.1182/bloodadvances.2023011661 | A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study. | Blood advances | Enshaei A, Joy M, Butler E, Kirkwood AA, Messina M, Pavoni C, Morgades M, Harrison CJ, Foà R, Ribera JM, Chiaretti S, Bassan R, Fielding AK, Moorman AV |
| 2024 | 38717861 | 10.1182/blood.2023023625 | Decitabine in Older Patients with AML: Quality of Life Results of the EORTC-GIMEMA-GMDS-SG Randomized Phase III Trial. | Blood | Efficace F, Kicinski M, Coens C, Suciu S, van der Velden WJFM, Noppeney R, Chantepie SP, Griskevicius L, Neubauer A, Audisio E, Luppi M, Fuhrmann S, Foà R, Crysandt M, Gaidano G, Vrhovac R, Venditti A, Posthuma EFM, Candoni A, Baron F, Legrand O, Mengarelli A, Fazi P, Vignetti M, Giraut A, Wijermans PW, Huls GA, Lübbert M |
| 2024 | 38582227 | 10.1016/j.critrevonc.2024.104345 | Patient-reported outcomes in randomized clinical trials of systemic therapy for advanced soft tissue sarcomas in adults: A systematic review. | Critical reviews in oncology/hematology | Roets E, van der Graaf W, van Riet BHG, Haas RL, Younger E, Sparano F, Wilson R, van der Mierden S, Steeghs N, Efficace F, Husson O |
| 2024 | 38744447 | 10.1136/spcare-2024-004842 | Early palliative care perceptions by patients with cancer and primary caregivers: metaphorical language. | BMJ supportive & palliative care | Bandieri E, Bigi S, Nava M, Borelli E, Porro CA, Castellucci E, Efficace F, Bruera E, Odejide O, Zimmermann C, Potenza L, Luppi M |
| 2024 | 38127722 | 10.1200/JCO.23.01075 | Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | Foà R, Bassan R, Elia L, Piciocchi A, Soddu S, Messina M, Ferrara F, Lunghi M, Mulè A, Bonifacio M, Fracchiolla N, Salutari P, Fazi P, Guarini A, Rambaldi A, Chiaretti S |
| 2024 | 35618412 | 10.1136/bmjspcare-2022-003572 | Edmonton symptom assessment system global distress score and overall survival among patients with advanced cancer receiving early palliative care. | BMJ supportive & palliative care | Bandieri E, Banchelli F, Borelli E, D'Amico R, Efficace F, Bruera E, Luppi M, Potenza L |
| 2024 | 38671298 | 10.1007/s00277-024-05771-3 | Long-term health-related quality of life and mental health in patients with immune thrombotic thrombocytopenic purpura. | Annals of hematology | Mulas O, Efficace F, Costa A, Baldi T, Zerbini F, Mantovani D, Morelli E, Perra D, La Nasa G, Caocci G |
| 2024 | 38461292 | 10.1038/s41409-024-02260-z | Effect of daratumumab on stem cell yields in patients with newly diagnosed multiple myeloma: a report from the Multiple Myeloma Group. | Bone marrow transplantation | Fazio F, Passucci M, Micozzi J, Di Landro F, Fianchi L, Za T, Manieri VM, Annibali O, Cupelli L, Bongarzoni V, Gentili S, De Padua L, Crisanti E, Garzia MG, Rago A, Piciocchi A, Mengarelli A, Morè S, De Stefano V, Bafti MS, Martelli M, Petrucci MT |
| 2024 | 38724222 | 10.1136/spcare-2024-004924 | Financial toxicity and health-related quality of life in long-term survivors of acute promyelocytic leukaemia. | BMJ supportive & palliative care | Sparano F, Voso MT, Venditti A, Giesinger JM, Baldi T, Breccia M, Fazi P, Vignetti M, Efficace F |
| 2024 | 38774655 | 10.1002/hem3.69 | Toward a more patient-centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS). | HemaSphere | Efficace F, Buckstein R, Abel GA, Giesinger JM, Fenaux P, Bewersdorf JP, Brunner AM, Bejar R, Borate U, DeZern AE, Greenberg P, Roboz GJ, Savona MR, Sparano F, Boultwood J, Komrokji R, Sallman DA, Xie Z, Sanz G, Carraway HE, Taylor J, Nimer SD, Della Porta MG, Santini V, Stahl M, Platzbecker U, Sekeres MA, Zeidan AM |
| 2024 | 38606605 | 10.7189/jogh-14-04068 | Key lifestyles and health outcomes across 16 prevalent chronic diseases: A network analysis of an international observational study. | Journal of global health | Li J, Fong DYT, Lok KYW, Wong JYH, Man Ho M, Choi EPH, Pandian V, Davidson PM, Duan W, Tarrant M, Lee JJ, Lin CC, Akingbade O, Alabdulwahhab KM, Ahmad MS, Alboraie M, Alzahrani MA, Bilimale AS, Boonpatcharanon S, Byiringiro S, Hasan MKC, Schettini LC, Corzo W, De Leon JM, De Leon AS, Deek H, Efficace F, El Nayal MA, El-Raey F, Ensaldo-Carrasco E, Escotorin P, Fadodun OA, Fawole IO, Goh YS, Irawan D, Khan NE, Koirala B, Krishna A, Kwok C, Le TT, Leal DG, Lezana-Fernández MÁ, Manirambona E, Mantoani LC, Meneses-González F, Mohamed IE, Mukeshimana M, Nguyen CTM, Nguyen HTT, Nguyen KT, Nguyen ST, Nurumal MS, Nzabonimana A, Omer NAMA, Ogungbe O, Poon ACY, Reséndiz-Rodriguez A, Puang-Ngern B, Sagun CG, Shaik RA, Shankar NG, Sommer K, Toro E, Tran HTH, Urgel EL, Uwiringiyimana E, Vanichbuncha T, Youssef N |
| 2024 | 38478023 | 10.1007/s00277-024-05704-0 | Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera: the "RAMP" Italian multicenter prospective study. | Annals of hematology | Palandri F, Auteri G, Abruzzese E, Caocci G, Bonifacio M, Mendicino F, Latagliata R, Iurlo A, Branzanti F, Garibaldi B, Trawinska MM, Cattaneo D, Krampera M, Mulas O, Martino EA, Cavo M, Vianelli N, Impera S, Efficace F, Heidel F, Breccia M, Elli EM, Palumbo GA |
| 2023 | 37276451 | 10.1182/bloodadvances.2022009596 | Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial. | Blood advances | Bassan R, Chiaretti S, Della Starza I, Spinelli O, Santoro A, Paoloni F, Messina M, Elia L, De Propris MS, Scattolin AM, Audisio E, Marbello L, Borlenghi E, Zappasodi P, Mauro E, Martinelli G, Mattei D, Fracchiolla N, Bocchia M, De Fabritiis P, Bonifacio M, Candoni A, Cassibba V, Di Bartolomeo P, Latte G, Trappolini S, Guarini A, Vitale A, Fazi P, Piciocchi A, Rambaldi A, Foà R |
| 2023 | 37705525 | 10.4084/MJHID.2023.047 | Multiparametric Flow Cytometry in Newly Diagnosed Multiple Myeloma Patients: An Italian Monocentric Experience. | Mediterranean journal of hematology and infectious diseases | Fazio F, Lapietra G, Limongi MZ, Intoppa S, Milani ML, Piciocchi A, Martelli M, Guarini A, Foà R, De Propris MS, Petrucci MT |
| 2023 | 37773265 | 10.1038/s41375-023-02046-0 | Real-world evaluation of UK high hyperdiploidy profile using a large cohort of patients provided by HARMONY data platform. | Leukemia | Enshaei A, Martinez Elicegui J, Anguiano E, Gibson J, Lawal S, Ampatzidou M, Doubek M, Fielding AK, La Sala E, Middleton E, Rijneveld AW, Turki AT, Zimmermann M, Vora A, Moorman AV |
| 2023 | 36864210 | 10.1007/s00277-023-05149-x | The prognostic value of patient-reported outcomes in allogeneic hematopoietic stem cell transplantation: exploratory analysis of a randomized nutrition intervention trial. | Annals of hematology | Gudmundstuen AM, Efficace F, Tjønnfjord GE, Skaarud KJ, Cottone F, Hjermstad MJ, Iversen PO |
| 2023 | 37509317 | 10.3390/cancers15143656 | Stigma of Palliative Care among Patients with Advanced Cancer and Their Caregivers on Early Palliative Care. | Cancers | Bandieri E, Borelli E, Gilioli F, Bigi S, Mucciarini C, Ferrari U, Eliardo S, Pinto L, Porro CA, Efficace F, Luppi M, Potenza L |
| 2023 | 36799715 | 10.1111/bjh.18615 | Correction to "Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 study". | British journal of haematology | |
| 2023 | 36651780 | 10.2217/fon-2022-0512 | ENABLE: treatment combination including decitabine and venetoclax in acute myeloid leukemia secondary to myeloproliferative neoplasms. | Future oncology (London, England) | Mannelli F, Guglielmelli P, Fazi P, Crea E, Piciocchi A, Vignetti M, Amadori S, Pane F, Venditti A, Vannucchi AM |
| 2023 | 36724453 | 10.1182/blood.2022018604 | Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes. | Blood | Zeidan AM, Platzbecker U, Bewersdorf JP, Stahl M, Adès L, Borate U, Bowen D, Buckstein R, Brunner A, Carraway HE, Daver N, Díez-Campelo M, de Witte T, DeZern AE, Efficace F, Garcia-Manero G, Garcia JS, Germing U, Giagounidis A, Griffiths EA, Hasserjian RP, Hellström-Lindberg E, Iastrebner M, Komrokji R, Kulasekararaj AG, Malcovati L, Miyazaki Y, Odenike O, Santini V, Sanz G, Scheinberg P, Stauder R, van de Loosdrecht AA, Wei AH, Sekeres MA, Fenaux P |
| 2023 | 37762987 | 10.3390/jcm12186047 | Health-Related Quality-of-Life Profile of Pediatric Patients with β Thalassemia after Hematopoietic Stem Cell Transplantation. | Journal of clinical medicine | Mulas O, Efficace F, Orofino MG, Piroddi A, Piras E, Vacca A, Barella S, Costa A, Giesinger JM, La Nasa G, Caocci G |
| 2023 | 37392141 | 10.1002/hon.3199 | Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study. | Hematological oncology | Autore F, Innocenti I, Reda G, Visentin A, Vitale C, Piciocchi A, Fresa A, Leone MMA, Farina L, Quaresmini G, Baratè C, Giordano A, Ferrari A, Angeletti I, De Paolis MR, Malerba L, Chiurazzi F, Loseto G, Catania G, Sportoletti P, Scortechini I, Moia R, Gentile M, Rigolin GM, Mattiello V, Gattei V, Coscia M, Trentin L, Foà R, Cuneo A, Laurenti L |
| 2023 | 36672325 | 10.3390/cancers15020374 | Optimizing Molecular Minimal Residual Disease Analysis in Adult Acute Lymphoblastic Leukemia. | Cancers | Della Starza I, De Novi LA, Elia L, Bellomarino V, Beldinanzi M, Soscia R, Cardinali D, Chiaretti S, Guarini A, Foà R |
| 2023 | 37629308 | 10.3390/jcm12165267 | Italian Physicians' Perceptions about the Role of Asciminib in Later Lines Chronic Myeloid Leukemia in Clinical Practice: A GIMEMA Survey. | Journal of clinical medicine | Breccia M, Piciocchi A, Abruzzese E, Cilloni D, Messina M, Soddu S, Castagnetti F, Stagno F, Fazi P, Iurlo A, Caocci G, Gozzini A, Intermesoli T, D'Adda M, Pane F |
| 2023 | 33941573 | 10.1136/bmjspcare-2020-002312 | Fatigue in newly diagnosed acute myeloid leukaemia: general population comparison and predictive factors. | BMJ supportive & palliative care | Oswald LB, Venditti A, Cella D, Cottone F, Candoni A, Melillo L, Cairoli R, Storti G, Salutari P, Luppi M, Albano F, Martelli MP, Cuneo A, Tafuri A, Trisolini SM, Tieghi A, Fazi P, Vignetti M, Efficace F |
| 2023 | 37452789 | 10.1080/10428194.2023.2235450 | Digital droplet PCR for T315I BCR::ABL1 KD mutation assessment in adult Ph-positive acute lymphoblastic leukemia with a minimal residual disease increase. | Leukemia & lymphoma | Cardinali D, Beldinanzi M, Ansuinelli M, Elia L, Della Starza I, Bellomarino V, Matarazzo M, Di Trani M, Cola M, Salutari P, Cedrone M, Bassan R, De Gobbi M, Della Porta MG, De Simone M, Alati C, Fracchiolla NS, Lunghi M, Intermesoli T, Cardinali V, Mulè A, Guarini A, Foà R, Chiaretti S |
| 2023 | 37327116 | 10.1182/bloodadvances.2023010173 | Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting. | Blood advances | Attardi E, Savi A, Borsellino B, Piciocchi A, Cipriani M, Ottone T, Fabiani E, Divona M, Travaglini S, Pascale MR, Awada H, Durmaz A, Visconte V, Della Porta MG, Venditti A, Maciejewski JP, Gurnari C, Voso MT |
| 2023 | 37517504 | 10.1016/j.jclinepi.2023.07.012 | Information about missing patient-reported outcome data in breast cancer trials is frequently not documented: a scoping review. | Journal of clinical epidemiology | Krepper D, Giesinger JM, Dirven L, Efficace F, Martini C, Thurner AMM, Al-Naesan I, Gross F, Sztankay MJ |
| 2023 | 37408515 | 10.1177/11297298231185222 | Peripherally inserted central venous catheter for pediatric acute leukemia: A retrospective 11-year single-center experience. | The journal of vascular access | Ligia S, Morano SG, Kaiser F, Micozzi A, Chistolini A, Barberi W, Arena V, Piciocchi A, Forgione M, Gasperini G, Berneschi P, Testi AM |
| 2023 | 37208556 | 10.1007/s12325-023-02497-y | Ponatinib vs. Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Matching Adjusted Indirect Comparison. | Advances in therapy | Ribera JM, Prawitz T, Freitag A, Sharma A, Dobi B, Rizzo F, Sabatelli L, Patos P |
| 2023 | 36998457 | 10.3389/fonc.2023.1152467 | Research Topic: Measurable Residual Disease in Hematologic Malignancies. Can digital droplet PCR improve measurable residual disease monitoring in chronic lymphoid malignancies? | Frontiers in oncology | Assanto GM, Del Giudice I, Della Starza I, Soscia R, Cavalli M, Cola M, Bellomarino V, Di Trani M, Guarini A, Foà R |
| 2023 | 37914482 | 10.1016/S2352-3026(23)00273-9 | 10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial. | The Lancet. Haematology | Lübbert M, Wijermans PW, Kicinski M, Chantepie S, Van der Velden WJFM, Noppeney R, Griškevičius L, Neubauer A, Crysandt M, Vrhovac R, Luppi M, Fuhrmann S, Audisio E, Candoni A, Legrand O, Foà R, Gaidano G, van Lammeren-Venema D, Posthuma EFM, Hoogendoorn M, Giraut A, Stevens-Kroef M, Jansen JH, de Graaf AO, Efficace F, Ammatuna E, Vilque JP, Wäsch R, Becker H, Blijlevens N, Dührsen U, Baron F, Suciu S, Amadori S, Venditti A, Huls G, |
| 2023 | 37048630 | 10.3390/jcm12072547 | Long-Term Health-Related Quality of Life and Clinical Outcomes in Patients with β-Thalassemia after Splenectomy. | Journal of clinical medicine | Caocci G, Mulas O, Barella S, Orecchia V, Mola B, Costa A, Efficace F, La Nasa G |
| 2023 | 36263593 | 10.1111/bjh.18510 | Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia. | British journal of haematology | Pereira-Martins DA, Coelho-Silva JL, Weinhäuser I, Franca-Neto PL, Silveira DR, Ortiz C, Moreira-Aguiar A, Lima MM, Koury LC, de Melo RA, Glória AB, Fagundes EM, Lino BK, Pagnano K, Bittencourt R, Nunes E, Traina F, Figueiredo-Pontes L, Keating A, Tallman MS, Ribeiro RC, Dilon R, Ganser A, Sanz MA, Berliner N, Valk P, Löwenberg B, Ottone T, Noguera NI, Voso MT, Paoloni F, Fazi P, Ammatuna E, Huls G, Schuringa JJ, Rego EM, Lucena-Araujo AR |
| 2023 | 37634702 | 10.1016/j.jclinepi.2023.08.009 | The estimand framework had implications in time to patient-reported outcomes deterioration analyses in cancer clinical trials. | Journal of clinical epidemiology | Cottone F, Efficace F, Cella D, Aaronson NK, Giesinger JM, Bachet JB, Louvet C, Charton E, Collins GS, Anota A |
| 2023 | 36607832 | 10.1182/bloodadvances.2022008360 | Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study. | Blood advances | Stojkov I, Conrads-Frank A, Rochau U, Arvandi M, Koinig KA, Schomaker M, Mittelman M, Fenaux P, Bowen D, Sanz GF, Malcovati L, Langemeijer S, Germing U, Madry K, Guerci-Bresler A, Culligan DJ, Kotsianidis I, Sanhes L, Mills J, Puntscher S, Schmid D, van Marrewijk C, Smith A, Efficace F, de Witte T, Stauder R, Siebert U |
| 2023 | 37565394 | 10.7189/jogh.13.06031 | Global impacts of COVID-19 on lifestyles and health and preparation preferences: An international survey of 30 countries. | Journal of global health | Li J, Fong DYT, Lok KYW, Wong JYH, Man Ho M, Choi EPH, Pandian V, Davidson PM, Duan W, Tarrant M, Lee JJ, Lin CC, Akingbade O, Alabdulwahhab KM, Ahmad MS, Alboraie M, Alzahrani MA, Bilimale AS, Boonpatcharanon S, Byiringiro S, Hasan MKC, Schettini LC, Corzo W, De Leon JM, De Leon AS, Deek H, Efficace F, El Nayal MA, El-Raey F, Ensaldo-Carrasco E, Escotorin P, Fadodun OA, Fawole IO, Goh YS, Irawan D, Khan NE, Koirala B, Krishna A, Kwok C, Le TT, Leal DG, Lezana-Fernández MÁ, Manirambona E, Mantoani LC, Meneses-González F, Mohamed IE, Mukeshimana M, Nguyen CTM, Nguyen HTT, Nguyen KT, Nguyen ST, Nurumal MS, Nzabonimana A, Omer NAMA, Ogungbe O, Poon ACY, Reséndiz-Rodriguez A, Puang-Ngern B, Sagun CG, Shaik RA, Shankar NG, Sommer K, Toro E, Tran HTH, Urgel EL, Uwiringiyimana E, Vanichbuncha T, Youssef N |
| 2023 | 37781192 | 10.3389/fonc.2023.1213906 | Caregiver's quality of life in advanced cancer: validation of the construct in a real-life setting of early palliative care. | Frontiers in oncology | Borelli E, Bigi S, Potenza L, Gilioli F, Efficace F, Porro CA, Luppi M, Bandieri E |
| 2023 | 37861130 | 10.7189/jogh.13.04125 | Key lifestyles and interim health outcomes for effective interventions in general populations: A network analysis of a large international observational study. | Journal of global health | Li J, Fong DYT, Lok KYW, Wong JYH, Ho MM, Choi EPH, Pandian V, Davidson PM, Duan W, Tarrant M, Lee JJ, Lin CC, Akingbade O, Alabdulwahhab KM, Ahmad MS, Alboraie M, Alzahrani MA, Bilimale AS, Boonpatcharanon S, Byiringiro S, Hasan MKC, Schettini LC, Corzo W, De Leon JM, De Leon AS, Deek H, Efficace F, El Nayal MA, El-Raey F, Ensaldo-Carrasco E, Escotorin P, Fadodun OA, Fawole IO, Goh YS, Irawan D, Khan NE, Koirala B, Krishna A, Kwok C, Le TT, Leal DG, Lezana-Fernández MÁ, Manirambona E, Mantoani LC, Meneses-González F, Mohamed IE, Mukeshimana M, Nguyen CTM, Nguyen HTT, Nguyen KT, Nguyen ST, Nurumal MS, Nzabonimana A, Omer NAMA, Ogungbe O, Poon ACY, Reséndiz-Rodriguez A, Puang-Ngern B, Sagun CG, Shaik RA, Shankar NG, Sommer K, Toro E, Tran HTH, Urgel EL, Uwiringiyimana E, Vanichbuncha T, Youssef N |
| 2023 | 37663671 | 10.1097/HS9.0000000000000944 | Health-related Quality of Life Profile of Newly Diagnosed Patients With Myelodysplastic Syndromes by Age, Sex, and Risk Group: A Real-world Study by the GIMEMA. | HemaSphere | Efficace F, Al Essa W, Platzbecker U, Niscola P, Palumbo GA, Caocci G, Cottone F, Breccia M, Luppi M, Stauder R, Ricco A, Petranovic D, Baron F, Voso MT, Fianchi L, Frairia C, Capodanno I, Sarlo C, Fedele M, Lemoli RM, Invernizzi R, Vallisa D, Di Renzo N, Fozza C, Doro M, Giesinger JM, Vignetti M |
| 2023 | 37751995 | 10.1136/spcare-2023-004524 | Early palliative care versus usual haematological care in multiple myeloma: retrospective cohort study. | BMJ supportive & palliative care | Giusti D, Colaci E, Pioli V, Banchelli F, Maccaferri M, Leonardi G, Marasca R, Morselli M, Forghieri F, Bettelli F, Cuoghi A, Bresciani P, Messerotti A, Gilioli A, Candoni A, Cassanelli L, Sbadili E, Bassoli I, Longo G, Gilioli F, Borelli E, Bigi S, D'Amico R, Porro CA, Odejide O, Zimmermann C, Efficace F, Bruera E, Luppi M, Bandieri E, Potenza L |
| 2023 | 36632738 | 10.3324/haematol.2022.282116 | High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study. | Haematologica | Mauro FR, Starza ID, Messina M, Reda G, Trentin L, Coscia M, Sportoletti P, Orsucci L, Arena V, Casaluci GM, Marasca R, Murru R, Laurenti L, Ilariucci F, Stelitano C, Mannina D, Massaia M, Rigolin GM, Scarfò L, Marchetti M, Levato L, Tani M, Arcari A, Musuraca G, Deodato M, Galieni P, Patrizi VB, Gottardi D, Liberati AM, Giordano A, Molinari MC, Pietrasanta D, Mattiello V, Visentin A, Vitale C, Albano F, Neri A, De Novi LA, De Propris MS, Nanni M, Del Giudice I, Guarini A, Fazi P, Vignetti M, Piciocchi A, Cuneo A, Foà R |
| 2023 | 38052104 | 10.1016/j.esmoop.2023.102192 | Confirmatory validation analysis of the PROFFIT questionnaire to assess financial toxicity in cancer patients. | ESMO open | Arenare L, Porta C, Barberio D, Terzolo S, Zagonel V, Pisconti S, Del Mastro L, Pinto C, Bilancia D, Cinieri S, Rizzo M, Migliaccio G, Montesarchio V, Del Campo L, De Lorenzo F, Iannelli E, Traclò F, Gitto L, Vaccaro MC, Frontini L, Giannarelli D, Bryce J, Piccirillo MC, Jommi C, Efficace F, Riva S, Di Maio M, Gallo C, Perrone F |
| 2023 | 36546426 | 10.3324/haematol.2022.282268 | Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study. | Haematologica | Benintende G, Innocenti I, Fresa A, Autore F, Tomasso A, Piciocchi A, Vuono F, Stirparo L, Mosca A, Bacigalupo A, Gattei V, Efremov D, Sangiorgi E, Laurenti L |
| 2023 | 36320128 | 10.1093/oncolo/oyac227 | Perceptions of Death Among Patients with Advanced Cancer Receiving Early Palliative Care and Their Caregivers: Results from a Mixed-Method Analysis. | The oncologist | Bigi S, Ganfi V, Borelli E, Potenza L, Artioli F, Eliardo S, Mucciarini C, Cottafavi L, Ferrari U, Lombardo L, Cagossi K, Pietramaggiori A, Fantuzzi V, Bernardini I, Cruciani M, Cacciari C, Odejide O, Adolfo Porro C, Zimmermann C, Efficace F, Bruera E, Luppi M, Bandieri E |
| 2023 | 37704469 | 10.1016/j.blre.2023.101128 | Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS). | Blood reviews | Stahl M, Bewersdorf JP, Xie Z, Porta MGD, Komrokji R, Xu ML, Abdel-Wahab O, Taylor J, Steensma DP, Starczynowski DT, Sekeres MA, Sanz G, Sallman DA, Roboz GJ, Platzbecker U, Patnaik MM, Padron E, Odenike O, Nimer SD, Nazha A, Majeti R, Loghavi S, Little RF, List AF, Kim TK, Hourigan CS, Hasserjian RP, Halene S, Griffiths EA, Gore SD, Greenberg P, Figueroa ME, Fenaux P, Efficace F, DeZern AE, Daver NG, Churpek JE, Carraway HE, Buckstein R, Brunner AM, Boultwood J, Borate U, Bejar R, Bennett JM, Wei AH, Santini V, Savona MR, Zeidan AM |
| 2023 | 36533589 | 10.1080/10428194.2022.2148217 | ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings. | Leukemia & lymphoma | Chiaretti S, Taherinasab A, Della Starza I, Canichella M, Ansuinelli M, De Propris MS, Messina M, Spinelli O, Santoro A, De Novi LA, Cardinali D, Schipani M, Arena V, Bassan R, Guarini A, Foà R |
| 2023 | 36260702 | 10.1182/bloodadvances.2022008747 | An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS. | Blood advances | Stahl M, Abdel-Wahab O, Wei AH, Savona MR, Xu ML, Xie Z, Taylor J, Starczynowski D, Sanz GF, Sallman DA, Santini V, Roboz GJ, Patnaik MM, Padron E, Odenike O, Nazha A, Nimer SD, Majeti R, Little RF, Gore S, List AF, Kutchroo V, Komrokji RS, Kim TK, Kim N, Hourigan CS, Hasserjian RP, Halene S, Griffiths EA, Greenberg PL, Figueroa M, Fenaux P, Efficace F, DeZern AE, Della Porta MG, Daver NG, Churpek JE, Carraway HE, Brunner AM, Borate U, Bennett JM, Bejar R, Boultwood J, Loghavi S, Bewersdorf JP, Platzbecker U, Steensma DP, Sekeres MA, Buckstein RJ, Zeidan AM |
| 2023 | 36251440 | 10.1002/hon.3087 | Circulating cell-free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre-analytical biases. | Hematological oncology | Soscia R, Della Starza I, De Novi LA, Ilari C, Ansuinelli M, Cavalli M, Bellomarino V, Cafforio L, Di Trani M, Cazzaniga G, Fazio G, Santoro A, Salemi D, Spinelli O, Tosi M, Terragna C, Robustelli V, Bellissimo T, Colafigli G, Breccia M, Chiaretti S, Di Rocco A, Martelli M, Guarini A, Del Giudice I, Foà R |
| 2023 | 37693118 | 10.1177/20406207231190683 | Impact on mental health, disease management, and socioeconomic modifications in hematological patients during the COVID-19 pandemic in Italy. | Therapeutic advances in hematology | De Muro M, Janssen AJ, Amadori S, de Fabritiis P, Sabatino D, Niscola P, Torti L, Trawinska MM, Tesei C, Bombaci F, Tarricone M, Bocchia M, Fava C, Galimberti S, Iurlo A, Luciano L, Abruzzese E |
| 2023 | 35661436 | 10.1002/cam4.4892 | Comprehensive global collaboration in the care of 1182 pediatric oncology patients over 12 years: The Iraqi-Italian experience. | Cancer medicine | Al-Jadiry MF, Uccini S, Testi AM, Moleti ML, Alsaadawi AR, Al-Darraji AF, Al-Saeed RM, Faraj Al-Badri SA, Sabhan AH, Ghali HH, Fadhil SA, Abed WM, Ameen NA, Abed YS, Yousif FS, Abed AR, Hussein HM, Shkara AM, Piciocchi A, Mohamed S, Ruco L, Qaddoumi I, Al-Hadad SA |
| 2023 | 36533415 | 10.1002/cam4.5487 | Raising the standards of patient-centered outcomes research in myelodysplastic syndromes: Clinical utility and validation of the subscales of the QUALMS from the MDS-RIGHT project. | Cancer medicine | Efficace F, Koinig K, Cottone F, Bowen D, Mittelman M, Sommer K, Langemeijer S, Culligan D, Filanovsky K, Storck M, Smith A, van Marrewijk C, Dugas M, Stojkov I, Siebert U, de Witte T, Stauder R |
| 2022 | 36102777 | 10.1016/S2666-7568(22)00172-6 | Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study. | The lancet. Healthy longevity | Efficace F, Gaidano G, Petrucci MT, Niscola P, Cottone F, Codeluppi K, Antonioli E, Tafuri A, Larocca A, Potenza L, Fozza C, Pastore D, Rigolin GM, Offidani M, Romano A, Kyriakou C, Cascavilla N, Gozzetti A, Derudas D, Vignetti M, Cavo M |
| 2022 | 35740677 | 10.3390/cancers14123012 | Prevalence and Prognostic Role of IDH Mutations in Acute Myeloid Leukemia: Results of the GIMEMA AML1516 Protocol. | Cancers | Messina M, Piciocchi A, Ottone T, Paolini S, Papayannidis C, Lessi F, Fracchiolla NS, Forghieri F, Candoni A, Mengarelli A, Martelli MP, Venditti A, Carella AM, Albano F, Mancini V, Massimo B, Arena V, Sargentini V, Sciumè M, Pastore D, Todisco E, Roti G, Siragusa S, Ladetto M, Pravato S, De Bellis E, Simonetti G, Marconi G, Cerchione C, Fazi P, Vignetti M, Amadori S, Martinelli G, Voso MT |
| 2022 | 35641207 | 10.1093/oncolo/oyab027 | Perceptions of Hope Among Bereaved Caregivers of Cancer Patients Who Received Early Palliative Care: A Content and Lexicographic Analysis. | The oncologist | Bigi S, Ganfi V, Borelli E, Potenza L, Artioli F, Eliardo S, Mucciarini C, Cottafavi L, Cruciani M, Cacciari C, Odejide O, Porro CA, Zimmermann C, Efficace F, Bruera E, Luppi M, Bandieri E |
| 2022 | 35789375 | 10.1182/bloodadvances.2022006964 | Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study. | Blood advances | Fresa A, Autore F, Piciocchi A, Catania G, Visentin A, Tomasso A, Moretti M, Vitale C, Chiarenza A, Morelli F, Sportoletti P, Marasca R, Sapienza G, Cuccaro A, Murru R, Sanna A, Patti C, Angeletti I, Coscia M, Trentin L, Pietrasanta D, Innocenti I, Laurenti L |
| 2022 | 35710027 | 10.1016/j.jmoldx.2022.04.014 | Digital Droplet PCR Is a Reliable Tool to Improve Minimal Residual Disease Stratification in Adult Philadelphia-Negative Acute Lymphoblastic Leukemia. | The Journal of molecular diagnostics : JMD | Della Starza I, De Novi LA, Santoro A, Salemi D, Spinelli O, Tosi M, Soscia R, Paoloni F, Cappelli LV, Cavalli M, Apicella V, Bellomarino V, Di Lello E, Vitale A, Vignetti M, Fabbiano F, Rambaldi A, Bassan R, Guarini A, Chiaretti S, Foà R |
| 2022 | 35963940 | 10.1038/s41375-022-01675-1 | Covid-19 in Philadelphia-negative myeloproliferative neoplasms: a GIMEMA survey on incidence, clinical management and vaccine. | Leukemia | Breccia M, Piciocchi A, Messina M, Soddu S, De Stefano V, Bellini M, Iurlo A, Martino B, Siragusa S, Albano F, Mora B, Fazi P, Vignetti M, Guglielmelli P, Palandri F |
| 2022 | 35617025 | 10.1111/ejh.13804 | Autologous stem cell transplantation in multiple myeloma patients over 70 years: A GIMEMA Lazio Working Group experience in a retrospective case-control study. | European journal of haematology | Rago A, Annibali O, Tomarchio V, Coppetelli U, Fazio F, Cupelli L, Fiorini A, Piciocchi A, Tafuri A, Caravita di Toritto T |
| 2022 | 34508610 | 10.1093/jnci/djab177 | Impact of Blinding on Patient-Reported Outcome Differences Between Treatment Arms in Cancer Randomized Controlled Trials. | Journal of the National Cancer Institute | Efficace F, Cella D, Aaronson NK, Calvert M, Cottone F, Di Maio M, Perrone F, Sparano F, Gamper EM, Vignetti M, Giesinger JM |
| 2022 | 35913396 | 10.1080/10428194.2022.2105328 | Childhood acute promyelocytic leukemia in a pediatric cancer referral center in Baghdad, Iraq. Improved results with ATRA extended consolidation. | Leukemia & lymphoma | Testi AM, Al-Jadiry MF, Ghali HH, Fadhil SA, Al-Darraji AF, Al-Saeed RM, Sabhan AH, Al-Badri SAF, Abed WM, Ameen NA, Al-Tameemi RZ, Al-Assaf AI, Moleti ML, Arena V, Piciocchi A, Foà R, Al-Hadad SA |
| 2022 | 36266326 | 10.1038/s41375-022-01724-9 | Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes. | Leukemia | Zeidan AM, Bewersdorf JP, Buckstein R, Sekeres MA, Steensma DP, Platzbecker U, Loghavi S, Boultwood J, Bejar R, Bennett JM, Borate U, Brunner AM, Carraway H, Churpek JE, Daver NG, Della Porta M, DeZern AE, Efficace F, Fenaux P, Figueroa ME, Greenberg P, Griffiths EA, Halene S, Hasserjian RP, Hourigan CS, Kim N, Kim TK, Komrokji RS, Kutchroo V, List AF, Little RF, Majeti R, Nazha A, Nimer SD, Odenike O, Padron E, Patnaik MM, Roboz GJ, Sallman DA, Sanz G, Stahl M, Starczynowski DT, Taylor J, Xie Z, Xu M, Savona MR, Wei AH, Abdel-Wahab O, Santini V |
| 2022 | 35622321 | 10.1007/978-1-0716-2115-8_5 | Minimal Residual Disease Analysis by Monitoring Immunoglobulin and T-Cell Receptor Gene Rearrangements by Quantitative PCR and Droplet Digital PCR. | Methods in molecular biology (Clifton, N.J.) | Starza ID, Eckert C, Drandi D, Cazzaniga G, |
| 2022 | 34492684 | 10.1182/bloodadvances.2021004568 | Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologists. | Blood advances | Stojkov I, Conrads-Frank A, Rochau U, Koinig KA, Arvandi M, Puntscher S, van Marrewijk C, Fenaux P, Symeonidis A, Chermat F, Garelius H, Bowen D, Mittelman M, Mora E, de Witte T, Efficace F, Siebert U, Stauder R |
| 2022 | 35158746 | 10.3390/cancers14030478 | Early Palliative Care in Acute Myeloid Leukemia. | Cancers | Potenza L, Borelli E, Bigi S, Giusti D, Longo G, Odejide O, Porro CA, Zimmermann C, Efficace F, Bruera E, Luppi M, Bandieri E |
| 2022 | 34491364 | 10.1093/jnci/djab185 | Quality of Life Improvements in Patients With Chronic Myeloid Leukemia After Stopping Long-Term Therapy: Who Can Benefit the Most? | Journal of the National Cancer Institute | Efficace F, Baccarani M |
| 2022 | 34521609 | 10.1016/j.jgo.2021.09.007 | Patient-reported outcomes predict overall survival in older patients with acute myeloid leukemia. | Journal of geriatric oncology | Peipert JD, Efficace F, Pierson R, Loefgren C, Cella D, He J |
| 2022 | 35133227 | 10.1080/10428194.2022.2032035 | Blast morphology in the diagnostic work-up of Ph-like acute lymphoblastic leukemia. | Leukemia & lymphoma | Fazio F, Cunsolo G, Mancini F, De Propris MS, Piciocchi A, Arena V, Messina M, Ansuinelli M, Taherinasab AT, Apicella V, Vitale A, Chiaretti S, Guarini A, Del Giudice I, Foà R |
| 2022 | 35853850 | 10.1038/s41408-022-00702-9 | Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study. | Blood cancer journal | Pagano L, Criscuolo M, Broccoli A, Piciocchi A, Varettoni M, Galli E, Anastasia A, Cantonetti M, Trentin L, Kovalchuk S, Orsucci L, Frustaci A, Spolzino A, Volpetti S, Annibali O, Storti S, Stelitano C, Marchesi F, Offidani M, Casadei B, Nizzoli ME, De Luca ML, Fianchi L, Motta M, Guarnera L, Simonetti E, Visentin A, Vassallo F, Deodato M, Sarlo C, Olivieri A, Falini B, Pulsoni A, Tiacci E, Zinzani PL |
| 2022 | 36504547 | 10.1097/HS9.0000000000000802 | Chimeric Antigen Receptor T-cell Therapy in Hematologic Malignancies and Patient-reported Outcomes: A Scoping Review. | HemaSphere | Efficace F, Cannella L, Sparano F, Giesinger JM, Vignetti M, Baron F, Bruera E, Luppi M, Platzbecker U |
| 2022 | 35255152 | 10.1111/bjh.18072 | International validation of the EORTC QLQ-CLL17 questionnaire for assessment of health-related quality of life for patients with chronic lymphocytic leukaemia. | British journal of haematology | Oerlemans S, Efficace F, Kieffer JM, Kyriakou C, Xochelli A, Levedahl K, Petranovic D, Borges FC, Bredart A, Shamieh O, Gziskevicius L, Lehmann J, Scholz CW, Caocci G, Molica S, Stamatopoulos K, Panteliadou AK, Papaioannou M, Alrjoob W, Baliakas P, Rosenquist R, Malak S, Miranda A, Cocks K, van de Poll-Franse L, |
| 2022 | 36353529 | 10.3389/fonc.2022.991250 | Gratitude among advanced cancer patients and their caregivers: The role of early palliative care. | Frontiers in oncology | Borelli E, Bigi S, Potenza L, Gilioli F, Artioli F, Porzio G, Porro CA, Efficace F, Bruera E, Luppi M, Bandieri E |
| 2022 | 35098366 | 10.1007/s00277-021-04750-2 | Health-related quality of life profile of patients with immune thrombocytopenia in the real life is impaired by splenectomy. | Annals of hematology | Caocci G, Efficace F, Mulas O, Cottone F, Maxia A, Costa A, Simula MP, Usala E, La Nasa G |
| 2022 | 35846211 | 10.1002/jha2.359 | Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio group. | EJHaem | Fazio F, Franceschini L, Tomarchio V, Rago A, Garzia MG, Cupelli L, Bongarzoni V, Andriani A, Gumenyuk S, Tafuri A, Siniscalchi A, Piciocchi A, De Fabritiis P, De Rosa L, Caravita di Toritto T, Annibali O, Cantonetti M, Petrucci MT |
| 2022 | 34649276 | 10.1182/bloodadvances.2021004821 | INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemia. | Blood advances | Martinelli G, Papayannidis C, Piciocchi A, Robustelli V, Soverini S, Terragna C, Marconi G, Lemoli RM, Guolo F, Fornaro A, Lunghi M, de Fabritiis P, Candoni A, Selleri C, Simonetti F, Bocchia M, Vitale A, Frison L, Tedeschi A, Cuneo A, Bonifacio M, Martelli MP, D'Ardia S, Trappolini S, Tosi P, Galieni P, Fabbiano F, Abbenante MC, Granier M, Zhu Z, Wang M, Sartor C, Paolini S, Cavo M, Foà R, Fazi P, Vignetti M, Baccarani M |
| 2022 | 35322932 | 10.1002/cam4.4692 | Patient-reported outcomes provide prognostic information for survival in patients with diffuse large B-cell lymphoma: Analysis of 1239 patients from the GOYA study. | Cancer medicine | Huang H, Datye A, Fan M, Knapp A, Nielsen T, Bottos A, Paulson JN, Trask PC, Efficace F |
| 2022 | 35372079 | 10.3389/fonc.2022.826040 | Physicians' Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Practice. Evidence From the GIMEMA-ALLIANCE Platform. | Frontiers in oncology | Efficace F, Patriarca A, Luppi M, Potenza L, Caocci G, Tafuri A, Fazio F, Cartoni C, Petrucci MT, Carmosino I, Moia R, Margiotta Casaluci G, Boggione P, Colaci E, Giusti D, Pioli V, Sparano F, Cottone F, De Fabritiis P, Ardu NR, Niscola P, Capodanno I, Leporace AP, Pelliccia S, Lugli E, La Sala E, Rigacci L, Santopietro M, Fozza C, Siragusa S, Breccia M, Fazi P, Vignetti M |
| 2022 | 35906881 | 10.1111/bjh.18385 | Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 study. | British journal of haematology | Marasco V, Piciocchi A, Candoni A, Pagano L, Guidetti A, Musto P, Bruna R, Bocchia M, Visentin A, Turrini M, Tucci A, Pilerci S, Fianchi L, Salvini M, Galimberti S, Coviello E, Selleri C, Luppi M, Crea E, Fazi P, Passamonti F, Corradini P |
| 2022 | 35199505 | 10.3324/haematol.2021.280325 | Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study. | Haematologica | Innocenti I, Reda G, Visentin A, Coscia M, Motta M, Murru R, Moia R, Gentile M, Pennese E, Quaglia FM, Albano F, Cassin R, Deodato M, Ielo C, Frustaci AM, Piciocchi A, Rughini A, Arena V, Di Sevo D, Tomasso A, Autore F, Del Poeta G, Scarfò L, Mauro FR, Tedeschi A, Trentin L, Pompili M, Foà R, Ghia P, Cuneo A, Laurenti L |
| 2022 | 35315128 | 10.1002/ajh.26537 | Repeated infusions of escalating doses of expanded and activated autologous natural killer cells in minimal residual disease-positive Ph+ acute lymphoblastic leukemia patients. A GIMEMA phase 1 trial. | American journal of hematology | Torelli GF, Chiaretti S, Peragine N, Barberi W, Santodonato L, D'Agostino G, Abruzzese E, Del Principe MI, Mancino A, Matarazzo M, Bafti MS, Mancini M, Messina M, Castiello L, Guarini A, Foà R |
| 2022 | 35295076 | 10.3324/haematol.2021.279777 | Clinical relevance of an objective flow cytometry approach based on limit of detection and limit of quantification for measurable residual disease assessment in acute myeloid leukemia. A post-hoc analysis of the GIMEMA AML1310 trial. | Haematologica | Buccisano F, Palmieri R, Piciocchi A, Arena V, Maurillo L, Del Principe MI, Paterno G, Irno-Consalvo MA, Ottone T, Divona M, Conti C, Fraboni D, Lavorgna S, Arcese W, Voso MT, Venditti A |
| 2022 | 34647439 | 10.3324/haematol.2020.263715 | Treatment with ibrutinib does not induce a clonal evolution in chronic lymphocytic leukemia. | Haematologica | Cafforio L, Raponi S, Cappelli LV, Ilari C, Soscia R, De Propris MS, Mariglia P, Rigolin GM, Bardi A, Peragine N, Piciocchi A, Arena V, Mauro FR, Cuneo A, Guarini A, Foa R, Del Giudice I |
| 2022 | 35183476 | 10.1016/j.clml.2022.01.009 | Patient-Reported Outcomes in Randomized Controlled Trials of Patients with Multiple Myeloma: A Systematic Literature Review of Studies Published Between 2014 and 2021. | Clinical lymphoma, myeloma & leukemia | Efficace F, Cottone F, Sparano F, Caocci G, Vignetti M, Chakraborty R |
| 2022 | 32680895 | 10.1136/bmjspcare-2020-002281 | Acute promyelocytic leukaemia long-term survivors: higher fatigue and greater overall symptom burden. | BMJ supportive & palliative care | Sommer K, Vignetti M, Cottone F, Breccia M, Annibali O, Luppi M, Intermesoli T, Borlenghi E, Carluccio P, Rodeghiero F, Fabbiano F, Romani C, Sborgia M, Martino B, Crugnola M, Efficace F |
| 2022 | 35610611 | 10.1186/s12889-022-13211-y | EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1,036 individuals. | BMC public health | Pilz MJ, Gamper EM, Efficace F, Arraras JI, Nolte S, Liegl G, Rose M, Giesinger JM, |
| 2022 | 34806525 | 10.1080/10428194.2021.2005042 | CD34 + CD38-CLL1+ leukemic stem cells persistence measured by multiparametric flow cytometry is a biomarker of poor prognosis in adult patients with acute myeloid leukemia. | Leukemia & lymphoma | Palmieri R, Buccisano F, Arena V, Irno Consalvo MA, Piciocchi A, Maurillo L, DelPrincipe MI, Di Veroli A, Paterno G, Conti C, Fraboni D, Voso MT, Arcese W, Venditti A |
| 2022 | 34731884 | 10.1182/bloodadvances.2021005717 | ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol. | Blood advances | Buccisano F, Palmieri R, Piciocchi A, Arena V, Candoni A, Melillo L, Calafiore V, Cairoli R, de Fabritiis P, Storti G, Salutari P, Lanza F, Martinelli G, Luppi M, Capria S, Maurillo L, Del Principe MI, Paterno G, Irno Consalvo MA, Ottone T, Lavorgna S, Voso MT, Fazi P, Vignetti M, Arcese W, Venditti A |
| 2022 | 35385922 | 10.3324/haematol.2021.280175 | Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study. | Haematologica | Gugliotta G, Castagnetti F, Breccia M, Levato L, Intermesoli T, D'Adda M, Salvucci M, Stagno F, Rege-Cambrin G, Tiribelli M, Martino B, Bocchia M, Cedrone M, Trabacchi E, Cavazzini F, Porretto F, Sorà F, Simula MP, Albano F, Soverini S, Foà R, Pane F, Cavo M, Saglio G, Baccarani M, Rosti G |
| 2022 | 36071048 | 10.1038/s41408-022-00724-3 | Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide. | Blood cancer journal | Gurnari C, Piciocchi A, Soddu S, Bonanni F, Scalzulli E, Niscola P, Di Veroli A, Piccioni AL, Piedimonte M, Maiorana G, Salutari P, Cicconi L, Santopietro M, Gumenyuk S, Sarlo C, Fenu S, Tafuri A, Latagliata R, Fianchi L, Criscuolo M, Maciejewski JP, Maurillo L, Buccisano F, Breccia M, Voso MT |
| 2021 | 33655199 | 10.1097/HS9.0000000000000543 | Droplet Digital PCR Improves IG-/TR-based MRD Risk Definition in Childhood B-cell Precursor Acute Lymphoblastic Leukemia. | HemaSphere | Della Starza I, Nunes V, Lovisa F, Silvestri D, Cavalli M, Garofalo A, Campeggio M, De Novi LA, Soscia R, Oggioni C, Mussolin L, Biondi A, Guarini A, Valsecchi MG, Conter V, Biffi A, Basso G, Foà R, Cazzaniga G |
| 2021 | 33153355 | 10.1080/10428194.2020.1838509 | Validation and reference values of the EORTC QLQ-CML24 questionnaire to assess health-related quality of life in patients with chronic myeloid leukemia. | Leukemia & lymphoma | Efficace F, Iurlo A, Patriarca A, Stagno F, Bee PC, Ector G, Capodanno I, Elena C, Bonifacio M, Blijlevens NMA, Caocci G, Wan C, Abruzzese E, Breccia M, Cottone F, Okumura I, Oerlemans S, Cascavilla N, Albano F, Kota V, Sztankay M, Miggiano MC, Saussele S, Di Renzo N, Sorà F, Castagnetti F, Baccarani M, Vignetti M, Rosti G |
| 2021 | 34514343 | 10.1097/HS9.0000000000000639 | Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network. | HemaSphere | Mantoan B, Genuardi E, Ferrante M, Della Starza I, Ciabatti E, Grassi S, De Novi LA, Cavalli M, Mannu C, Gazzola A, Bomben R, Degan M, Alessandria B, Pott C, Delfau-Larue MH, García-Sanz R, Agostinelli C, Gattei V, Galimberti S, Del Giudice I, Gaidano G, Ladetto M, Ferrero S, Drandi D |
| 2021 | 33840437 | 10.1016/j.jval.2020.11.004 | Past and Current Practice of Patient-Reported Outcome Measurement in Randomized Cancer Clinical Trials: A Systematic Review. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | Giesinger JM, Efficace F, Aaronson N, Calvert M, Kyte D, Cottone F, Cella D, Gamper EM |
| 2021 | 33538150 | 10.3324/haematol.2020.260935 | A multicenter total therapy strategy for adult Philadelphia chromosome positive acute lymphoblastic leukemia patients: final results of the GIMEMA LAL1509 protocol. | Haematologica | Chiaretti S, Ansuinelli M, Vitale A, Elia L, Matarazzo M, Piciocchi A, Fazi P, Di Raimondo F, Santoro L, Fabbiano F, Califano C, Martinelli G, Ronco F, Ferrara F, Cascavilla N, Bigazzi C, Tedeschi A, Sica S, Di Renzo N, Melpignano A, Beltrami G, Vignetti M, Foa R |
| 2021 | 33462837 | 10.1002/hon.2837 | Non-overt disseminated intravascular coagulopathy associated with the first obinutuzumab administration in patients with chronic lymphocytic leukemia. | Hematological oncology | Fresa A, Autore F, Innocenti I, Piciocchi A, Tomasso A, Morelli F, Sorà F, Sica S, De Stefano V, Laurenti L |
| 2021 | 33739461 | 10.1002/hon.2861 | Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group. | Hematological oncology | Rigolin GM, Cavazzini F, Piciocchi A, Arena V, Visentin A, Reda G, Zamprogna G, Cibien F, Vitagliano O, Coscia M, Farina L, Gaidano G, Murru R, Varettoni M, Paolini R, Sportoletti P, Pietrasanta D, Molinari AL, Quaglia FM, Laurenti L, Marasca R, Marchetti M, Mauro FR, Crea E, Vignetti M, Gentile M, Montillo M, Foà R, Cuneo A, |
| 2021 | 33528611 | 10.1007/s00277-020-04374-y | Daratumumab in multiple myeloma: experience of the multiple myeloma GIMEMA Lazio group. | Annals of hematology | Vozella F, Siniscalchi A, Rizzo M, Za T, Antolino G, Coppetelli U, Piciocchi A, Andriani A, Annibali O, De Rosa L, Cimino G, La Verde G, De Stefano V, Cantonetti M, di Toritto TC, Petrucci MT |
| 2021 | 34355644 | 10.1080/10428194.2021.1961237 | Treatment of childhood acute lymphoblastic leukemia in Iraq: a 17-year experience from a single center. | Leukemia & lymphoma | Al-Hadad SA, Al-Jadiry MF, Ghali HH, Al-Badri SAF, Al-Saeed RM, Al-Darraji AF, Sabhan AH, Fadhil SA, Hussein HM, Abed WM, Ameen NA, Sahan JKA, Jaafar GQ, Abed AR, Mohamed S, Moleti ML, Piciocchi A, Foà R, Testi AM |
| 2021 | 34002030 | 10.1038/s41375-021-01292-4 | Eutos long-term survival score discriminates different Sokal score categories in chronic myeloid leukemia patients, showing better survival prediction. Analysis of the GIMEMA CML observational study. | Leukemia | Breccia M, Pregno P, Castagnetti F, Bonifacio M, Tiribelli M, Gozzini A, Scortechini AR, Luciano L, Martino B, Stagno F, Caocci G, La Barba G, Pizzuti M, Ciccone G, Saglio G, Specchia G |
| 2021 | 33890580 | 10.2196/25271 | The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational Study. | JMIR research protocols | Efficace F, Breccia M, Fazi P, Cottone F, Holzner B, Vignetti M |
| 2021 | 33150691 | 10.1002/onco.13587 | COVID-19 Pandemic and Cancer: The Importance of Early Palliative Care. | The oncologist | Potenza L, Luppi M, Efficace F, Bruera E, Bandieri E |
| 2021 | 33937038 | 10.3389/fonc.2021.637186 | TH2/TH1 Shift Under Ibrutinib Treatment in Chronic Lymphocytic Leukemia. | Frontiers in oncology | Puzzolo MC, Del Giudice I, Peragine N, Mariglia P, De Propris MS, Cappelli LV, Trentin L, Reda G, Cuneo A, Molica S, Piciocchi A, Arena V, Mauro FR, Guarini A, Foà R |
| 2021 | 34750145 | 10.1136/bmjspcare-2021-002898 | Early palliative/supportive care in acute myeloid leukaemia allows low aggression end-of-life interventions: observational outpatient study. | BMJ supportive & palliative care | Potenza L, Scaravaglio M, Fortuna D, Giusti D, Colaci E, Pioli V, Morselli M, Forghieri F, Bettelli F, Messerotti A, Catellani H, Gilioli A, Marasca R, Borelli E, Bigi S, Longo G, Banchelli F, D'Amico R, L Back A, Efficace F, Bruera E, Luppi M, Bandieri E |
| 2021 | 33788893 | 10.1371/journal.pone.0248755 | Different semantic and affective meaning of the words associated to physical and social pain in cancer patients on early palliative/supportive care and in healthy, pain-free individuals. | PloS one | Borelli E, Bigi S, Potenza L, Artioli F, Eliardo S, Mucciarini C, Cagossi K, Razzini G, Pasqualini A, Lui F, Ferlazzo F, Cruciani M, Bruera E, Efficace F, Luppi M, Cacciari C, Porro CA, Bandieri E |
| 2021 | 33284999 | 10.1002/ajh.26066 | Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric-like GIMEMA LAL-1308 trial. | American journal of hematology | Testi AM, Canichella M, Vitale A, Piciocchi A, Guarini A, Starza ID, Cavalli M, De Propris MS, Messina M, Elia L, Moleti ML, Martino B, Luppi M, D'Aloisio M, Candoni A, Conter V, Fazi P, Vignetti M, Chiaretti S, Foà R |
| 2021 | 33165751 | 10.1007/s11523-020-00769-z | Developing Symptom Lists for People with Cancer Treated with Targeted Therapies. | Targeted oncology | Sodergren SC, Wheelwright SJ, Fitzsimmons D, Efficace F, Sprangers M, Fayers P, Harle A, Schmidt H, Bottomley A, Darlington AS, Benson C, Bredart A, Hentschel L, Arraras JI, Ioannidis G, Leahy M, Lugowska I, Nicolatou-Galitis O, Petranovic D, Rohde GE, Vassiliou V, Johnson CD, |
| 2021 | 33518032 | 10.1016/j.jval.2020.10.017 | Patient-Reported Outcomes as Independent Prognostic Factors for Survival in Oncology: Systematic Review and Meta-Analysis. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | Efficace F, Collins GS, Cottone F, Giesinger JM, Sommer K, Anota A, Schlussel MM, Fazi P, Vignetti M |
| 2021 | 33094357 | 10.1007/s00520-020-05840-z | A qualitative analysis and development of a conceptual model assessing financial toxicity in cancer patients accessing the universal healthcare system. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | Riva S, Efficace F, Di Maio M, Bryce J, Del Campo L, De Lorenzo F, Frontini L, Giannarelli D, Gitto L, Iannelli E, Jommi C, Montesarchio V, Traclò F, Vaccaro CM, Arenare L, Canzanella G, Gimigliano A, Romano F, Savio A, Sparavigna L, Piccirillo MC, Guizzaro L, Gallo C, Perrone F |
| 2021 | 33554672 | 10.1080/17474086.2021.1886918 | Optimizing health-related quality of life in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors. | Expert review of hematology | Efficace F, Vignetti M, Sparano F, Scalzulli E, Breccia M |
| 2021 | 34145572 | 10.1111/bjh.17637 | Outcome of relapsed/refractory acute promyelocytic leukaemia in children, adolescents and young adult patients - a 25-year Italian experience. | British journal of haematology | Testi AM, Mohamed S, Diverio D, Piciocchi A, Menna G, Rizzari C, Timeus F, Micalizzi C, Lo Nigro L, Santoro N, Masetti R, Micheletti MV, Ziino O, Onofrillo D, Ladogana S, Putti C, Pierani P, Arena V, Zecca M, Foà R, Locatelli F |
| 2021 | 33618438 | 10.1111/bjh.17334 | Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective study. | British journal of haematology | Lucchini E, Palandri F, Volpetti S, Vianelli N, Auteri G, Rossi E, Patriarca A, Carli G, Barcellini W, Celli M, Consoli U, Valeri F, Santoro C, Crea E, Vignetti M, Paoloni F, Gigliotti CL, Boggio E, Dianzani U, Giardini I, Carpenedo M, Rodeghiero F, Fanin R, Zaja F, |
| 2021 | 33753228 | 10.1016/j.jclinepi.2021.03.015 | The EORTC QLU-C10D was more efficient in detecting clinical known group differences in myelodysplastic syndromes than the EQ-5D-3L. | Journal of clinical epidemiology | Gamper EM, Cottone F, Sommer K, Norman R, King M, Breccia M, Caocci G, Patriarca A, Palumbo GA, Stauder R, Niscola P, Platzbecker U, Caers J, Vignetti M, Efficace F |
| 2021 | 33388860 | 10.1007/s00277-020-04392-w | Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib. | Annals of hematology | Caocci G, Mulas O, Capodanno I, Bonifacio M, Annunziata M, Galimberti S, Luciano L, Tiribelli M, Martino B, Castagnetti F, Binotto G, Pregno P, Stagno F, Abruzzese E, Bocchia M, Gozzini A, Albano F, Fozza C, Luzi D, Efficace F, Simula MP, Scaffidi L, Baratè C, De Gregorio F, Stella R, Gugliotta G, Pirillo F, Trawinska MM, Sicuranza A, Cattaneo D, Attolico I, Scalzulli E, Iurlo A, Foà R, Breccia M, La Nasa G |
| 2021 | 35444708 | 10.2174/1745017902117010307 | Health-Related Quality of Life Assessment in Patients with Myelodysplastic Syndromes: Evidence from Randomized Clinical Trials. | Clinical practice and epidemiology in mental health : CP & EMH | Giesinger JM, La Nasa G, Sparano F, Angermeyer M, Morelli E, Mulas O, Efficace F, Caocci G |
| 2021 | 34510624 | 10.1002/onco.13974 | Changes in Cancer Patients' and Caregivers' Disease Perceptions While Receiving Early Palliative Care: A Qualitative and Quantitative Analysis. | The oncologist | Borelli E, Bigi S, Potenza L, Eliardo S, Artioli F, Mucciarini C, Cottafavi L, Cagossi K, Razzini G, Cruciani M, Pietramaggiori A, Fantuzzi V, Lombardo L, Ferrari U, Ganfi V, Lui F, Odejide O, Cacciari C, Porro CA, Zimmermann C, Efficace F, Bruera E, Luppi M, Bandieri E |
| 2021 | 34125642 | 10.1080/17474086.2021.1943352 | Health-related quality of life in patients with acute promyelocytic leukemia: a systematic literature review. | Expert review of hematology | Efficace F, Cannella L, Breccia M, Olivieri J, Platzbecker U, Vignetti M |
| 2021 | 33270529 | 10.1089/jpm.2020.0396 | Early Palliative Home Care versus Hospital Care for Patients with Hematologic Malignancies: A Cost-Effectiveness Study. | Journal of palliative medicine | Cartoni C, Breccia M, Giesinger JM, Baldacci E, Carmosino I, Annechini G, Palumbo G, Armiento D, Niscola P, Tendas A, Brunetti GA, Minotti C, Marini MG, Reale L, Martone N, Martelli M, Efficace F |
| 2021 | 33802502 | 10.3390/cancers13051083 | Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation. | Cancers | Buccisano F, Palmieri R, Piciocchi A, Maurillo L, Del Principe MI, Paterno G, Soddu S, Cerretti R, De Angelis G, Mariotti B, Irno Consalvo MA, Conti C, Fraboni D, Divona M, Ottone T, Lavorgna S, Panetta P, Voso MT, Arcese W, Venditti A |
| 2021 | 34661826 | 10.1007/s11523-021-00831-4 | Making Treatment-Free Remission (TFR) Easier in Chronic Myeloid Leukemia: Fact-Checking and Practical Management Tools. | Targeted oncology | Castagnetti F, Binotto G, Capodanno I, Billio A, Calistri E, Cavazzini F, Crugnola M, Gozzini A, Gugliotta G, Krampera M, Lucchesi A, Merli A, Miggiano MC, Minotto C, Poggiaspalla M, Salvucci M, Scappini B, Tiribelli M, Trabacchi E, Rosti G, Galimberti S, Bonifacio M |
| 2021 | 34219395 | 10.1002/cam4.4111 | International perspectives on suboptimal patient-reported outcome trial design and reporting in cancer clinical trials: A qualitative study. | Cancer medicine | Retzer A, Calvert M, Ahmed K, Keeley T, Armes J, Brown JM, Calman L, Gavin A, Glaser AW, Greenfield DM, Lanceley A, Taylor RM, Velikova G, Brundage M, Efficace F, Mercieca-Bebber R, King MT, Kyte D |
| 2021 | 34529768 | 10.1182/bloodadvances.2021004649 | Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic trioxide vs chemotherapy. | Blood advances | Efficace F, Platzbecker U, Breccia M, Cottone F, Carluccio P, Salutari P, Di Bona E, Borlenghi E, Autore F, Levato L, Finizio O, Mancini V, D'Ardia S, Schlenk RF, Melillo L, Fumagalli M, Fiedler W, Beltrami G, Fracchiolla NS, Bernardi M, Fazi P, Annibali O, Mayer K, Voso MT, Vignetti M |
| 2021 | 34048072 | 10.1002/ajh.26253 | Prognostic impact of KMT2A-AFF1-positivity in 926 BCR-ABL1-negative B-lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996. | American journal of hematology | Piciocchi A, Messina M, Elia L, Vitale A, Soddu S, Testi AM, Chiaretti S, Mancini M, Albano F, Spadano A, Krampera M, Bonifacio M, Cairoli R, Vetro C, Colella F, Ferrara F, Cimino G, Bassan R, Fazi P, Vignetti M |
| 2021 | 34513714 | 10.3389/fonc.2021.739171 | Prognostic Factors for Overall Survival In Chronic Myeloid Leukemia Patients: A Multicentric Cohort Study by the Italian CML GIMEMA Network. | Frontiers in oncology | Specchia G, Pregno P, Breccia M, Castagnetti F, Monagheddu C, Bonifacio M, Tiribelli M, Stagno F, Caocci G, Martino B, Luciano L, Pizzuti M, Gozzini A, Scortechini AR, Albano F, Bergamaschi M, Capodanno I, Patriarca A, Fava C, Rege-Cambrin G, Sorà F, Galimberti S, Bocchia M, Binotto G, Reddiconto G, DiTonno P, Maggi A, Sanpaolo G, De Candia MS, Giai V, Abruzzese E, Miggiano MC, La Barba G, Pietrantuono G, Guella A, Levato L, Mulas O, Saccona F, Rosti G, Musto P, Di Raimondo F, Pane F, Baccarani M, Saglio G, Ciccone G |
| 2021 | 34461909 | 10.1186/s12955-021-01820-x | General Spanish population normative data analysis for the EORTC QLQ-C30 by sex, age, and health condition. | Health and quality of life outcomes | Arraras JI, Nolte S, Liegl G, Rose M, Manterola A, Illarramendi JJ, Zarandona U, Rico M, Teiejria L, Asin G, Hernandez I, Barrado M, Vera R, Efficace F, Giesinger JM, |
| 2021 | 34254530 | 10.2217/fon-2021-0388 | AMELIORATE: early intensification in -mutated acute myeloid leukemia based on peripheral blast clearance - MYNERVA-GIMEMA AML1919 trial. | Future oncology (London, England) | Mannelli F, Gianfaldoni G, Guglielmelli P, Buccisano F, Caporale R, Chiarini M, Rossi G, Venditti A, Fazi P, Crea E, Piciocchi A, Voso MT, Vignetti M, Amadori S, Vannucchi AM |
| 2021 | 34644376 | 10.1182/bloodadvances.2021005802 | Blastic plasmocitoid dendritic cell neoplasm with leukemic spread: a GIMEMA survey. | Blood advances | Valentini CG, Piciocchi A, Facchetti F, Guolo F, Pulsoni A, Vignetti M, Pagano L |
| 2021 | 34670762 | 10.1136/bmjopen-2021-049128 | Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system. | BMJ open | Riva S, Arenare L, Di Maio M, Efficace F, Montesarchio V, Frontini L, Giannarelli D, Bryce J, Del Campo L, De Lorenzo F, Iannelli E, Traclò F, Gitto L, Jommi C, Vaccaro CM, Barberio D, Cinieri S, Porta C, Del Mastro L, Zagonel V, Cogoni AA, Bordonaro R, Gimigliano A, Piccirillo MC, Guizzaro L, Gallo C, Perrone F |
| 2021 | 32835601 | 10.1089/jpm.2020.0159 | Evaluating the Thresholds for Clinical Importance of the EORTC QLQ-C15-PAL in Patients Receiving Palliative Treatment. | Journal of palliative medicine | Pilz MJ, Aaronson NK, Arraras JI, Caocci G, Efficace F, Groenvold M, Holzner B, van Leeuwen M, Loth FLC, Petersen MA, Ramage J, Tomaszewski KA, Young T, Giesinger JM |
| 2021 | 31879328 | 10.3324/haematol.2019.231704 | Clinical significance of occult central nervous system disease in adult acute lymphoblastic leukemia. A multicenter report from the Campus ALL Network. | Haematologica | Del Principe MI, Buzzatti E, Piciocchi A, Forghieri F, Bonifacio M, Lessi F, Imbergamo S, Orciuolo E, Rossi G, Fracchiolla N, Trappolini S, Neri B, Sarlo C, Zappasodi P, Dargenio M, Cefalo M, Irno-Consalvo MA, Conti C, Paterno G, De Angelis G, Sciumè M, Della Starza I, Venditti A, Foà R, Guarini AR |
| 2021 | 35008372 | 10.3390/cancers14010207 | Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study. | Cancers | Mauro FR, Paoloni F, Molica S, Reda G, Trentin L, Sportoletti P, Marchetti M, Pietrasanta D, Marasca R, Gaidano G, Coscia M, Stelitano C, Mannina D, Di Renzo N, Ilariucci F, Liberati AM, Orsucci L, Re F, Tani M, Musuraca G, Gottardi D, Zinzani PL, Gozzetti A, Molinari A, Gentile M, Chiarenza A, Laurenti L, Varettoni M, Ibatici A, Murru R, Ruocco V, Del Giudice I, De Propris MS, Della Starza I, Raponi S, Nanni M, Fazi P, Neri A, Guarini A, Rigolin GM, Piciocchi A, Cuneo A, Foà R |
| 2021 | 34587233 | 10.1182/blood.2021011883 | Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study. | Blood | Rigolin GM, Del Giudice I, Bardi A, Melandri A, García-Jacobo RE, Cura F, Raponi S, Ilari C, Cafforio L, Piciocchi A, Arena V, Reda G, Albano F, Molica S, Sportoletti P, Trentin L, Marchetti M, Nanni M, Peragine N, Mariglia P, Vignetti M, Guarini A, Mauro FR, Foà R, Cuneo A |
| 2021 | 33677654 | 10.1007/s00277-021-04477-0 | Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients. | Annals of hematology | Scalzulli E, Caocci G, Efficace F, Rizzo L, Colafigli G, Di Prima A, Pepe S, Fegatelli DA, Carmosino I, Diverio D, Latagliata R, La Nasa G, Martelli M, Foà R, Breccia M |
| 2021 | 34838268 | 10.1016/j.jval.2021.06.003 | Investigating Trends in the Quality of Reporting of Patient-Reported Outcomes in Oncology Over Time: Analysis of 631 Randomized Controlled Trials Published Between 2004 and 2019. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | Efficace F, Giesinger JM, Cella D, Cottone F, Sparano F, Vignetti M, Aaronson NK |
| 2021 | 34075852 | 10.1080/17474086.2021.1938534 | Measuring prognosis in chronic myeloid leukemia: what's new? | Expert review of hematology | Breccia M, Efficace F, Scalzulli E, Ciotti G, Maestrini G, Colafigli G, Martelli M |
| 2021 | 32808672 | 10.1111/bjh.17018 | Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico-biological parameters. | British journal of haematology | Gurnari C, Breccia M, Di Giuliano F, Scalzulli E, Divona M, Piciocchi A, Cicconi L, De Bellis E, Venditti A, Del Principe MI, Arcese W, Lo-Coco F, Garaci F, Voso MT |
| 2021 | 32467145 | 10.3324/haematol.2020.247973 | Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913. | Haematologica | Chiaretti S, Messina M, Della Starza I, Piciocchi A, Cafforio L, Cavalli M, Taherinasab A, Ansuinelli M, Elia L, Albertini Petroni G, La Starza R, Canichella M, Lauretti A, Puzzolo MC, Pierini V, Santoro A, Spinelli O, Apicella V, Capria S, Di Raimondo F, De Fabritiis P, Papayannidis C, Candoni A, Cairoli R, Cerrano M, Fracchiolla N, Mattei D, Cattaneo C, Vitale A, Crea E, Fazi P, Mecucci C, Rambaldi A, Guarini A, Bassan R, Foà R |
| 2021 | 34297829 | 10.1182/blood.2021011822 | Host immune system modulation in Ph+ acute lymphoblastic leukemia patients treated with dasatinib and blinatumomab. | Blood | Puzzolo MC, Radice G, Peragine N, de Propris MS, Mariglia P, Vignetti M, Vitale A, Bassan R, Annunziata M, Gaidano G, Rambaldi A, Chiaretti S, Guarini A, Foà R |
| 2021 | 32975904 | 10.1002/cncy.22344 | Human herpesvirus-8-positive primary effusion lymphoma in HIV-negative patients: Single institution case series with a multidisciplinary characterization. | Cancer cytopathology | Rossi G, Cozzi I, Della Starza I, De Novi LA, De Propris MS, Gaeta A, Petrucci L, Pulsoni A, Pulvirenti F, Ascoli V |
| 2021 | 34402088 | 10.1002/hon.2913 | Applicability of droplet digital polymerase chain reaction for minimal residual disease monitoring in Philadelphia-positive acute lymphoblastic leukaemia. | Hematological oncology | Ansuinelli M, Della Starza I, Lauretti A, Elia L, Siravo V, Messina M, De Novi LA, Taherinasab A, Canichella M, Guarini A, Foà R, Chiaretti S |
| 2020 | 31253733 | 10.1136/bmjspcare-2018-001755 | Physical activity and health-related quality of life in multiple myeloma survivors: the PROFILES registry. | BMJ supportive & palliative care | Servadio M, Cottone F, Sommer K, Oerlemans S, van de Poll-Franse L, Efficace F |
| 2020 | 31097634 | 10.3324/haematol.2019.221333 | Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients. | Haematologica | Baron F, Efficace F, Cannella L, Willemze R, Vignetti M, Muus P, Marie JP, Ferrero D, Fazi P, La Sala E, Bourhis JH, Fabbiano F, Bosi A, Sborgia M, Martinelli G, Wittnebel S, Trisolini S, Petti MC, Halkes CJM, van der Velden WJFM, de Witte T, Amadori S, Zittoun RA, Suciu S |
| 2020 | 32935955 | 10.23736/S1973-9087.20.06412-6 | Treatments in neurogenic bowel dysfunctions: evidence reviews and clinical recommendations in adults. | European journal of physical and rehabilitation medicine | Musco S, Bazzocchi G, Martellucci J, Amato MP, Manassero A, Putignano D, Lopatriello S, Cafiero D, Paoloni F, Del Popolo G |
| 2020 | 32873088 | 10.1080/17474086.2020.1816819 | The advantages and risks of ruxolitinib for the treatment of polycythemia vera. | Expert review of hematology | Colafigli G, Scalzulli E, Pepe S, Di Prima A, Efficace F, Martelli M, Foà R, Breccia M |
| 2020 | 33187229 | 10.3390/cancers12113334 | Survival Improvement over Time of 960 s-AML Patients Included in 13 EORTC-GIMEMA-HOVON Trials. | Cancers | Ramadan SM, Suciu S, Stevens-Kroef MJPL, Willemze R, Amadori S, de Witte T, Löwenberg B, Muus P, Labar B, Meert L, de Schaetzen G, Meloni G, Leone G, Vignetti M, Marie JP, Lübbert M, Baron F |
| 2020 | 32846465 | 10.1002/cam4.3335 | Investigating the impact of open label design on patient-reported outcome results in prostate cancer randomized controlled trials. | Cancer medicine | Mouillet G, Efficace F, Thiery-Vuillemin A, Charton E, Van Hemelrijck M, Sparano F, Anota A |
| 2020 | 33085860 | 10.1056/NEJMoa2016272 | Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults. | The New England journal of medicine | Foà R, Bassan R, Vitale A, Elia L, Piciocchi A, Puzzolo MC, Canichella M, Viero P, Ferrara F, Lunghi M, Fabbiano F, Bonifacio M, Fracchiolla N, Di Bartolomeo P, Mancino A, De Propris MS, Vignetti M, Guarini A, Rambaldi A, Chiaretti S, |
| 2020 | 32588394 | 10.1007/s12185-020-02920-y | High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity. | International journal of hematology | Caocci G, Vignetti M, Patriarca A, Breccia M, Platzbecker U, Palumbo GA, Stauder R, Cottone F, Petranovic D, Voso MT, Tafuri A, Invernizzi R, Caers J, Luppi M, La Nasa G, Niscola P, Efficace F |
| 2020 | 33054124 | 10.3324/haematol.2020.262071 | Modulated expression of adhesion, migration and activation molecules may predict the degree of response in chronic lymphocytic leukemia patients treated with ibrutinib plus rituximab. | Haematologica | Peragine N, De Propris MS, Intoppa S, Milani ML, Mariglia P, Mauro FR, Raponi S, Soddu S, Cuneo A, Rigolin GM, Del Giudice I, Foà R, Guarini A |
| 2020 | 32998243 | 10.3390/ijerph17197097 | Independent Research on Cancer Pain Management in the Setting of Early Palliative Care: A Flywheel to Counteract General Opioid Misuse and Abuse. | International journal of environmental research and public health | Bandieri E, Potenza L, Efficace F, Bruera E, Luppi M |
| 2020 | 32969597 | 10.1002/cam4.3470 | Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study. | Cancer medicine | Cuneo A, Mato AR, Rigolin GM, Piciocchi A, Gentile M, Laurenti L, Allan JN, Pagel JM, Brander DM, Hill BT, Winter A, Lamanna N, Tam CS, Jacobs R, Lansigan F, Barr PM, Shadman M, Skarbnik AP, Pu JJ, Sehgal AR, Schuster SJ, Shah NN, Ujjani CS, Roeker L, Orlandi EM, Billio A, Trentin L, Spacek M, Marchetti M, Tedeschi A, Ilariucci F, Gaidano G, Doubek M, Farina L, Molica S, Di Raimondo F, Coscia M, Mauro FR, de la Serna J, Medina Perez A, Ferrarini I, Cimino G, Cavallari M, Cucci R, Vignetti M, Foà R, Ghia P, |
| 2020 | 31201152 | 10.1136/bmjspcare-2019-001794 | Early versus delayed palliative/supportive care in advanced cancer: an observational study. | BMJ supportive & palliative care | Bandieri E, Banchelli F, Artioli F, Mucciarini C, Razzini G, Cruciani M, Potenza L, D'Amico R, Efficace F, Bruera E, Luppi M |
| 2020 | 33262951 | 10.3389/fonc.2020.594129 | UK Experience of an Alternative ATO Dosing Regimen in APL. | Frontiers in oncology | Russell N, Dillon R |
| 2020 | 31477798 | 10.1038/s41375-019-0563-0 | Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy. | Leukemia | Efficace F, Stagno F, Iurlo A, Breccia M, Cottone F, Bonifacio M, Abruzzese E, Castagnetti F, Caocci G, Crugnola M, Capodanno I, Martino B, Tiribelli M, Patriarca A, Gozzini A, Pregno P, Saussele S, Cascavilla N, Fozza C, Bergamaschi M, Binotto G, Vignetti M, Rosti G |
| 2020 | 33242446 | 10.1016/S2352-3026(20)30292-1 | Quality of patient-reported outcome reporting in randomised controlled trials of haematological malignancies according to international quality standards: a systematic review. | The Lancet. Haematology | Chakraborty R, Cannella L, Cottone F, Efficace F |
| 2020 | 32843716 | 10.1038/s41375-020-01032-0 | COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey. | Leukemia | Breccia M, Piciocchi A, De Stefano V, Finazzi G, Iurlo A, Fazi P, Soddu S, Martino B, Palandri F, Siragusa S, Albano F, Passamonti F, Vignetti M, Vannucchi AM |
| 2020 | 32767367 | 10.1002/bjs.11800 | Impact of asymptomatic COVID-19 patients in global surgical practice during the COVID-19 pandemic. | The British journal of surgery | Bellato V, Konishi T, Pellino G, An Y, Piciocchi A, Sensi B, Siragusa L, Khanna K, Pirozzi BM, Franceschilli M, Campanelli M, Efetov S, Sica GS, |
| 2020 | 33205694 | 10.1080/17474086.2021.1852924 | Tyrosine kinase inhibitor discontinuation in the management of chronic myeloid leukemia: a critical review of the current practice. | Expert review of hematology | Breccia M, Efficace F, Colafigli G, Scalzulli E, Di Prima A, Martelli M, Foà R |
| 2020 | 33131259 | 10.3324/haematol.2019.235705 | High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2). | Haematologica | Mauro FR, Molica S, Soddu S, Ilariucci F, Coscia M, Zaja F, Angelucci E, Re F, Liberati AM, Tedeschi A, Reda G, Pietrasanta D, Gozzetti A, Battistini R, Del Poeta G, Musolino C, Nanni M, Piciocchi A, Vignetti M, Neri A, Albano F, Cuneo A, Del Giudice I, Della Starza I, De Propris MS, Raponi S, Guarini AR, Foà R |
| 2020 | 31248973 | 10.3324/haematol.2019.220657 | First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trials. | Haematologica | Larocca A, Mina R, Offidani M, Liberati AM, Ledda A, Patriarca F, Evangelista A, Spada S, Benevolo G, Oddolo D, Innao V, Cangiolosi C, Bernardini A, Musto P, Amico V, Fraticelli V, Paris L, Giuliani N, Falcone AP, Zambello R, De Paoli L, Romano A, Palumbo A, Montefusco V, Hájek R, Boccadoro M, Bringhen S |
| 2020 | 32697337 | 10.1002/ajh.25942 | Early peripheral blast cell clearance predicts minimal residual disease status and refines disease prognosis in acute myeloid leukemia. | American journal of hematology | Mannelli F, Gianfaldoni G, Bencini S, Piccini M, Cutini I, Bonetti MI, Scappini B, Pancani F, Ponziani V, Chiarini M, Borlenghi E, Bassan R, Rossi G, Bosi A |
| 2020 | 32762755 | 10.1186/s12955-020-01504-y | Investigating the association between physicians self-efficacy regarding communication skills and risk of "burnout". | Health and quality of life outcomes | Messerotti A, Banchelli F, Ferrari S, Barbieri E, Bettelli F, Bandieri E, Giusti D, Catellani H, Borelli E, Colaci E, Pioli V, Morselli M, Forghieri F, Galeazzi GM, Marasca R, Bigi S, D'Amico R, Martin P, Efficace F, Luppi M, Potenza L |
| 2020 | 33110590 | 10.7189/jogh.10.020507 | Screening policies, preventive measures and in-hospital infection of COVID-19 in global surgical practices. | Journal of global health | Bellato V, Konishi T, Pellino G, An Y, Piciocchi A, Sensi B, Siragusa L, Khanna K, Pirozzi BM, Franceschilli M, Campanelli M, Efetov S, Sica GS, |
| 2020 | 32514110 | 10.1038/s41408-020-0333-2 | Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study. | Blood cancer journal | Caocci G, Mulas O, Capodanno I, Abruzzese E, Iurlo A, Luciano L, Albano F, Annunziata M, Tiribelli M, Bonifacio M, Galimberti S, Castagnetti F, Sgherza N, Stagno F, Gozzini A, Orlandi EM, Luzi D, Binotto G, Pregno P, Fozza C, Efficace F, Simula MP, Trawinska MM, Cattaneo D, De Gregorio F, Attolico I, Stella R, Scaffidi L, Baratè C, Gugliotta G, Scalzulli E, Elena C, Pirillo F, Foà R, Breccia M, Nasa G |
| 2020 | 33091616 | 10.1016/j.leukres.2020.106462 | Terminal deoxynucleotidyl transferase (TdT) expression is associated with FLT3-ITD mutations in Acute Myeloid Leukemia. | Leukemia research | De Bellis E, Ottone T, Mercante L, Falconi G, Cugini E, Consalvo MI, Travaglini S, Paterno G, Piciocchi A, Rossi ELL, Gurnari C, Maurillo L, Buccisano F, Arcese W, Voso MT |
| 2020 | 32620840 | 10.1038/s41375-020-0953-3 | How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy-a GIMEMA MPN WP survey. | Leukemia | Palandri F, Piciocchi A, De Stefano V, Breccia M, Finazzi G, Iurlo A, Fazi P, Soddu S, Martino B, Siragusa S, Albano F, Passamonti F, Vignetti M, Vannucchi AM |
| 2020 | 32441419 | 10.1111/ejh.13454 | Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the "Ph1-negative Myeloproliferative Neoplasms Latium Group". | European journal of haematology | Mazzucconi MG, Baldacci E, Latagliata R, Breccia M, Paoloni F, Di Veroli A, Cedrone M, Anaclerico B, Villivà N, Porrini R, Montefusco E, Andriani A, Montanaro M, Scaramucci L, Spadea A, Rago A, Cimino G, Spirito F, Santoro C |
| 2020 | 32086447 | 10.1038/s41375-020-0746-8 | The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index. | Leukemia | Efficace F, Cottone F, Oswald LB, Cella D, Patriarca A, Niscola P, Breccia M, Platzbecker U, Palumbo GA, Caocci G, Stauder R, Ricco A, Petranovic D, Caers J, Luppi M, Fianchi L, Frairia C, Capodanno I, Follini E, Sarlo C, Fazi P, Vignetti M |
| 2020 | 32562837 | 10.1016/j.jclinepi.2020.06.016 | Time to health-related quality of life improvement analysis was developed to enhance evaluation of modern anticancer therapies. | Journal of clinical epidemiology | Cottone F, Collins GS, Anota A, Sommer K, Giesinger JM, Kieffer JM, Aaronson NK, Van Steen K, Charton E, Castagnetti F, Fazi P, Vignetti M, Cella D, Efficace F |
| 2020 | 31928952 | 10.1016/j.clml.2019.12.004 | Early Palliative Care: A Necessary Intervention for Patients Ineligibile to Approved Potentially Life-saving CAR T-cell Therapy. | Clinical lymphoma, myeloma & leukemia | Potenza L, Luppi M, Efficace F, Bruera E, Bandieri E |
| 2020 | 32410281 | 10.1111/bjh.16654 | Development of a core outcome set for myelodysplastic syndromes - a Delphi study from the EUMDS Registry Group. | British journal of haematology | Rochau U, Stojkov I, Conrads-Frank A, Borba HH, Koinig KA, Arvandi M, van Marrewijk C, Garelius H, Germing U, Symeonidis A, Sanz GF, Fenaux P, de Witte T, Efficace F, Siebert U, Stauder R |
| 2020 | 32474619 | 10.1007/s00277-020-04102-6 | Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors. | Annals of hematology | Mulas O, Caocci G, Stagno F, Bonifacio M, Annunziata M, Luciano L, Orlandi EM, Abruzzese E, Sgherza N, Martino B, Albano F, Galimberti S, Pregno P, Bocchia M, Castagnetti F, Tiribelli M, Binotto G, Gozzini A, Capodanno I, Fozza C, Luzi D, Efficace F, Simula MP, Scaffidi L, De Gregorio F, Elena C, Trawinska MM, Cattaneo D, Attolico I, Baratè C, Pirillo F, Sicuranza A, Gugliotta G, Stella R, Scalzulli E, Iurlo A, Foà R, Breccia M, La Nasa G |
| 2020 | 32309784 | 10.1097/HS9.0000000000000347 | Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow-up Samples From Four Prospective Trials of the European MCL Network. | HemaSphere | Drandi D, Alcantara M, Benmaad I, Söhlbrandt A, Lhermitte L, Zaccaria G, Ferrante M, Genuardi E, Mantoan B, Villarese P, Cheminant M, Starza ID, Ciabatti E, Bomben R, Jimenez C, Callanan M, Abdo C, Eckert C, Ribrag V, Cortelazzo S, Dreyling M, Hermine O, Delfau-Larue MH, Pott C, Ladetto M, Ferrero S, Macintyre E |
| 2020 | 32458409 | 10.1007/s11136-020-02536-z | EORTC QLU-C10D value sets for Austria, Italy, and Poland. | Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation | Gamper EM, King MT, Norman R, Efficace F, Cottone F, Holzner B, Kemmler G, |
| 2020 | 32333639 | 10.1002/cam4.3018 | Harnessing the patient voice in prostate cancer research: Systematic review on the use of patient-reported outcomes in randomized controlled trials to support clinical decision-making. | Cancer medicine | Van Hemelrijck M, Sparano F, Moris L, Beyer K, Cottone F, Sprangers M, Efficace F |
| 2020 | 32080829 | 10.1111/bjh.16532 | Importance of quality of life in early phase clinical trials: A case study of selinexor in multiple myeloma. | British journal of haematology | Chakraborty R, Efficace F |
| 2020 | 32233095 | 10.1002/ajh.25795 | Impact of the type of anthracycline and of stem cell transplantation in younger patients with acute myeloid leukaemia: Long-term follow up of a phase III study. | American journal of hematology | Baron F, Efficace F, Cannella L, Muus P, Trisolini S, Halkes CJM, Fazi P, Vignetti M, Marie JP, Chiusolo P, van der Velden W, La Sala E, Vitolo U, Thomas X, Lefrère F, Di Raimondo F, Bourhis JH, Specchia G, Guimarães JE, Allione B, Vrhovac R, Ferrara F, Stevens-Kroef M, Meert L, de Witte T, Willemze R, Amadori S, Suciu S |
| 2020 | 32557531 | 10.1111/bjh.16877 | Younger age at diagnosis of acute promyelocytic leukaemia is associated with better long-term cognitive functioning. | British journal of haematology | Breccia M, Vignetti M, Annibali O, Cottone F, Luppi M, Borlenghi E, Rodeghiero F, Efficace F |
| 2020 | 32389233 | 10.1016/j.jval.2020.02.007 | Differences in Patient-Reported Outcomes That Are Most Frequently Detected in Randomized Controlled Trials in Patients With Solid Tumors: A Pooled Analysis of 229 Trials. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | Giesinger JM, Blazeby J, Aaronson NK, Sprangers M, Fayers P, Sparano F, Rees J, Anota A, Wan C, Pezold M, Isharwal S, Cottone F, Efficace F, |
| 2020 | 32621754 | 10.1111/bjh.16996 | The COVID-19 pandemic and management of GIMEMA clinical trials: changes and challenges. | British journal of haematology | Piciocchi A, Messina M, Soddu S, La Sala E, Paoloni F, Giuliani G, Marino MR, Petrelli C, Gorreo Renzulli L, Fazi P, Vignetti M |
| 2020 | 31593797 | 10.1016/j.jclinepi.2019.09.028 | Thresholds for clinical importance were defined for the European Organisation for Research and Treatment of Cancer Computer Adaptive Testing Core-an adaptive measure of core quality of life domains in oncology clinical practice and research. | Journal of clinical epidemiology | Giesinger JM, Loth FLC, Aaronson NK, Arraras JI, Caocci G, Efficace F, Groenvold M, van Leeuwen M, Petersen MA, Ramage J, Tomaszewski KA, Young T, Holzner B, |
| 2020 | 31686561 | 10.1080/10428194.2019.1675881 | The effects of different schedules of bortezomib, melphalan, and prednisone for patients with newly diagnosed multiple myeloma who are transplant ineligible: a matching-adjusted indirect comparison. | Leukemia & lymphoma | Mateos MV, San-Miguel J, Goldschmidt H, Sonneveld P, Dimopoulos MA, Heeg B, Hashim M, Deraedt W, Hu P, Lam A, He J |
| 2020 | 33242443 | 10.1016/S2352-3026(20)30323-9 | Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study. | The Lancet. Haematology | Tacchetti P, Pantani L, Patriarca F, Petrucci MT, Zamagni E, Dozza L, Galli M, Di Raimondo F, Crippa C, Boccadoro M, Barbato S, Tosi P, Narni F, Montefusco V, Testoni N, Spadano A, Terragna C, Pescosta N, Marzocchi G, Cellini C, Galieni P, Ronconi S, Gobbi M, Catalano L, Lazzaro A, De Sabbata G, Cangialosi C, Ciambelli F, Musto P, Elice F, Cavo M, |
| 2020 | 31782016 | 10.1007/s11136-019-02369-5 | Consistency matters: measurement invariance of the EORTC QLQ-C30 questionnaire in patients with hematologic malignancies. | Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation | Sommer K, Cottone F, Aaronson NK, Fayers P, Fazi P, Rosti G, Angelucci E, Gaidano G, Venditti A, Voso MT, Baccarani M, Vignetti M, Efficace F |
| 2020 | 31797711 | 10.1080/10428194.2019.1699078 | WT1 evaluation in higher-risk myelodysplastic syndrome patients treated with azacitidine. | Leukemia & lymphoma | Falconi G, Fabiani E, Ottone T, Piciocchi A, Lavorgna S, Criscuolo M, Fianchi L, Gurnari C, Postorino M, Picardi A, Palmieri R, Lo-Coco F, Voso MT |
| 2020 | 31611624 | 10.1038/s41375-019-0589-3 | Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial. | Leukemia | Cicconi L, Platzbecker U, Avvisati G, Paoloni F, Thiede C, Vignetti M, Fazi P, Ferrara F, Divona M, Albano F, Efficace F, Sborgia M, Di Bona E, Breccia M, Borlenghi E, Cairoli R, Rambaldi A, Melillo L, La Nasa G, Fiedler W, Brossart P, Hertenstein B, Salih HR, Annibali O, Wattad M, Lubbert M, Brandts CH, Hanel M, Rollig C, Schmitz N, Link H, Frairia C, Fozza C, Maria D'Arco A, Di Renzo N, Cortelezzi A, Fabbiano F, Dohner K, Ganser A, Dohner H, Amadori S, Mandelli F, Voso MT, Ehninger G, Schlenk RF, Lo-Coco F |
| 2020 | 32064595 | 10.1111/bjh.16434 | Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations. | British journal of haematology | Raponi S, Ilari C, Della Starza I, Cappelli LV, Cafforio L, Piciocchi A, Arena V, Mariglia P, Mauro FR, Gentile M, Cutrona G, Moia R, Favini C, Morabito F, Rossi D, Gaidano G, Guarini A, Del Giudice I, Foà R |
| 2020 | 31776827 | 10.1007/s11136-019-02367-7 | Time to deterioration in cancer randomized clinical trials for patient-reported outcomes data: a systematic review. | Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation | Charton E, Cuer B, Cottone F, Efficace F, Touraine C, Hamidou Z, Fiteni F, Bonnetain F, Woronoff-Lemsi MC, Bascoul-Mollevi C, Anota A |
| 2020 | 32606615 | 10.2147/PPA.S249079 | Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) Medication Adherence Scale (PMAS). | Patient preference and adherence | Peipert JD, Badawy SM, Baik SH, Oswald LB, Efficace F, Garcia SF, Mroczek DK, Wolf M, Kaiser K, Yanez B, Cella D |
| 2020 | 31558067 | 10.1080/10428194.2019.1668938 | Efficacy of imatinib and chemotherapy in a pediatric patient with Philadelphia-like acute lymphoblastic leukemia with fusion transcript. | Leukemia & lymphoma | Fazio F, Barberi W, Cazzaniga G, Fazio G, Messina M, Della Starza I, De Propris MS, Mancini F, Mohamed S, Del Giudice I, Chiaretti S, Moleti ML, Guarini A, Foà R, Testi AM |
| 2020 | 31639445 | 10.1016/j.jclinepi.2019.10.003 | Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research. | Journal of clinical epidemiology | Giesinger JM, Loth FLC, Aaronson NK, Arraras JI, Caocci G, Efficace F, Groenvold M, van Leeuwen M, Petersen MA, Ramage J, Tomaszewski KA, Young T, Holzner B, |
| 2020 | 33049054 | 10.1182/bloodadvances.2020002904 | Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial. | Blood advances | Voso MT, Larson RA, Jones D, Marcucci G, Prior T, Krauter J, Heuser M, Lavorgna S, Nomdedeu J, Geyer SM, Walker A, Wei AH, Sierra J, Sanz MA, Brandwein JM, de Witte TM, Jansen JH, Niederwieser D, Appelbaum FR, Medeiros BC, Tallman MS, Schlenk RF, Ganser A, Amadori S, Cheng Y, Chen Y, Pallaud C, Du L, Piciocchi A, Ehninger G, Byrd J, Thiede C, Döhner K, Stone RM, Döhner H, Bloomfield CD, Lo-Coco F |
| 2019 | 30776156 | 10.1111/ejh.13222 | Update of the GIMEMA MDS0306 study: Deferasirox for lower risk transfusion-dependent patients with myelodysplastic syndromes. | European journal of haematology | Piciocchi A, Sargentini V, Cotugno F, Bontempi K, Beltrami G, Di Tucci AA, Riva M, Quaresmini G, Vallisa D, Finelli C, Borin L, Fazi P, Vignetti M, Angelucci E |
| 2019 | 30838883 | 10.2217/cer-2018-0092 | Clinician-reported symptomatic adverse events in cancer trials: are they concordant with patient-reported outcomes? | Journal of comparative effectiveness research | Sparano F, Aaronson NK, Cottone F, Piciocchi A, La Sala E, Anota A, Deliu N, Kieffer JM, Efficace F |
| 2019 | 30784132 | 10.1002/pds.4756 | Propensity score methods and regression adjustment for analysis of nonrandomized studies with health-related quality of life outcomes. | Pharmacoepidemiology and drug safety | Cottone F, Anota A, Bonnetain F, Collins GS, Efficace F |
| 2019 | 31050551 | 10.1080/10428194.2019.1607325 | Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemia. | Leukemia & lymphoma | Della Starza I, De Novi LA, Santoro A, Salemi D, Tam W, Cavalli M, Menale L, Soscia R, Apicella V, Ilari C, Vitale A, Testi AM, Inghirami G, Chiaretti S, Foà R, Guarini A |
| 2019 | 30997873 | 10.1080/10428194.2018.1519810 | Long-term results with the adapted LMB 96 protocol in children with B-cell non Hodgkin lymphoma treated in Iraq: comparison in two subsequent cohorts of patients. | Leukemia & lymphoma | Moleti ML, Al-Jadiry MF, Shateh WA, Al-Darraji AF, Mohamed S, Uccini S, Piciocchi A, Foà R, Testi AM, Al-Hadad S |
| 2019 | 30833741 | 10.1038/s41409-019-0497-1 | Anti-HLA donor-specific antibodies in allogeneic stem cell transplantation: management and desensitization protocol. | Bone marrow transplantation | La Rocca U, Perrone MP, Piciocchi A, Cinti P, Barberi W, Gozzer M, Baftii MS, Torelli GF, Quattrocchi L, Gesuiti P, Lattanzi R, Cavallari C, Ricci R, Laurenti L, Foà R, Girelli G, Iori AP |
| 2019 | 30635628 | 10.1038/s41375-018-0352-1 | Prof. Franco Mandelli Leukaemia Visionary. May 12, 1931- July 15, 2018. | Leukemia | Amadori S, Arcese W, Avvisati G, Gale RP, Lo-Coco F |
| 2019 | 30188230 | 10.1080/10428194.2018.1499906 | IL7R overexpression in adult acute lymphoblastic leukemia is associated to JAK/STAT pathway mutations and identifies patients who could benefit from targeted therapies. | Leukemia & lymphoma | Gianfelici V, Messina M, Paoloni F, Peragine N, Lauretti A, Fedullo AL, Di Giacomo F, Vignetti M, Vitale A, Guarini A, Chiaretti S, Foà R |
| 2019 | 30573776 | 10.1038/s41375-018-0325-4 | Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemia. | Leukemia | Efficace F, Breccia M, Avvisati G, Cottone F, Intermesoli T, Borlenghi E, Carluccio P, Rodeghiero F, Fabbiano F, Luppi M, Romani C, Sborgia M, D'Ardia S, Nobile F, Cantore N, Crugnola M, Nadali G, Vignetti M, Amadori S, Lo Coco F |
| 2019 | 30411646 | 10.1080/17474086.2019.1547189 | Time for patient reported outcomes assessment in routine hematology practice: the case of chronic myeloid leukemia. | Expert review of hematology | Efficace F, Cottone F |
| 2019 | 30291338 | 10.1038/s41375-018-0284-9 | Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes. | Leukemia | Falconi G, Fabiani E, Piciocchi A, Criscuolo M, Fianchi L, Lindfors Rossi EL, Finelli C, Cerqui E, Ottone T, Molteni A, Parma M, Santarone S, Candoni A, Sica S, Leone G, Lo-Coco F, Voso MT |
| 2019 | 30190342 | 10.3324/haematol.2018.196055 | Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia. | Haematologica | Fedullo AL, Messina M, Elia L, Piciocchi A, Gianfelici V, Lauretti A, Soddu S, Puzzolo MC, Minotti C, Ferrara F, Martino B, Chiusolo P, Calafiore V, Paolini S, Vignetti M, Vitale A, Guarini A, Foà R, Chiaretti S |
| 2019 | 30659449 | 10.1007/s11136-018-02097-2 | Modeling strategies to improve parameter estimates in prognostic factors analyses with patient-reported outcomes in oncology. | Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation | Cottone F, Deliu N, Collins GS, Anota A, Bonnetain F, Van Steen K, Cella D, Efficace F |
| 2019 | 31053971 | 10.1007/s00520-019-04743-y | Pain and related complaints in patients with acute leukemia: time for simultaneous care in hemato-oncology. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | Niscola P, Tendas A, Mazzone C, Efficace F |
| 2019 | 31364153 | 10.1111/bjh.16123 | Venetoclax in CLL patients who progress after B-cell Receptor inhibitor treatment: a retrospective multi-centre Italian experience. | British journal of haematology | Innocenti I, Morelli F, Autore F, Piciocchi A, Frustaci A, Mauro FR, Schiattone L, Trentin L, Del Poeta G, Reda G, Rigolin GM, Ibatici A, Ciolli S, Coscia M, Sportoletti P, Murru R, Levato L, Gentile M, D'Arena G, Efremov DG, Tedeschi A, Scarfò L, Cuneo A, Foà R, Laurenti L |
| 2019 | 29785734 | 10.1111/bjh.15405 | Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease. | British journal of haematology | Raponi S, Del Giudice I, Ilari C, Cafforio L, Messina M, Cappelli LV, Bonina S, Piciocchi A, Marinelli M, Peragine N, Mariglia P, Mauro FR, Rigolin GM, Rossi F, Bomben R, Dal Bo M, Del Poeta G, Diop F, Favini C, Rossi D, Gaidano G, Cuneo A, Gattei V, Guarini A, Foá R |
| 2019 | 31179561 | 10.1002/ajh.25555 | Italian survey on clinical practice in myeloproliferative neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party initiative. | American journal of hematology | Loscocco GG, Mannelli F, Guglielmelli P, Paoli C, Marone I, Cucci R, Coltro G, Sordi B, Albano F, Breccia M, De Stefano V, Finazzi G, Iurlo A, Martino B, Palandri F, Passamonti F, Siragusa S, Mannelli L, Fantoni D, Fazi P, Amadori S, Vignetti M, Barbui T, Vannucchi AM |
| 2019 | 31555576 | 10.3389/fonc.2019.00689 | Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal? | Frontiers in oncology | Del Giudice I, Raponi S, Della Starza I, De Propris MS, Cavalli M, De Novi LA, Cappelli LV, Ilari C, Cafforio L, Guarini A, Foà R |
| 2019 | 31448230 | 10.3389/fonc.2019.00726 | Minimal Residual Disease in Acute Lymphoblastic Leukemia: Technical and Clinical Advances. | Frontiers in oncology | Della Starza I, Chiaretti S, De Propris MS, Elia L, Cavalli M, De Novi LA, Soscia R, Messina M, Vitale A, Guarini A, Foà R |
| 2019 | 31606418 | 10.1016/S1470-2045(19)30641-2 | Quality of life and CAR-T cell therapy in children, adolescents, and young adults with haematological malignancies. | The Lancet. Oncology | Efficace F, Vignetti M |
| 2019 | 31501130 | 10.1136/bmjopen-2019-031485 | Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocol. | BMJ open | Riva S, Bryce J, De Lorenzo F, Del Campo L, Di Maio M, Efficace F, Frontini L, Giannarelli D, Gitto L, Iannelli E, Jommi C, Montesarchio V, Traclò F, Vaccaro CM, Gallo C, Perrone F |
| 2019 | 31708068 | 10.1016/j.jval.2019.06.004 | Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic Malignancies. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | Efficace F, Cottone F, Sommer K, Kieffer J, Aaronson N, Fayers P, Groenvold M, Caocci G, Lo Coco F, Gaidano G, Niscola P, Baccarani M, Rosti G, Venditti A, Angelucci E, Fazi P, Vignetti M, Giesinger J |
| 2019 | 31869412 | 10.1182/bloodadvances.2019000865 | Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP. | Blood advances | Baccarani M, Abruzzese E, Accurso V, Albano F, Annunziata M, Barulli S, Beltrami G, Bergamaschi M, Binotto G, Bocchia M, Caocci G, Capodanno I, Cavazzini F, Cedrone M, Cerrano M, Crugnola M, D'Adda M, Elena C, Fava C, Fazi P, Fozza C, Galimberti S, Giai V, Gozzini A, Gugliotta G, Iurlo A, La Barba G, Levato L, Lucchesi A, Luciano L, Lunghi F, Lunghi M, Malagola M, Marasca R, Martino B, Melpignano A, Miggiano MC, Montefusco E, Musolino C, Palmieri F, Pregno P, Rapezzi D, Rege-Cambrin G, Rupoli S, Salvucci M, Sancetta R, Sica S, Spadano R, Stagno F, Tiribelli M, Tomassetti S, Trabacchi E, Bonifacio M, Breccia M, Castagnetti F, Pane F, Russo D, Saglio G, Soverini S, Vigneri P, Rosti G |
| 2019 | 31719051 | 10.1136/bmjspcare-2019-001902 | Inclusion of older patients with cancer in randomised controlled trials with patient-reported outcomes: a systematic review. | BMJ supportive & palliative care | Sparano F, Aaronson NK, Sprangers MAG, Fayers P, Pusic A, Kieffer JM, Cottone F, Rees J, Pezold M, Anota A, Charton E, Vignetti M, Wan C, Blazeby J, Efficace F |
| 2019 | 31079264 | 10.1007/s00277-019-03706-x | Ten-year outcome of chronic-phase chronic myeloid leukemia patients treated with imatinib in real life. | Annals of hematology | Molica M, Colafigli G, Scalzulli E, Alunni Fegatelli D, Chiatamone Ranieri S, Rizzo L, Diverio D, Efficace F, Latagliata R, Foà R, Breccia M |
| 2019 | 31395600 | 10.1182/blood.2018886960 | GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia. | Blood | Venditti A, Piciocchi A, Candoni A, Melillo L, Calafiore V, Cairoli R, de Fabritiis P, Storti G, Salutari P, Lanza F, Martinelli G, Luppi M, Mazza P, Martelli MP, Cuneo A, Albano F, Fabbiano F, Tafuri A, Chierichini A, Tieghi A, Fracchiolla NS, Capelli D, Foà R, Alati C, La Sala E, Fazi P, Vignetti M, Maurillo L, Buccisano F, Del Principe MI, Irno-Consalvo M, Ottone T, Lavorgna S, Voso MT, Lo-Coco F, Arcese W, Amadori S |
| 2019 | 31317793 | 10.1080/17474086.2019.1645005 | Towards the integration of patient-reported outcomes into the global clinical management of multiple myeloma. | Expert review of hematology | Niscola P, Scaramucci L, Efficace F |
| 2019 | 31298059 | 10.1080/10428194.2019.1639170 | Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocol. | Leukemia & lymphoma | Bassan R, Fumagalli M, Chiaretti S, Audisio E, Cascavilla N, Paolini S, Delia M, Cerqui E, Micò C, Fabbiano F, Canichella M, Scattolin AM, Perfetti P, Paoloni F, Iodice M, Vitale A, Della Starza I, Fazi P, Vignetti M, Foà R |
| 2019 | 31124415 | 10.2217/pgs-2018-0202 | Genomic profiling and predicting treatment response in acute myeloid leukemia. | Pharmacogenomics | Isidori A, Loscocco F, Curti A, Amadori S, Visani G |
| 2019 | 30626425 | 10.1186/s13045-018-0691-4 | Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial. | Journal of hematology & oncology | Saltarella I, Morabito F, Giuliani N, Terragna C, Omedè P, Palumbo A, Bringhen S, De Paoli L, Martino E, Larocca A, Offidani M, Patriarca F, Nozzoli C, Guglielmelli T, Benevolo G, Callea V, Baldini L, Grasso M, Leonardi G, Rizzo M, Falcone AP, Gottardi D, Montefusco V, Musto P, Petrucci MT, Dammacco F, Boccadoro M, Vacca A, Ria R |
| 2019 | 31168652 | 10.1007/s00277-019-03724-9 | Identification of predictive factors for overall survival at baseline and during azacitidine treatment in high-risk myelodysplastic syndrome patients treated in the clinical practice. | Annals of hematology | Scalzulli E, Molica M, Alunni Fegatelli D, Colafigli G, Rizzo L, Mancini M, Efficace F, Latagliata R, Foà R, Breccia M |
| 2019 | 31521149 | 10.1186/s12894-019-0518-9 | Patient-reported outcomes in randomised clinical trials of bladder cancer: an updated systematic review. | BMC urology | Van Hemelrijck M, Sparano F, Josephs D, Sprangers M, Cottone F, Efficace F |
| 2019 | 31386932 | 10.1016/j.leukres.2019.106191 | Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome. | Leukemia research | Falconi G, Fabiani E, Criscuolo M, Fianchi L, Finelli C, Cerqui E, Pelosi E, Screnci M, Gurnari C, Zangrilli I, Postorino M, Laurenti L, Piciocchi A, Testa U, Lo-Coco F, Voso MT |
| 2018 | 29910180 | 10.1016/j.clml.2018.05.019 | Treatment Intensification With Autologous Stem Cell Transplantation and Lenalidomide Maintenance Improves Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma in Complete Response. | Clinical lymphoma, myeloma & leukemia | Mina R, Petrucci MT, Corradini P, Spada S, Patriarca F, Cerrato C, De Paoli L, Pescosta N, Ria R, Malfitano A, Musto P, Baldini L, Guglielmelli T, Gamberi B, Mannina D, Benevolo G, Zambello R, Falcone AP, Palumbo A, Nagler A, Calafiore V, Hájek R, Spencer A, Boccadoro M, Bringhen S |
| 2018 | 29898955 | 10.1182/blood-2018-03-835413 | Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study. | Blood | Rossi G, Gramegna D, Paoloni F, Fattizzo B, Binda F, D'Adda M, Farina M, Lucchini E, Mauro FR, Salvi F, Marchetti M, Fazi P, Zaja F, Barcellini W |
| 2018 | 29926156 | 10.1007/s00277-018-3396-4 | Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15-60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trials. | Annals of hematology | Baron F, Stevens-Kroef M, Kicinski M, Meloni G, Muus P, Marie JP, Halkes CJM, Thomas X, Vrhovac R, Specchia G, Lefrere F, Sica S, Mancini M, Venditti A, Hagemeijer A, Becker H, Jansen JH, Amadori S, de Witte T, Willemze R, Suciu S |
| 2018 | 30502849 | 10.1053/j.seminhematol.2018.02.006 | Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome. | Seminars in hematology | Del Principe MI, Buccisano F, Soddu S, Maurillo L, Cefalo M, Piciocchi A, Consalvo MI, Paterno G, Sarlo C, De Bellis E, Zizzari A, De Angelis G, Fraboni D, Divona M, Voso MT, Sconocchia G, Del Poeta G, Lo-Coco F, Arcese W, Amadori S, Venditti A |
| 2018 | 29675792 | 10.1007/s00432-018-2641-5 | Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysis. | Journal of cancer research and clinical oncology | Cerrato C, Di Raimondo F, De Paoli L, Spada S, Patriarca F, Crippa C, Mina R, Guglielmelli T, Ben-Yehuda D, Oddolo D, Nozzoli C, Angelucci E, Cascavilla N, Rizzi R, Rocco S, Baldini L, Ponticelli E, Marcatti M, Cangialosi C, Caravita T, Benevolo G, Ria R, Nagler A, Musto P, Tacchetti P, Corradini P, Offidani M, Palumbo A, Petrucci MT, Boccadoro M, Gay F |
| 2018 | 29950875 | 10.2147/CEOR.S152437 | Cost-effectiveness analysis of treating transplant-eligible multiple myeloma patients in Macedonia. | ClinicoEconomics and outcomes research : CEOR | Qerimi V, Nestorovska AK, Sterjev Z, Genadieva-Stavric S, Suturkova L |
| 2018 | 30419889 | 10.1186/s12885-018-5036-8 | International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26. | BMC cancer | Sztankay M, Aaronson NK, Arraras JI, Basso U, Bumbasirevic U, Efficace F, Giesinger JM, Johnson CD, van Leeuwen M, Oberguggenberger AS, Sosnowski R, Young T, Holzner B, |
| 2018 | 30361409 | 10.1136/bmjopen-2018-025054 | Evaluating methodological quality of Prognostic models Including Patient-reported HeAlth outcomes iN oncologY (EPIPHANY): a systematic review protocol. | BMJ open | Deliu N, Cottone F, Collins GS, Anota A, Efficace F |
| 2018 | 29932105 | 10.3390/cancers10070211 | Immunosenescence and Immunotherapy in Elderly Acute Myeloid Leukemia Patients: Time for a Biology-Driven Approach. | Cancers | Isidori A, Loscocco F, Ciciarello M, Corradi G, Lecciso M, Ocadlikova D, Parisi S, Salvestrini V, Amadori S, Visani G, Curti A |
| 2018 | 30537955 | 10.1186/s12955-018-1055-z | Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review. | Health and quality of life outcomes | Ousmen A, Touraine C, Deliu N, Cottone F, Bonnetain F, Efficace F, Brédart A, Mollevi C, Anota A |
| 2018 | 29914509 | 10.1186/s12955-018-0953-4 | A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed/refractory multiple myeloma: the CLARITY study protocol. | Health and quality of life outcomes | Efficace F, Boccadoro M, Palumbo A, Petrucci MT, Cottone F, Cannella L, Zamagni E, Niscola P, Kyriakou C, Caravita T, Offidani M, Mandelli F, Cavo M |
| 2018 | 29675955 | 10.1111/bjh.15251 | Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications. | British journal of haematology | Chiaretti S, Messina M, Grammatico S, Piciocchi A, Fedullo AL, Di Giacomo F, Peragine N, Gianfelici V, Lauretti A, Bareja R, Martelli MP, Vignetti M, Apicella V, Vitale A, Li LS, Salek C, Elemento O, Inghirami G, Weinstock DM, Guarini A, Foà R |
| 2018 | 29845876 | 10.1080/14740338.2018.1480719 | Intolerance to tyrosine kinase inhibitors in chronic myeloid leukemia: the possible role of ponatinib. | Expert opinion on drug safety | Breccia M, Efficace F, Iurlo A, Luciano L, Abruzzese E, Gozzini A, Pregno P, Tiribelli M, Rosti G, Minotti G |
| 2018 | 30029156 | 10.1016/j.leukres.2018.07.002 | Erythropoietin levels and erythroid differentiation parameters in patients with lower-risk myelodysplastic syndromes. | Leukemia research | Gurnari C, Latagliata R, Buccisano F, Piciocchi A, Fenu S, Mancini S, Fianchi L, Criscuolo M, Sarlo C, Romano A, Falconi G, Niscola P, Di Veroli A, Breccia M, Piccioni A, Aloe-Spiriti MA, Lo-Coco F, Voso MT, , |
| 2018 | 29127596 | 10.1007/s11136-017-1718-y | International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia. | Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation | van de Poll-Franse L, Oerlemans S, Bredart A, Kyriakou C, Sztankay M, Pallua S, Daniëls L, Creutzberg CL, Cocks K, Malak S, Caocci G, Molica S, Chie W, Efficace F, |
| 2018 | 30447931 | 10.1016/j.critrevonc.2018.09.008 | Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials. | Critical reviews in oncology/hematology | D'Agostino M, De Paoli L, Conticello C, Offidani M, Ria R, Petrucci MT, Spada S, Marcatti M, Catalano L, Gilestro M, Guglielmelli T, Baldini L, Gamberi B, Rizzi R, De Sabbata G, Di Renzo N, Patriarca F, Pezzatti S, Siniscalchi A, Ribolla R, Palumbo A, Montefusco V, Nagler A, Boccadoro M, Gay F |
| 2018 | 30239387 | 10.1097/SPC.0000000000000386 | How should we assess patient-reported outcomes in the onco-hematology clinic? | Current opinion in supportive and palliative care | Cannella L, Efficace F, Giesinger J |
| 2018 | 29431123 | 10.1136/bmjopen-2017-017282 | Evaluation of patient-reported outcome protocol content and reporting in UK cancer clinical trials: the EPiC study qualitative protocol. | BMJ open | Retzer A, Keeley T, Ahmed K, Armes J, Brown JM, Calman L, Copland C, Efficace F, Gavin A, Glaser A, Greenfield DM, Lanceley A, Taylor RM, Velikova G, Brundage M, Mercieca-Bebber R, King MT, Calvert M, Kyte D |
| 2018 | 29572506 | 10.1038/s41375-018-0089-x | Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study. | Leukemia | Stauder R, Yu G, Koinig KA, Bagguley T, Fenaux P, Symeonidis A, Sanz G, Cermak J, Mittelman M, Hellström-Lindberg E, Langemeijer S, Holm MS, Mądry K, Malcovati L, Tatic A, Germing U, Savic A, van Marrewijk C, Guerci-Bresler A, Luño E, Droste J, Efficace F, Smith A, Bowen D, de Witte T |
| 2018 | 29560502 | 10.1007/s00520-018-4137-x | Patient-reported outcomes in relapsed/refractory multiple myeloma: a systematic review. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | Sparano F, Cavo M, Niscola P, Caravita T, Efficace F |
| 2018 | 29633312 | 10.1002/ajh.25102 | Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis. | American journal of hematology | Caocci G, Mulas O, Annunziata M, Luciano L, Bonifacio M, Orlandi EM, Pregno P, Galimberti S, Russo Rossi A, Abruzzese E, Iurlo A, Martino B, Sgherza N, Binotto G, Castagnetti F, Gozzini A, Fozza C, Bocchia M, Sicuranza A, Stagno F, Efficace F, Usala E, De Gregorio F, Scaffidi L, Elena C, Pirillo F, Baratè C, Trawinska MM, Cattaneo D, Labate C, Gugliotta G, Molica M, Specchia G, La Nasa G, Foà R, Breccia M |
| 2018 | 29279145 | 10.1016/j.ejrad.2017.10.025 | Diffusion-weighted magnetic resonance imaging in painful bone metastases: Using quantitative apparent diffusion coefficient as an indicator of effectiveness of single fraction versus multiple fraction radiotherapy. | European journal of radiology | Musio D, De Francesco I, Galdieri A, Marsecano C, Piciocchi A, Napoli A, De Felice F, Tombolini V |
| 2018 | 29502153 | 10.1007/s00520-018-4124-2 | Sexual health in patients with hematological malignancies: a neglected issue. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | Niscola P, Efficace F, Abruzzese E |
| 2018 | 29231969 | 10.1002/cncr.31193 | Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes. | Cancer | Efficace F, Cottone F, Abel G, Niscola P, Gaidano G, Bonnetain F, Anota A, Caocci G, Cronin A, Fianchi L, Breccia M, Stauder R, Platzbecker U, Palumbo GA, Luppi M, Invernizzi R, Bergamaschi M, Borin L, Di Tucci AA, Zhang H, Sprangers M, Vignetti M, Mandelli F |
| 2018 | 29205204 | 10.1038/tpj.2017.48 | MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine. | The pharmacogenomics journal | Visani G, Loscocco F, Ruzzo A, Galimberti S, Graziano F, Voso MT, Giacomini E, Finelli C, Ciabatti E, Fabiani E, Barulli S, Volpe A, Magro D, Piccaluga P, Fuligni F, Vignetti M, Fazi P, Piciocchi A, Gabucci E, Rocchi M, Magnani M, Isidori A |
| 2018 | 29191722 | 10.1016/j.jpainsymman.2017.11.023 | Early Palliative Care in Patients With Hematological Malignancies: Where Do We Go From Here? | Journal of pain and symptom management | Niscola P, Tendas A, Efficace F |
| 2018 | 28857424 | 10.1002/pon.4548 | A cross-cultural convergent parallel mixed methods study of what makes a cancer-related symptom or functional health problem clinically important. | Psycho-oncology | Giesinger JM, Aaronson NK, Arraras JI, Efficace F, Groenvold M, Kieffer JM, Loth FL, Petersen MA, Ramage J, Tomaszewski KA, Young T, Holzner B, |
| 2018 | 29674504 | 10.3324/haematol.2018.189837 | Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study. | Haematologica | Cuneo A, Follows G, Rigolin GM, Piciocchi A, Tedeschi A, Trentin L, Perez AM, Coscia M, Laurenti L, Musuraca G, Farina L, Delgado AR, Orlandi EM, Galieni P, Mauro FR, Visco C, Amendola A, Billio A, Marasca R, Chiarenza A, Meneghini V, Ilariucci F, Marchetti M, Molica S, Re F, Gaidano G, Gonzalez M, Forconi F, Ciolli S, Cortelezzi A, Montillo M, Smolej L, Schuh A, Eyre TA, Kennedy B, Bowles KM, Vignetti M, de la Serna J, Moreno C, Foà R, Ghia P, |
| 2018 | 29365086 | 10.1093/annonc/mdy021 | Genetic landscape of ultra-stable chronic lymphocytic leukemia patients. | Annals of oncology : official journal of the European Society for Medical Oncology | Raponi S, Del Giudice I, Marinelli M, Wang J, Cafforio L, Ilari C, Piciocchi A, Messina M, Bonina S, Tavolaro S, Bordyuh M, Mariglia P, Peragine N, Mauro FR, Chiaretti S, Molica S, Gentile M, Visentin A, Trentin L, Rigolin GM, Cuneo A, Diop F, Rossi D, Gaidano G, Guarini A, Rabadan R, Foà R |
| 2018 | 28924243 | 10.1038/leu.2017.292 | Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low- and very-low-risk genetic profile. | Leukemia | Giudice ID, Rigolin GM, Raponi S, Cafforio L, Ilari C, Wang J, Bordyuh M, Piciocchi A, Marinelli M, Nanni M, Tavolaro S, Filetti M, Bardi A, Tammiso E, Volta E, Negrini M, Saccenti E, Mauro FR, Rossi D, Gaidano G, Guarini A, Rabadan R, Cuneo A, Foà R |
| 2017 | 28490338 | 10.1186/s12955-017-0670-4 | International evaluation of the psychometrics of health-related quality of life questionnaires for use among long-term survivors of testicular and prostate cancer. | Health and quality of life outcomes | van Leeuwen M, Kieffer JM, Efficace F, Fosså SD, Bolla M, Collette L, Colombel M, De Giorgi U, Holzner B, van de Poll-Franse LV, van Poppel H, White J, de Wit R, Osanto S, Aaronson NK, , , |
| 2017 | 28535695 | 10.1080/10428194.2017.1330476 | Are chronic myeloid leukemia patients ready to stop long-term treatment? | Leukemia & lymphoma | Breccia M, Efficace F |
| 2017 | 28791622 | 10.1007/s40265-017-0795-0 | Lenalidomide: A Review in Newly Diagnosed Multiple Myeloma as Maintenance Therapy After ASCT. | Drugs | Syed YY |
| 2017 | 28655808 | 10.3324/haematol.2017.166280 | Chronic myeloid leukemia: room for improvement? | Haematologica | Baccarani M, Pane F, Rosti G, Russo D, Saglio G |
| 2017 | 28694324 | 10.1182/blood-2017-03-737403 | Patient-reported outcomes in hematology: is it time to focus more on them in clinical trials and hematology practice? | Blood | Efficace F, Gaidano G, Lo-Coco F |
| 2017 | 29047379 | 10.1186/s12955-017-0788-4 | Physicians' attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients. | Health and quality of life outcomes | Breccia M, Baccarani M, Rosti G, Cottone F, Cannella L, Guilhot F, Vignetti M, Efficace F |
| 2017 | 28596282 | 10.3324/haematol.2016.156901 | Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification. | Haematologica | Laurenti L, Innocenti I, Autore F, Ciolli S, Mauro FR, Mannina D, Del Poeta G, D'Arena G, Massaia M, Coscia M, Molica S, Pozzato G, Efremov DG, Vannata B, Marasca R, Galieni P, Cuneo A, Orlando S, Piciocchi A, Boncompagni R, Vincelli D, Liberati AM, Russo F, Foá R |
| 2017 | 29020286 | 10.1093/cid/cix690 | Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | Girmenia C, Bertaina A, Piciocchi A, Perruccio K, Algarotti A, Busca A, Cattaneo C, Raiola AM, Guidi S, Iori AP, Candoni A, Irrera G, Milone G, Marcacci G, Scimè R, Musso M, Cudillo L, Sica S, Castagna L, Corradini P, Marchesi F, Pastore D, Alessandrino EP, Annaloro C, Ciceri F, Santarone S, Nassi L, Farina C, Viscoli C, Rossolini GM, Bonifazi F, Rambaldi A, |
| 2017 | 28370510 | 10.1111/ejh.12887 | Socioeconomic burden of participation in clinical trials in patients with myeloproliferative neoplasms. | European journal of haematology | Goel S, Paoli C, Iurlo A, Pereira A, Efficace F, Barbui T, Tefferi A, Vannucchi AM, Cervantes F |
| 2017 | 28093565 | 10.1038/leu.2017.20 | Treatment-free remission in chronic myeloid leukemia: floating between expectation and evidence. | Leukemia | Baccarani M |
| 2017 | 27915304 | | Invasive aspergillosis in acute myeloid leukemia: Are we making progress in reducing mortality? | Medical mycology | Dragonetti G, Criscuolo M, Fianchi L, Pagano L |
| 2017 | 27881039 | 10.1080/10428194.2016.1258698 | Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I-II GIMEMA trial. | Leukemia & lymphoma | Mauro FR, Carella AM, Molica S, Paoloni F, Liberati AM, Zaja F, Belsito V, Cortellezzi A, Rizzi R, Tosi P, Spriano M, Ferretti A, Nanni M, Marinelli M, De Propris MS, Orlando SM, Vignetti M, Cuneo A, Guarini AR, Foà R |
| 2017 | 28439887 | 10.1111/bjh.14721 | Clinical significance of recurrent copy number aberrations in B-lineage acute lymphoblastic leukaemia without recurrent fusion genes across age cohorts. | British journal of haematology | Messina M, Chiaretti S, Fedullo AL, Piciocchi A, Puzzolo MC, Lauretti A, Gianfelici V, Apicella V, Fazi P, Te Kronnie G, Testi AM, Vitale A, Guarini A, Foà R |
| 2017 | 27789677 | 10.3324/haematol.2016.153130 | Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: combined phase I/II results of the EORTC/GIMEMA AML-14A trial. | Haematologica | Selleslag D, Suciu S, Meloni G, Muus P, Halkes CJ, Venditti A, Ramadan SM, Pruijt H, Meert L, Vignetti M, Marie JP, Wittnebel S, de Witte T, Amadori S, Willemze R, Baron F |
| 2017 | 27941782 | 10.1038/bmt.2016.308 | Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia. | Bone marrow transplantation | Buccisano F, Maurillo L, Piciocchi A, Del Principe MI, Picardi A, Cerretti R, Cudillo L, De Angelis G, Sarlo C, Cefalo M, Ditto C, Di Veroli A, Mariotti B, Nasso D, De Bellis E, Del Poeta G, Voso MT, Sconocchia G, Lo Coco F, Arcese W, Amadori S, Venditti A |
| 2016 | 26684545 | 10.1111/bjh.13870 | Clinical features and prognostic factors in solitary plasmacytoma. | British journal of haematology | Finsinger P, Grammatico S, Chisini M, Piciocchi A, Foà R, Petrucci MT |
| 2016 | 26546359 | 10.1007/s00277-015-2541-6 | The impact of comorbidity on health-related quality of life in elderly patients with chronic myeloid leukemia. | Annals of hematology | Efficace F, Rosti G, Breccia M, Cottone F, Giesinger JM, Stagno F, Iurlo A, Russo Rossi A, Luciano L, Martino B, Galimberti S, Turri D, Bergamaschi M, Tiribelli M, Fava C, Angelucci E, Mandelli F, Baccarani M |
| 2016 | 27526406 | 10.1016/j.leukres.2016.08.003 | Pushing the boundaries of care in myelodysplastic syndromes: Physical exercise to improve fatigue and health-related quality of life outcomes. | Leukemia research | Efficace F, Cannella L, Cottone F |
| 2016 | 27448405 | | Psychological well-being and social support in chronic myeloid leukemia patients receiving lifelong targeted therapies. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | Efficace F, Breccia M, Cottone F, Okumura I, Doro M, Riccardi F, Rosti G, Baccarani M |
| 2016 | 30302209 | 10.2217/ijh-2016-0013 | Trisenox: a paradigm shift in APL therapy, an interview with Francesco Lo-Coco. | International journal of hematologic oncology | Lo-Coco F |
| 2016 | 27655263 | 10.1136/bmjopen-2016-012863 | Systematic evaluation of patient-reported outcome (PRO) protocol content and reporting in UK cancer clinical trials: the EPiC study protocol. | BMJ open | Ahmed K, Kyte D, Keeley T, Efficace F, Armes J, Brown JM, Calman L, Copland C, Gavin A, Glaser A, Greenfield DM, Lanceley A, Taylor R, Velikova G, Brundage M, Mercieca-Bebber R, King MT, Calvert M |
| 2016 | 25204541 | 10.1136/bmjspcare-2014-000726 | Health-related quality of life in transfusion-dependent patients with myelodysplastic syndromes: a prospective study to assess the impact of iron chelation therapy. | BMJ supportive & palliative care | Efficace F, Santini V, La Nasa G, Cottone F, Finelli C, Borin L, Quaresmini G, Di Tucci AA, Volpe A, Cilloni D, Quarta G, Sanpaolo G, Rivellini F, Salvi F, Molteni A, Voso MT, Alimena G, Fenu S, Mandelli F, Angelucci E |
| 2016 | 26275979 | 10.1007/s11136-015-1099-z | International Society for Quality of Life Research commentary on the draft European Medicines Agency reflection paper on the use of patient-reported outcome (PRO) measures in oncology studies. | Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation | Kyte D, Reeve BB, Efficace F, Haywood K, Mercieca-Bebber R, King MT, Norquist JM, Lenderking WR, Snyder C, Ring L, Velikova G, Calvert M |
| 2016 | 26851406 | 10.1016/j.ejca.2015.12.025 | Patient-reported outcomes in head and neck and thyroid cancer randomised controlled trials: A systematic review of completeness of reporting and impact on interpretation. | European journal of cancer (Oxford, England : 1990) | Mercieca-Bebber RL, Perreca A, King M, Macann A, Whale K, Soldati S, Jacobs M, Efficace F |
| 2016 | 26754556 | 10.1016/j.leukres.2015.11.018 | CRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalities. | Leukemia research | Chiaretti S, Brugnoletti F, Messina M, Paoloni F, Fedullo AL, Piciocchi A, Elia L, Vitale A, Mauro E, Ferrara F, De Fabritiis P, Luppi M, Ronco F, De Propris MS, Raponi S, Kronnie GT, Vignetti M, Guarini A, Foà R |
| 2016 | 27913477 | | The value of quality of life assessment in chronic myeloid leukemia patients receiving tyrosine kinase inhibitors. | Hematology. American Society of Hematology. Education Program | Efficace F, Cannella L |
| 2016 | 27515250 | | A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 study. | Haematologica | Chiaretti S, Vitale A, Vignetti M, Piciocchi A, Fazi P, Elia L, Falini B, Ronco F, Ferrara F, De Fabritiis P, Luppi M, La Nasa G, Tedeschi A, Califano C, Fanin R, Dore F, Mandelli F, Meloni G, Foà R |
| 2016 | 26677846 | 10.1007/s11523-015-0409-2 | Systematic Review of the Side Effects Associated With Anti-HER2-Targeted Therapies Used in the Treatment of Breast Cancer, on Behalf of the EORTC Quality of Life Group. | Targeted oncology | Sodergren SC, Copson E, White A, Efficace F, Sprangers M, Fitzsimmons D, Bottomley A, Johnson CD |
| 2016 | 26238628 | 10.1007/s00520-015-2868-5 | Towards a better understanding of the relationship between side effects of analgesia and quality of life in patients with multiple myeloma. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | Niscola P, Siniscalchi A, Tendas A, de Fabritiis P, Caravita T, Efficace F |
| 2016 | 26910388 | 10.1002/ajh.24341 | Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study. | American journal of hematology | Zaja F, Barcellini W, Cantoni S, Carpenedo M, Caparrotti G, Carrai V, Di Renzo N, Santoro C, Di Nicola M, Veneri D, Simonetti F, Liberati AM, Ferla V, Paoloni F, Crea E, Volpetti S, Tuniz E, Fanin R |
| 2016 | 26811524 | 10.1200/JCO.2015.64.0060 | Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | Amadori S, Suciu S, Selleslag D, Aversa F, Gaidano G, Musso M, Annino L, Venditti A, Voso MT, Mazzone C, Magro D, De Fabritiis P, Muus P, Alimena G, Mancini M, Hagemeijer A, Paoloni F, Vignetti M, Fazi P, Meert L, Ramadan SM, Willemze R, de Witte T, Baron F |
| 2016 | 27151993 | 10.3324/haematol.2015.139410 | RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications. | Haematologica | Gianfelici V, Chiaretti S, Demeyer S, Di Giacomo F, Messina M, La Starza R, Peragine N, Paoloni F, Geerdens E, Pierini V, Elia L, Mancini M, De Propris MS, Apicella V, Gaidano G, Testi AM, Vitale A, Vignetti M, Mecucci C, Guarini A, Cools J, Foà R |
| 2016 | 26944474 | 10.3324/haematol.2015.140335 | Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS). | Haematologica | Abel GA, Efficace F, Buckstein RJ, Tinsley S, Jurcic JG, Martins Y, Steensma DP, Watts CD, Raza A, Lee SJ, List AF, Klaassen RJ |
| 2016 | 26883104 | 10.18632/oncotarget.7356 | Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes. | Oncotarget | Messina M, Chiaretti S, Wang J, Fedullo AL, Peragine N, Gianfelici V, Piciocchi A, Brugnoletti F, Di Giacomo F, Pauselli S, Holmes AB, Puzzolo MC, Ceglie G, Apicella V, Mancini M, Te Kronnie G, Testi AM, Vitale A, Vignetti M, Guarini A, Rabadan R, Foà R |
| 2016 | 27133819 | 10.1038/leu.2016.122 | PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy. | Leukemia | Cicconi L, Divona M, Ciardi C, Ottone T, Ferrantini A, Lavorgna S, Alfonso V, Paoloni F, Piciocchi A, Avvisati G, Ferrara F, Di Bona E, Albano F, Breccia M, Cerqui E, Sborgia M, Kropp MG, Santoro A, Levis A, Sica S, Amadori S, Voso MT, Mandelli F, Lo-Coco F |
| 2016 | 27260015 | 10.1007/s00520-016-3286-z | Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysis. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | Breccia M, Graffigna G, Galimberti S, Iurlo A, Pungolino E, Pizzuti M, Maggi A, Falzetti F, Capalbo SF, Intermesoli T, Maffioli M, Elena C, Melosi A, Simonetti F, Capochiani E, Seta RD, Pacilli M, Luppi M, Di Renzo N, Mastrullo L, Trabacchi E, Vallisa D, Rapezzi D, Orlandi EM, Gambacorti-Passerini C, Efficace F, Alimena G |
| 2016 | 26913809 | 10.1111/bjh.13991 | Can chronic myeloid leukaemia in children and adolescents be successfully treated without haematopoietic stem cell transplant? A single centre experience. | British journal of haematology | Giona F, Moleti ML, De Benedittis D, Santopietro M, Nanni M, Testi AM, Orlando S, Iori AP, Piciocchi A, Gottardi E, Barberi W, Diverio D, Saglio G, Foà R |
| 2016 | 27351715 | 10.1002/ajh.24463 | Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease. | American journal of hematology | Efficace F, Mandelli F, Fazi P, Santoro C, Gaidano G, Cottone F, Borchiellini A, Carpenedo M, Simula MP, Di Giacomo V, Bergamaschi M, Vincelli ID, Rodeghiero F, Ruggeri M, Scaramucci L, Rambaldi A, Cascavilla N, Forghieri F, Petrungaro A, Ditonno P, Caocci G, Cirrincione S, Mazzucconi MG |
| 2016 | 26886181 | 10.1016/j.ejca.2016.01.001 | Developing a core set of patient-reported outcomes in pancreatic cancer: A Delphi survey. | European journal of cancer (Oxford, England : 1990) | Gerritsen A, Jacobs M, Henselmans I, van Hattum J, Efficace F, Creemers GJ, de Hingh IH, Koopman M, Molenaar IQ, Wilmink HW, Busch OR, Besselink MG, van Laarhoven HW, |
| 2016 | 27007970 | 10.1056/NEJMc1513710 | Targeted Therapy Alone for Acute Promyelocytic Leukemia. | The New England journal of medicine | Lo-Coco F, Di Donato L, , Schlenk RF, |
| 2016 | 26954305 | 10.1586/17474086.2016.1164030 | Improving accuracy of prognosis in patients with myelodysplastic syndromes using self-reported quality of life data. Opportunities for a new research agenda in developing prognostic models. | Expert review of hematology | Niscola P, Mandelli F, Efficace F |
| 2016 | 27142666 | 10.1080/03007995.2016.1185399 | Health-related quality of life outcomes in chronic myeloid leukemia patients treated with second generation tyrosine kinase inhibitors: do we know enough? | Current medical research and opinion | Breccia M, Efficace F |
| 2016 | 26943037 | 10.18632/oncotarget.7819 | Immunoglobulin gene rearrangements in Chinese and Italian patients with chronic lymphocytic leukemia. | Oncotarget | Marinelli M, Ilari C, Xia Y, Del Giudice I, Cafforio L, Della Starza I, Raponi S, Mariglia P, Bonina S, Yu Z, Yang W, Qiu L, Chan T, Piciocchi A, Kwong YL, Tse E, Li J, Guarini A, Xu W, Foà R |
| 2016 | 27059006 | 10.1002/ajh.24379 | Clinical characteristics and outcome of patients with autoimmune hemolytic anemia uniformly defined as primary by a diagnostic work-up. | American journal of hematology | Mauro FR, Coluzzi S, Paoloni F, Trastulli F, Armiento D, Ferretti A, Giovannetti G, Colafigli G, Molica M, la Rocca U, De Propris MS, Caronna R, Morano G, Guarini A, Girelli G, Foà R |
| 2016 | 27416570 | 10.2450/2016.0321-15 | Italian daily platelet transfusion practice for haematological patients undergoing high dose chemotherapy with or without stem cell transplantation: a survey by the GIMEMA Haemostasis and Thrombosis Working Party. | Blood transfusion = Trasfusione del sangue | Tagariello G, Castaman G, Falanga A, Santoro R, Napolitano M, Storti S, Veneri D, Basso M, Candiotto L, Tassinari C, Federici AB, De Stefano V, |
| 2015 | 25642764 | 10.1038/bmt.2014.322 | Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantation. | Bone marrow transplantation | Brioli A, Perrone G, Patriarca F, Pezzi A, Nobile F, Ballerini F, Motta MR, Ronconi S, Tacchetti P, Catalano L, Zannetti BA, Rizzi S, Volpe S, Zamagni E, Liberati AM, Mancuso K, Boccadoro M, Davies FE, Morgan GJ, Palumbo A, Cavo M |
| 2015 | 25862702 | 10.3324/haematol.2015.125484 | Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: an Italian multidisciplinary consensus statement. | Haematologica | Girmenia C, Viscoli C, Piciocchi A, Cudillo L, Botti S, Errico A, Sarmati L, Ciceri F, Locatelli F, Giannella M, Bassetti M, Tascini C, Lombardini L, Majolino I, Farina C, Luzzaro F, Rossolini GM, Rambaldi A |
| 2015 | 25650091 | 10.1038/leu.2015.21 | Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease. | Leukemia | Mauro FR, Chauvie S, Paoloni F, Biggi A, Cimino G, Rago A, Gentile M, Morabito F, Coscia M, Bellò M, Sacchetti GM, Rossi D, Laurenti L, Autore F, Campanelli M, Trastulli F, Nicolai E, Riminucci M, Gaidano G, Guarini A, Gallamini A, Foà R |
| 2015 | 25310302 | 10.1038/bmt.2014.231 | Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy. | Bone marrow transplantation | Girmenia C, Rossolini GM, Piciocchi A, Bertaina A, Pisapia G, Pastore D, Sica S, Severino A, Cudillo L, Ciceri F, Scimè R, Lombardini L, Viscoli C, Rambaldi A, , |
| 2015 | 25691680 | 10.1200/JCO.2014.60.3597 | Reply to M. Koehler et al. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | Efficace F, Cottone F, Lo-Coco F |
| 2015 | 25272332 | 10.1111/bjh.13138 | Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes. | British journal of haematology | Efficace F, Gaidano G, Breccia M, Criscuolo M, Cottone F, Caocci G, Bowen D, Lübbert M, Angelucci E, Stauder R, Selleslag D, Platzbecker U, Sanpaolo G, Jonasova A, Buccisano F, Specchia G, Palumbo GA, Niscola P, Wan C, Zhang H, Fenu S, Klimek V, Beyne-Rauzy O, Nguyen K, Mandelli F |
| 2015 | 25096636 | 10.1007/s00277-014-2177-y | Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies. | Annals of hematology | Oosterveld M, Suciu S, Muus P, Germing U, Delforge M, Belhabri A, Aul C, Selleslag D, Ferrant A, Marie JP, Amadori S, Jehn U, Mandelli F, Hess U, Hellström-Lindberg E, Cakmak-Wollgast S, Vignetti M, Labar B, Willemze R, de Witte T |
| 2015 | 25027515 | 10.1038/leu.2014.219 | Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival. | Leukemia | Ferrero S, Ladetto M, Drandi D, Cavallo F, Genuardi E, Urbano M, Caltagirone S, Grasso M, Rossini F, Guglielmelli T, Cangialosi C, Liberati AM, Callea V, Carovita T, Crippa C, De Rosa L, Pisani F, Falcone AP, Pregno P, Oliva S, Terragna C, Musto P, Passera R, Boccadoro M, Palumbo A |
| 2015 | 25361995 | 10.1093/annonc/mdu490 | Differences among young adults, adults and elderly chronic myeloid leukemia patients. | Annals of oncology : official journal of the European Society for Medical Oncology | Castagnetti F, Gugliotta G, Baccarani M, Breccia M, Specchia G, Levato L, Abruzzese E, Rossi G, Iurlo A, Martino B, Pregno P, Stagno F, Cuneo A, Bonifacio M, Gobbi M, Russo D, Gozzini A, Tiribelli M, de Vivo A, Alimena G, Cavo M, Martinelli G, Pane F, Saglio G, Rosti G, |
| 2015 | 25430625 | 10.1111/bjh.13250 | Managing children with chronic myeloid leukaemia. | British journal of haematology | Baccarani M |
| 2015 | 26453660 | 10.1182/blood-2015-07-658922 | Time to improve health-related quality of life outcomes in patients with acute promyelocytic leukemia. | Blood | Efficace F, Mandelli F, Platzbecker U, Cottone F, Lo Coco F |
| 2015 | 26120100 | 10.1016/j.leukres.2015.05.012 | Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes. | Leukemia research | Caocci G, Voso MT, Angelucci E, Stauder R, Cottone F, Abel G, Nguyen K, Platzbecker U, Beyne-Rauzy O, Gaidano G, Invernizzi R, Molica S, Criscuolo M, Breccia M, Lübbert M, Sanpaolo G, Buccisano F, Ricco A, Palumbo GA, Niscola P, Zhang H, Fenu S, La Nasa G, Mandelli F, Efficace F |
| 2015 | 25402418 | 10.1038/bmt.2014.262 | High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT. | Bone marrow transplantation | Hengeveld M, Suciu S, Chelgoum Y, Marie JP, Muus P, Lefrère F, Mandelli F, Pane F, Amadori S, Fioritoni G, Labar B, Baron F, Cermak J, Bourhis JH, Storti G, Fazi P, Hagemeijer A, Vignetti M, Willemze R, de Witte T |
| 2015 | 25824293 | 10.1159/000370023 | Does low-molecular-weight heparin influence the antimyeloma effects of thalidomide? A retrospective analysis of data from the GIMEMA, Nordic and Turkish myeloma study groups. | Acta haematologica | Beksac M, Waage A, Bringhen S, Kristinsson SY, Sucak GT, Gimsing P, Lupparelli G, Fıratlı-Tuğlular T, Juliusson G, Turesson I, Palumbo A |
| 2015 | 25910987 | 10.1007/s00432-015-1970-x | Patient-reported outcomes in randomised controlled trials of colorectal cancer: an analysis determining the availability of robust data to inform clinical decision-making. | Journal of cancer research and clinical oncology | Rees JR, Whale K, Fish D, Fayers P, Cafaro V, Pusic A, Blazeby JM, Efficace F |
| 2015 | 26410352 | 10.1007/s00277-015-2486-9 | Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013). | Annals of hematology | de Witte T, Suciu S, Meert L, Halkes C, Selleslag D, Bron D, Amadori S, Willemze R, Muus P, Baron F |
| 2015 | 25891192 | 10.1111/bjh.13453 | Long-term results of high-dose imatinib in children and adolescents with chronic myeloid leukaemia in chronic phase: the Italian experience. | British journal of haematology | Giona F, Putti MC, Micalizzi C, Menna G, Moleti ML, Santoro N, Iaria G, Ladogana S, Burnelli R, Consarino C, Varotto S, Tucci F, Messina C, Nanni M, Diverio D, Biondi A, Pession A, Locatelli F, Piciocchi A, Gottardi E, Saglio G, Foà R |
| 2015 | 26404501 | 10.1016/S1470-2045(15)00206-5 | Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study. | The Lancet. Oncology | Efficace F, Gaidano G, Breccia M, Voso MT, Cottone F, Angelucci E, Caocci G, Stauder R, Selleslag D, Sprangers M, Platzbecker U, Ricco A, Sanpaolo G, Beyne-Rauzy O, Buccisano F, Palumbo GA, Bowen D, Nguyen K, Niscola P, Vignetti M, Mandelli F |
| 2015 | 26324461 | 10.1016/j.critrevonc.2015.07.012 | Health-related quality of life and symptom assessment in randomized controlled trials of patients with leukemia and myelodysplastic syndromes: What have we learned? | Critical reviews in oncology/hematology | Cannella L, Caocci G, Jacobs M, Vignetti M, Mandelli F, Efficace F |
| 2015 | 26282944 | 10.1016/j.leukres.2015.07.004 | Adherence and future discontinuation of tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia. A patient-based survey on 1133 patients. | Leukemia research | Breccia M, Efficace F, Sica S, Abruzzese E, Cedrone M, Turri D, Gobbi M, Carella AM, Gozzini A, Usala E, Cavazzini F, Danise P, Tiribelli M, Binotto G, Pregno P, Bocchia M, Gaidano G, Crugnola M, Bonifacio M, Avanzini P, Celesti F, Guella A, Martino B, Annunziata M, Luciano L, Stagno F, Vallisa D, Pungolino E, Iurlo A, Rambaldi A, Nardiello I, Orlandi E, Gambacorti-Passerini C, Alimena G |
| 2015 | 25869029 | 10.1007/s00277-015-2364-5 | Minimal residual disease negativity in elderly patients with acute myeloid leukemia may indicate different postremission strategies than in younger patients. | Annals of hematology | Buccisano F, Maurillo L, Piciocchi A, Del Principe MI, Sarlo C, Cefalo M, Ditto C, Di Veroli A, De Santis G, Irno Consalvo M, Fraboni D, Panetta P, Palomba P, Attrotto C, Del Poeta G, Sconocchia G, Lo-Coco F, Amadori S, Venditti A |
| 2015 | 26113419 | 10.3324/haematol.2015.129221 | Long-term outcome of a phase 2 trial with nilotinib 400 mg twice daily in first-line treatment of chronic myeloid leukemia. | Haematologica | Gugliotta G, Castagnetti F, Breccia M, Levato L, D'Adda M, Stagno F, Tiribelli M, Salvucci M, Fava C, Martino B, Cedrone M, Bocchia M, Trabacchi E, Cavazzini F, Usala E, Russo Rossi A, Bochicchio MT, Soverini S, Alimena G, Cavo M, Pane F, Martinelli G, Saglio G, Baccarani M, Rosti G, |
| 2015 | 25956189 | 10.1016/j.urolonc.2015.04.002 | Quality of life and symptom assessment in randomized clinical trials of bladder cancer: A systematic review. | Urologic oncology | Feuerstein MA, Jacobs M, Piciocchi A, Bochner B, Pusic A, Fayers P, Blazeby J, Efficace F, |
| 2015 | 26212516 | 10.1111/bjh.13576 | Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation. | British journal of haematology | Symeonidis A, van Biezen A, de Wreede L, Piciocchi A, Finke J, Beelen D, Bornhäuser M, Cornelissen J, Volin L, Mufti G, Chalandon Y, Ganser A, Bruno B, Niederwieser D, Kobbe G, Schwerdtfeger R, de Witte T, Robin M, Kröger N, |
| 2014 | 24597984 | 10.3109/10428194.2014.898760 | NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment. | Leukemia & lymphoma | Chiaretti S, Marinelli M, Del Giudice I, Bonina S, Piciocchi A, Messina M, Vignetti M, Rossi D, Di Maio V, Mauro FR, Guarini A, Gaidano G, Foà R |
| 2014 | 24813918 | 10.1038/leu.2014.155 | Circulating miRNA markers show promise as new prognosticators for multiple myeloma. | Leukemia | Rocci A, Hofmeister CC, Geyer S, Stiff A, Gambella M, Cascione L, Guan J, Benson DM, Efebera YA, Talabere T, Dirisala V, Smith EM, Omedè P, Isaia G, De Luca L, Rossi D, Gentili S, Uccello G, Consiglio J, Ria R, Benevolo G, Bringhen S, Callea V, Weiss B, Ferro A, Magarotto V, Alder H, Byrd JC, Boccadoro M, Marcucci G, Palumbo A, Pichiorri F |
| 2014 | 24702186 | 10.1111/ejh.12337 | Patient-reported outcomes in acute leukemia: a roadmap for future research. | European journal of haematology | Efficace F, Breccia M, Lo Coco F |
| 2014 | 25159313 | 10.1002/ajh.23835 | Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study. | American journal of hematology | Tacchetti P, Terragna C, Galli M, Zamagni E, Petrucci MT, Pezzi A, Montefusco V, Martello M, Tosi P, Baldini L, Peccatori J, Ruggieri M, Pantani L, Lazzaro A, Elice F, Rocchi S, Gozzetti A, Cavaletti G, Palumbo A, Cavo M |
| 2014 | 24763402 | 10.3324/haematol.2013.099341 | Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapy. | Haematologica | Mateos MV, Bringhen S, Richardson PG, Lahuerta JJ, Larocca A, Oriol A, Boccadoro M, García-Sanz R, Di Raimondo F, Esseltine DL, van de Velde H, Desai A, Londhe A, San Miguel JF, Palumbo A |
| 2014 | 24682421 | 10.1007/s00277-014-2056-6 | Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial). | Annals of hematology | Willemze R, Suciu S, Muus P, Halkes CJ, Meloni G, Meert L, Karrasch M, Rapion J, Vignetti M, Amadori S, de Witte T, Marie JP |
| 2014 | 24994606 | 10.1007/s00277-014-2055-7 | Clinical and biological impact of TET2 mutations and expression in younger adult AML patients treated within the EORTC/GIMEMA AML-12 clinical trial. | Annals of hematology | Aslanyan MG, Kroeze LI, Langemeijer SM, Koorenhof-Scheele TN, Massop M, van Hoogen P, Stevens-Linders E, van de Locht LT, Tönnissen E, van der Heijden A, da Silva-Coelho P, Cilloni D, Saglio G, Marie JP, Tang R, Labar B, Amadori S, Muus P, Willemze R, Marijt EW, de Witte T, van der Reijden BA, Suciu S, Jansen JH |
| 2014 | 24820932 | 10.1016/j.ejca.2014.04.018 | Recruiting long-term survivors of European Organisation for Research and Treatment of Cancer phase III clinical trials into quality of life studies: challenges and opportunities. | European journal of cancer (Oxford, England : 1990) | van Leeuwen M, Efficace F, Fosså SD, Bolla M, De Giorgi U, de Wit R, Holzner B, van de Poll-Franse LV, van Poppel H, White J, Collette L, Osanto S, Aaronson NK, , , |
| 2014 | 25034656 | 10.1016/j.ejca.2014.06.016 | The level of patient-reported outcome reporting in randomised controlled trials of brain tumour patients: a systematic review. | European journal of cancer (Oxford, England : 1990) | Dirven L, Taphoorn MJ, Reijneveld JC, Blazeby J, Jacobs M, Pusic A, La Sala E, Stupp R, Fayers P, Efficace F, |
| 2014 | 24888806 | 10.1200/JCO.2013.53.0329 | Combination of international scoring system 3, high lactate dehydrogenase, and t(4;14) and/or del(17p) identifies patients with multiple myeloma (MM) treated with front-line autologous stem-cell transplantation at high risk of early MM progression-related death. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | Moreau P, Cavo M, Sonneveld P, Rosinol L, Attal M, Pezzi A, Goldschmidt H, Lahuerta JJ, Marit G, Palumbo A, van der Holt B, Bladé J, Petrucci MT, Neben K, san Miguel J, Patriarca F, Lokhorst H, Zamagni E, Hulin C, Gutierrez N, Facon T, Caillot D, Benboubker L, Harousseau JL, Leleu X, Avet-Loiseau H, Mary JY |
| 2014 | 24902767 | 10.1186/1477-7525-12-86 | Overcoming barriers to the implementation of patient-reported outcomes in cancer clinical trials: the PROMOTION Registry. | Health and quality of life outcomes | Efficace F, Rees J, Fayers P, Pusic A, Taphoorn M, Greimel E, Reijneveld J, Whale K, Blazeby J, |
| 2014 | 24986689 | 10.1182/blood-2013-08-518514 | Characterization of acute myeloid leukemia based on levels of global hydroxymethylation. | Blood | Kroeze LI, Aslanyan MG, van Rooij A, Koorenhof-Scheele TN, Massop M, Carell T, Boezeman JB, Marie JP, Halkes CJ, de Witte T, Huls G, Suciu S, Wevers RA, van der Reijden BA, Jansen JH, |
| 2014 | 25015938 | 10.3324/haematol.2014.103853 | Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies. | Haematologica | Caltagirone S, Ruggeri M, Aschero S, Gilestro M, Oddolo D, Gay F, Bringhen S, Musolino C, Baldini L, Musto P, Petrucci MT, Gaidano G, Passera R, Bruno B, Palumbo A, Boccadoro M, Omedè P |
| 2014 | 24631738 | 10.1016/j.bbmt.2014.03.004 | Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO). | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | Girmenia C, Raiola AM, Piciocchi A, Algarotti A, Stanzani M, Cudillo L, Pecoraro C, Guidi S, Iori AP, Montante B, Chiusolo P, Lanino E, Carella AM, Zucchetti E, Bruno B, Irrera G, Patriarca F, Baronciani D, Musso M, Prete A, Risitano AM, Russo D, Mordini N, Pastore D, Vacca A, Onida F, Falcioni S, Pisapia G, Milone G, Vallisa D, Olivieri A, Bonini A, Castagnola E, Sica S, Majolino I, Bosi A, Busca A, Arcese W, Bandini G, Bacigalupo A, Rambaldi A, Locasciulli A |
| 2014 | 24825114 | 10.1016/j.ejca.2014.04.005 | Patient-reported outcomes in randomised controlled trials of gynaecological cancers: investigating methodological quality and impact on clinical decision-making. | European journal of cancer (Oxford, England : 1990) | Efficace F, Jacobs M, Pusic A, Greimel E, Piciocchi A, Kieffer JM, Gilbert A, Fayers P, Blazeby J, |
| 2014 | 24241488 | 10.3324/haematol.2013.093724 | Patient- versus physician-reporting of symptoms and health status in chronic myeloid leukemia. | Haematologica | Efficace F, Rosti G, Aaronson N, Cottone F, Angelucci E, Molica S, Vignetti M, Mandelli F, Baccarani M |
| 2014 | 24580147 | 10.1111/ejh.12300 | Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial). | European journal of haematology | Angelucci E, Santini V, Di Tucci AA, Quaresmini G, Finelli C, Volpe A, Quarta G, Rivellini F, Sanpaolo G, Cilloni D, Salvi F, Caocci G, Molteni A, Vallisa D, Voso MT, Fenu S, Borin L, Latte G, Alimena G, Storti S, Piciocchi A, Fazi P, Vignetti M, Tura S |
| 2014 | 24478321 | 10.1093/annonc/mdt557 | Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromes. | Annals of oncology : official journal of the European Society for Medical Oncology | Efficace F, Gaidano G, Sprangers M, Cottone F, Breccia M, Voso MT, Caocci G, Stauder R, Di Tucci AA, Sanpaolo G, Selleslag D, Angelucci E, Platzbecker U, Mandelli F |
| 2014 | 25232059 | 10.1182/blood-2014-06-583021 | Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients. | Blood | Barcellini W, Fattizzo B, Zaninoni A, Radice T, Nichele I, Di Bona E, Lunghi M, Tassinari C, Alfinito F, Ferrari A, Leporace AP, Niscola P, Carpenedo M, Boschetti C, Revelli N, Villa MA, Consonni D, Scaramucci L, De Fabritiis P, Tagariello G, Gaidano G, Rodeghiero F, Cortelezzi A, Zanella A |
| 2014 | 24455119 | 10.4084/MJHID.2014.010 | A critical history of chromic myeloid leukemia. | Mediterranean journal of hematology and infectious diseases | Baccarani M, Pane F |
| 2014 | 24210091 | 10.1016/j.eururo.2013.10.017 | Patient-reported outcomes in randomised controlled trials of prostate cancer: methodological quality and impact on clinical decision making. | European urology | Efficace F, Feuerstein M, Fayers P, Cafaro V, Eastham J, Pusic A, Blazeby J, |
| 2014 | 24534569 | 10.1016/j.leukres.2014.01.007 | Invasive fungal diseases during first induction chemotherapy affect complete remission achievement and long-term survival of patients with acute myeloid leukemia. | Leukemia research | Girmenia C, Micozzi A, Piciocchi A, Gentile G, Di Caprio L, Nasso D, Minotti C, Capria S, Cartoni C, Alimena G, Meloni G, Amadori S, Foà R, Venditti A |
| 2014 | 24497557 | 10.3324/haematol.2013.094045 | Moving towards patient-centered decision-making in chronic myeloid leukemia: assessment of quality of life and symptom burden. | Haematologica | Baccarani M, Efficace F, Rosti G |
| 2014 | 24495942 | 10.1016/j.critrevonc.2014.01.002 | Systematic review of the side effects associated with tyrosine kinase inhibitors used in the treatment of gastrointestinal stromal tumours on behalf of the EORTC Quality of Life Group. | Critical reviews in oncology/hematology | Sodergren SC, White A, Efficace F, Sprangers M, Fitzsimmons D, Bottomley A, Johnson CD |
| 2014 | 24314589 | 10.1016/j.leukres.2013.11.009 | Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile. | Leukemia research | Mauro FR, Molica S, Laurenti L, Cortelezzi A, Carella AM, Zaja F, Chiarenza A, Angrilli F, Nobile F, Marasca R, Musolino C, Brugiatelli M, Piciocchi A, Vignetti M, Fazi P, Gentile G, De Propris MS, Della Starza I, Marinelli M, Chiaretti S, Del Giudice I, Nanni M, Albano F, Cuneo A, Guarini A, Foà R, |
| 2014 | 23906625 | 10.1016/j.leukres.2013.07.003 | Profiling chronic myeloid leukemia patients reporting intentional and unintentional non-adherence to lifelong therapy with tyrosine kinase inhibitors. | Leukemia research | Efficace F, Rosti G, Cottone F, Breccia M, Castagnetti F, Iurlo A, Mandelli F, Baccarani M |
| 2014 | 24297940 | 10.1200/JCO.2013.51.8571 | High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | Willemze R, Suciu S, Meloni G, Labar B, Marie JP, Halkes CJ, Muus P, Mistrik M, Amadori S, Specchia G, Fabbiano F, Nobile F, Sborgia M, Camera A, Selleslag DL, Lefrère F, Magro D, Sica S, Cantore N, Beksac M, Berneman Z, Thomas X, Melillo L, Guimaraes JE, Leoni P, Luppi M, Mitra ME, Bron D, Fillet G, Marijt EW, Venditti A, Hagemeijer A, Mancini M, Jansen J, Cilloni D, Meert L, Fazi P, Vignetti M, Trisolini SM, Mandelli F, de Witte T |
| 2014 | 24220274 | 10.1038/leu.2013.334 | Bendamustine in combination with ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial. | Leukemia | Cortelezzi A, Sciumè M, Liberati AM, Vincenti D, Cuneo A, Reda G, Laurenti L, Zaja F, Marasca R, Chiarenza A, Gritti G, Orsucci L, Storti S, Angelucci E, Cascavilla N, Gobbi M, Mauro FR, Morabito F, Fabris S, Piciocchi A, Vignetti M, Neri A, Rossi D, Giannarelli D, Guarini A, Foà R |
| 2014 | 25245446 | 10.1200/JCO.2014.55.3453 | Randomized phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: health-related quality-of-life outcomes. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | Efficace F, Mandelli F, Avvisati G, Cottone F, Ferrara F, Di Bona E, Specchia G, Breccia M, Levis A, Sica S, Finizio O, Kropp MG, Fioritoni G, Cerqui E, Vignetti M, Amadori S, Schlenk RF, Platzbecker U, Lo-Coco F |
| 2014 | 24582783 | 10.1016/j.bbmt.2014.02.018 | Primary prophylaxis of invasive fungal diseases in allogeneic stem cell transplantation: revised recommendations from a consensus process by Gruppo Italiano Trapianto Midollo Osseo (GITMO). | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | Girmenia C, Barosi G, Piciocchi A, Arcese W, Aversa F, Bacigalupo A, Bandini G, Bosi A, Busca A, Castagnola E, Caselli D, Cesaro S, Ciceri F, Locasciulli A, Locatelli F, Mikulska M, Pagano L, Prete A, Raiola AM, Rambaldi A |
| 2014 | 24026634 | 10.1007/s11136-013-0523-5 | International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24. | Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation | Efficace F, Baccarani M, Breccia M, Saussele S, Abel G, Caocci G, Guilhot F, Cocks K, Naeem A, Sprangers M, Oerlemans S, Chie W, Castagnetti F, Bombaci F, Sharf G, Cardoni A, Noens L, Pallua S, Salvucci M, Nicolatou-Galitis O, Rosti G, Mandelli F |
| 2013 | 23740803 | 10.1002/sim.5868 | The added value of propensity score matching when using health-related quality of life reference data. | Statistics in medicine | Cottone F, Efficace F, Apolone G, Collins GS |
| 2013 | 24127442 | 10.1200/JCO.2013.49.0771 | Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: results of a randomized phase III trial by the EORTC and GIMEMA consortium (AML-17). | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | Amadori S, Suciu S, Stasi R, Salih HR, Selleslag D, Muus P, De Fabritiis P, Venditti A, Ho AD, Lübbert M, Thomas X, Latagliata R, Halkes CJ, Falzetti F, Magro D, Guimaraes JE, Berneman Z, Specchia G, Karrasch M, Fazi P, Vignetti M, Willemze R, de Witte T, Marie JP |
| 2013 | 23897961 | 10.1200/JCO.2012.48.4626 | Bortezomib-based versus nonbortezomib-based induction treatment before autologous stem-cell transplantation in patients with previously untreated multiple myeloma: a meta-analysis of phase III randomized, controlled trials. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | Sonneveld P, Goldschmidt H, Rosiñol L, Bladé J, Lahuerta JJ, Cavo M, Tacchetti P, Zamagni E, Attal M, Lokhorst HM, Desai A, Cakana A, Liu K, van de Velde H, Esseltine DL, Moreau P |
| 2013 | 24168680 | 10.1186/1477-7525-11-184 | The CONSORT Patient-Reported Outcome (PRO) extension: implications for clinical trials and practice. | Health and quality of life outcomes | Calvert M, Brundage M, Jacobsen PB, Schünemann HJ, Efficace F |
| 2013 | 23417029 | 10.1038/leu.2013.51 | Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib. | Leukemia | Efficace F, Baccarani M, Breccia M, Cottone F, Alimena G, Deliliers GL, Baratè C, Specchia G, Di Lorenzo R, Luciano L, Turri D, Martino B, Stagno F, Dabusti M, Bergamaschi M, Leoni P, Simula MP, Levato L, Fava C, Veneri D, Sica S, Rambaldi A, Rosti G, Vignetti M, Mandelli F |
| 2013 | 23177797 | 10.1016/j.leukres.2012.10.021 | Tyrosine-kinase inhibitors and patient-reported outcomes in chronic myeloid leukemia: a systematic review. | Leukemia research | Efficace F, Cardoni A, Cottone F, Vignetti M, Mandelli F |
| 2013 | 23716539 | 10.3324/haematol.2012.080432 | Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts. | Haematologica | Chiaretti S, Vitale A, Cazzaniga G, Orlando SM, Silvestri D, Fazi P, Valsecchi MG, Elia L, Testi AM, Mancini F, Conter V, te Kronnie G, Ferrara F, Di Raimondo F, Tedeschi A, Fioritoni G, Fabbiano F, Meloni G, Specchia G, Pizzolo G, Mandelli F, Guarini A, Basso G, Biondi A, Foà R |
| 2012 | 22985353 | 10.1111/ejh.12004 | Predicting survival in advanced hematologic malignancies: do patient-reported symptoms matter? | European journal of haematology | Efficace F, Cartoni C, Niscola P, Tendas A, Meloni E, Scaramucci L, Soldati S, Brunetti GA, Marini MG, Mandelli F |
| 2012 | 22871884 | 10.1038/bjc.2012.348 | Investigating factors associated with adherence behaviour in patients with chronic myeloid leukemia: an observational patient-centered outcome study. | British journal of cancer | Efficace F, Baccarani M, Rosti G, Cottone F, Castagnetti F, Breccia M, Alimena G, Iurlo A, Rossi AR, Pardini S, Gherlinzoni F, Salvucci M, Tiribelli M, Vignetti M, Mandelli F |
| 2012 | 22786730 | 10.1002/cncr.27657 | Prognostic factors associated with progression of smoldering multiple myeloma to symptomatic form. | Cancer | Rago A, Grammatico S, Za T, Levi A, Mecarocci S, Siniscalchi A, De Rosa L, Felici S, Bongarzoni V, Piccioni AL, La Verde G, Pisani F, Franceschini L, Paviglianiti AL, Caravita T, Petrucci MT, De Stefano V, Cimino G, |
| 2012 | 22543826 | 10.1007/s00277-012-1458-6 | Which health-related quality of life aspects are important to patients with chronic myeloid leukemia receiving targeted therapies and to health care professionals? GIMEMA and EORTC Quality of Life Group. | Annals of hematology | Efficace F, Breccia M, Saussele S, Kossak-Roth U, Cardoni A, Caocci G, Chie W, Naeem A, Nicolatou-Galitis O, Cocks K, Vignetti M, Baccarani M, Mandelli F, Sprangers M |
| 2012 | 22367411 | 10.1007/s11060-012-0819-2 | Methodological issues in designing and reporting health-related quality of life in cancer clinical trials: the challenge of brain cancer studies. | Journal of neuro-oncology | Efficace F, Taphoorn M |
| 2012 | 22460947 | 10.1007/s00277-012-1436-z | Intensive consolidation therapy compared with standard consolidation and maintenance therapy for adults with acute myeloid leukaemia aged between 46 and 60 years: final results of the randomized phase III study (AML 8B) of the European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. | Annals of hematology | Hengeveld M, Suciu S, Karrasch M, Specchia G, Marie JP, Muus P, Petti MC, Rotoli B, Amadori S, Fioritoni G, Leoni P, Morra E, Thaler J, Resegotti L, Fazi P, Vignetti M, Mandelli F, Zittoun R, de Witte T |
| 2012 | 22082314 | 10.1111/j.1365-2141.2011.08940.x | Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107). | British journal of haematology | Amadori S, Stasi R, Martelli AM, Venditti A, Meloni G, Pane F, Martinelli G, Lunghi M, Pagano L, Cilloni D, Rossetti E, Di Raimondo F, Fozza C, Annino L, Chiarini F, Ricci F, Ammatuna E, La Sala E, Fazi P, Vignetti M |
| 2012 | 21435899 | 10.1016/j.critrevonc.2011.02.007 | Time for a new era in the evaluation of targeted therapies for patients with chronic myeloid leukemia: inclusion of quality of life and other patient-reported outcomes. | Critical reviews in oncology/hematology | Efficace F, Cocks K, Breccia M, Sprangers M, Meyers CA, Vignetti M, Baccarani M, Mandelli F, |
| 2012 | 22692507 | | Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis. | Blood | Luatti S, Castagnetti F, Marzocchi G, Baldazzi C, Gugliotta G, Iacobucci I, Specchia G, Zanatta L, Rege-Cambrin G, Mancini M, Abruzzese E, Zaccaria A, Grimoldi MG, Gozzetti A, Ameli G, Capucci MA, Palka G, Bernasconi P, Palandri F, Pane F, Saglio G, Martinelli G, Rosti G, Baccarani M, Testoni N, |
| 2012 | 22381082 | 10.1186/1756-9966-31-17 | IgD multiple myeloma a descriptive report of 17 cases: survival and response to therapy. | Journal of experimental & clinical cancer research : CR | Pisani F, Petrucci MT, Giannarelli D, Bongarzoni V, Montanaro M, De Stefano V, La Verde G, Gentilini F, Levi A, Za T, Moscetti A, Annino L, Petti MC, |
| 2012 | 21932386 | 10.1002/cncr.26447 | Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: a retrospective survey of 50 patients. | Cancer | Gozzetti A, Cerase A, Lotti F, Rossi D, Palumbo A, Petrucci MT, Patriarca F, Nozzoli C, Cavo M, Offidani M, Floridia M, Berretta S, Vallone R, Musto P, Lauria F, , Marchini E, Fabbri A, Oliva S, Zamagni E, Sapienza FG, Ballanti S, Mele G, Galli M, Pirrotta MT, Di Raimondo F |
| 2012 | 22039089 | 10.1093/annonc/mdr480 | Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party. | Annals of oncology : official journal of the European Society for Medical Oncology | D'Arena G, Valentini CG, Pietrantuono G, Guariglia R, Martorelli MC, Mansueto G, Villani O, Onofrillo D, Falcone A, Specchia G, Semenzato G, Di Renzo N, Mastrullo L, Venditti A, Ferrara F, Palumbo A, Pagano L, Musto P |
| 2012 | 22049518 | 10.1182/blood-2011-07-369595 | Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols. | Blood | Breccia M, Mazzarella L, Bagnardi V, Disalvatore D, Loglisci G, Cimino G, Testi AM, Avvisati G, Petti MC, Minotti C, Latagliata R, Foà R, Pelicci PG, Lo-Coco F |
| 2011 | 21931113 | 10.1182/blood-2011-05-351403 | Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. | Blood | Foà R, Vitale A, Vignetti M, Meloni G, Guarini A, De Propris MS, Elia L, Paoloni F, Fazi P, Cimino G, Nobile F, Ferrara F, Castagnola C, Sica S, Leoni P, Zuffa E, Fozza C, Luppi M, Candoni A, Iacobucci I, Soverini S, Mandelli F, Martinelli G, Baccarani M, |
| 2011 | 21915304 | 10.1371/journal.pone.0024265 | Targeted drug delivery by gemtuzumab ozogamicin: mechanism-based mathematical model for treatment strategy improvement and therapy individualization. | PloS one | Jager E, van der Velden VH, te Marvelde JG, Walter RB, Agur Z, Vainstein V |
| 2011 | 22084668 | 10.1155/2011/794240 | The CYTO-PV: A Large-Scale Trial Testing the Intensity of CYTOreductive Therapy to Prevent Cardiovascular Events in Patients with Polycythemia Vera. | Thrombosis | Marchioli R, Finazzi G, Specchia G, Masciulli A, Mennitto MR, Barbui T |
| 2011 | 21953617 | 10.1002/ajh.22171 | The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experience. | American journal of hematology | Laurenti L, Tarnani M, Nichele I, Ciolli S, Cortelezzi A, Forconi F, Rossi D, Mauro FR, D'Arena G, Del Poeta G, Montanaro M, Morabito F, Musolino C, Callea V, Falchi L, Tedeschi A, Ambrosetti A, Gaidano G, Leone G, Foà R |
| 2011 | 22053278 | 10.4081/pr.2011.s2.e2 | Acute lymphoblastic leukemia: age and biology. | Pediatric reports | Foà R |
| 2011 | 22215391 | | [Results of treatment of acute lymphoblastic leukemia in two cohorts of Mexican patients]. | Revista medica de Chile | Ramos C, Rozen E, León M, Martínez T A, Olarte I, Catellanos H, Martínez C, Montaño E, Kassack I J, Zamora J, Miranda E, De la Ros A, Gutiérrez M, Collazo J |
| 2011 | 21450900 | 10.1182/blood-2010-12-324228 | Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party. | Blood | Gugliotta G, Castagnetti F, Palandri F, Breccia M, Intermesoli T, Capucci A, Martino B, Pregno P, Rupoli S, Ferrero D, Gherlinzoni F, Montefusco E, Bocchia M, Tiribelli M, Pierri I, Grifoni F, Marzocchi G, Amabile M, Testoni N, Martinelli G, Alimena G, Pane F, Saglio G, Baccarani M, Rosti G, |
| 2011 | 21447834 | 10.1182/blood-2011-01-328294 | Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis. | Blood | Marzocchi G, Castagnetti F, Luatti S, Baldazzi C, Stacchini M, Gugliotta G, Amabile M, Specchia G, Sessarego M, Giussani U, Valori L, Discepoli G, Montaldi A, Santoro A, Bonaldi L, Giudici G, Cianciulli AM, Giacobbi F, Palandri F, Pane F, Saglio G, Martinelli G, Baccarani M, Rosti G, Testoni N, |
| 2011 | 21750313 | 10.1182/blood-2011-04-347575 | Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population. | Blood | Efficace F, Baccarani M, Breccia M, Alimena G, Rosti G, Cottone F, Deliliers GL, Baratè C, Rossi AR, Fioritoni G, Luciano L, Turri D, Martino B, Di Raimondo F, Dabusti M, Bergamaschi M, Leoni P, Simula MP, Levato L, Ulisciani S, Veneri D, Sica S, Rambaldi A, Vignetti M, Mandelli F, |
| 2011 | 21751984 | 10.1111/j.1365-2141.2011.08593.x | GIMEMA AIDA 0493 amended protocol for elderly patients with acute promyelocytic leukaemia. Long-term results and prognostic factors. | British journal of haematology | Latagliata R, Breccia M, Fazi P, Vignetti M, Di Raimondo F, Sborgia M, Vincelli D, Candoni A, Salvi F, Rupoli S, Martinelli G, Kropp MG, Tonso A, Venditti A, Melillo L, Cimino G, Petti MC, Avvisati G, Lo-Coco F, Mandelli F, |
| 2011 | 20971821 | 10.3324/haematol.2010.030189 | Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group. | Haematologica | Molica S, Mauro FR, Giannarelli D, Lauria F, Cortelezzi A, Brugiatelli M, Liso V, Cuneo A, Foà R |
| 2010 | 20393021 | | Acute promyelocytic leukemia in patients aged over 60 years: multicenter experience of 34 consecutive unselected patients. | Anticancer research | Ferrara F, Finizio O, D'Arco A, Mastrullo L, Cantore N, Musto P |
| 2010 | 19903673 | 10.3324/haematol.2009.011767 | The utility of a prognostic index for predicting time to first treatment in early chronic lymphocytic leukemia: the GIMEMA experience. | Haematologica | Molica S, Mauro FR, Callea V, Giannarelli D, Lauria F, Rotoli B, Cortelezzi A, Liso V, Foà R |
| 2010 | 19930441 | 10.1111/j.1600-0609.2009.01385.x | Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMA. | European journal of haematology | Morabito F, Gentile M, Ciolli S, Petrucci MT, Galimberti S, Mele G, Casulli AF, Mannina D, Piro E, Pinotti G, Palmieri S, Catalano L, Callea V, Offidani M, Musto P, Bringhen S, Baldini L, Tosi P, Di Raimondo F, Boccadoro M, Palumbo A, Cavo M |
| 2010 | 20067559 | 10.1111/j.1365-2141.2009.08056.x | Rescue of genomic information in adult acute lymphoblastic leukaemia (ALL) with normal/failed cytogenetics: a GIMEMA centralized biological study. | British journal of haematology | Matteucci C, Barba G, Varasano E, Vitale A, Mancini M, Testoni N, Cuneo A, Rege-Cambrin G, Elia L, La Starza R, Pierini V, Brandimarte L, Vignetti M, Foà R, Mecucci C, |
| 2010 | 20107154 | 10.3324/haematol.2009.009035 | The therapeutic response and clinical outcome of adults with ALL1(MLL)/AF4 fusion positive acute lymphoblastic leukemia according to the GIMEMA experience. | Haematologica | Cimino G, Cenfra N, Elia L, Sica S, Luppi M, Meloni G, Vignetti M, Paoloni F, Foà R, Mandelli F |
| 2010 | 20534699 | 10.3324/haematol.2009.020792 | The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party. | Haematologica | Iacobucci I, Lonetti A, Paoloni F, Papayannidis C, Ferrari A, Storlazzi CT, Vignetti M, Cilloni D, Messa F, Guadagnuolo V, Paolini S, Elia L, Messina M, Vitale A, Meloni G, Soverini S, Pane F, Baccarani M, Foà R, Martinelli G |
| 2010 | 20230405 | 10.1111/j.1365-2141.2010.08095.x | Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukaemia groups (AML-19). | British journal of haematology | Amadori S, Suciu S, Selleslag D, Stasi R, Alimena G, Baila L, Rizzoli V, Borlenghi E, Gaidano G, Magro D, Torelli G, Muus P, Venditti A, Cacciola E, Lauria F, Vignetti M, de Witte T |
| 2010 | 20644121 | 10.1182/blood-2010-03-276196 | Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group. | Blood | Lo-Coco F, Avvisati G, Vignetti M, Breccia M, Gallo E, Rambaldi A, Paoloni F, Fioritoni G, Ferrara F, Specchia G, Cimino G, Diverio D, Borlenghi E, Martinelli G, Di Raimondo F, Di Bona E, Fazi P, Peta A, Bosi A, Carella AM, Fabbiano F, Pogliani EM, Petti MC, Amadori S, Mandelli F, |
| 2010 | 20944181 | | Autologous stem cell transplantation for patients with acute promyelocytic leukemia in second molecular remission. | Anticancer research | Ferrara F, Finizio O, Izzo T, Riccardi C, Criscuolo C, Carbone A, Borlenghi E, Rossi G |
| 2010 | 20509769 | 10.3109/10428194.2010.487959 | Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches. | Leukemia & lymphoma | Engelhardt M, Kleber M, Udi J, Wäsch R, Spencer A, Patriarca F, Knop S, Bruno B, Gramatzki M, Morabito F, Kropff M, Neri A, Sezer O, Hajek R, Bunjes D, Boccadoro M, Straka C, Cavo M, Polliack A, Einsele H, Palumbo A |
| 2010 | 20439635 | 10.1200/JCO.2009.26.7963 | Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate: GIMEMA CML Working Party analysis. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | Castagnetti F, Testoni N, Luatti S, Marzocchi G, Mancini M, Kerim S, Giugliano E, Albano F, Cuneo A, Abruzzese E, Martino B, Palandri F, Amabile M, Iacobucci I, Alimena G, Pane F, Martinelli G, Saglio G, Baccarani M, Rosti G |
| 2009 | 19663768 | | First-line treatment of multiple myeloma in elderly patients: the GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) multiple myeloma working party perspective. | Current drug targets | Musto P, D'Auria F, Pietrantuono G, Baldini L, Bringhen S, Caravita T, Di Raimondo F, Morabito F, Offidani M, Petrucci MT, Tosi P, Gay F, Cavo M, Boccadoro M, Palumbo A |
| 2009 | 19589926 | 10.1182/blood-2008-08-173963 | Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP). | Blood | Iacobucci I, Storlazzi CT, Cilloni D, Lonetti A, Ottaviani E, Soverini S, Astolfi A, Chiaretti S, Vitale A, Messa F, Impera L, Baldazzi C, D'Addabbo P, Papayannidis C, Lonoce A, Colarossi S, Vignetti M, Piccaluga PP, Paolini S, Russo D, Pane F, Saglio G, Baccarani M, Foà R, Martinelli G |
| 2009 | 19144656 | 10.3324/haematol.13529 | The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML Working Party experience after a 7-year follow-up. | Haematologica | Palandri F, Castagnetti F, Alimena G, Testoni N, Breccia M, Luatti S, Rege-Cambrin G, Stagno F, Specchia G, Martino B, Levato L, Merante S, Liberati AM, Pane F, Saglio G, Alberti D, Martinelli G, Baccarani M, Rosti G |
| 2009 | 19539961 | 10.1016/j.medcli.2008.09.046 | [B-chronic lymphocytic leukemia: epidemiological study and comparison of MDACC and GIMENA pronostic indexes]. | Medicina clinica | González Rodríguez AP, González García E, Fernández Alvarez C, González Huerta AJ, González Rodríguez S |
| 2009 | 19211938 | 10.1182/blood-2007-08-103499 | Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: a phase 2 trial of the GIMEMA CML Working Party. | Blood | Castagnetti F, Palandri F, Amabile M, Testoni N, Luatti S, Soverini S, Iacobucci I, Breccia M, Rege Cambrin G, Stagno F, Specchia G, Galieni P, Iuliano F, Pane F, Saglio G, Alimena G, Martinelli G, Baccarani M, Rosti G, |
| 2009 | 19826132 | 10.1200/JCO.2008.20.6490 | Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | Mandelli F, Vignetti M, Suciu S, Stasi R, Petti MC, Meloni G, Muus P, Marmont F, Marie JP, Labar B, Thomas X, Di Raimondo F, Willemze R, Liso V, Ferrara F, Baila L, Fazi P, Zittoun R, Amadori S, de Witte T |
| 2009 | 19770381 | 10.1200/JCO.2008.21.6408 | IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | Martinelli G, Iacobucci I, Storlazzi CT, Vignetti M, Paoloni F, Cilloni D, Soverini S, Vitale A, Chiaretti S, Cimino G, Papayannidis C, Paolini S, Elia L, Fazi P, Meloni G, Amadori S, Saglio G, Pane F, Baccarani M, Foà R |
| 2009 | 19797518 | 10.1182/blood-2009-07-229864 | Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP. | Blood | Testoni N, Marzocchi G, Luatti S, Amabile M, Baldazzi C, Stacchini M, Nanni M, Rege-Cambrin G, Giugliano E, Giussani U, Abruzzese E, Kerim S, Grimoldi MG, Gozzetti A, Crescenzi B, Carcassi C, Bernasconi P, Cuneo A, Albano F, Fugazza G, Zaccaria A, Martinelli G, Pane F, Rosti G, Baccarani M |
| 2008 | 18950458 | 10.1111/j.1365-2141.2008.07400.x | Liposomal daunorubicin versus standard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia. | British journal of haematology | Latagliata R, Breccia M, Fazi P, Iacobelli S, Martinelli G, Di Raimondo F, Sborgia M, Fabbiano F, Pirrotta MT, Zaccaria A, Amadori S, Caramatti C, Falzetti F, Candoni A, Mattei D, Morselli M, Alimena G, Vignetti M, Baccarani M, Mandelli F |
| 2008 | 18555682 | 10.1016/j.ejca.2008.03.017 | Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials - a systematic review to evaluate the added value in supporting clinical decision making. | European journal of cancer (Oxford, England : 1990) | Efficace F, Kemmler G, Vignetti M, Mandelli F, Molica S, Holzner B |
| 2008 | 18508801 | 10.3324/haematol.11889 | M4 acute myeloid leukemia: the role of eosinophilia and cytogenetics in treatment response and survival. The GIMEMA experience. | Haematologica | Pulsoni A, Iacobelli S, Bernardi M, Borgia M, Camera A, Cantore N, Di Raimondo F, Fazi P, Ferrara F, Leoni F, Liso V, Mancini M, Marmont F, Matturro A, Maurillo L, Melillo L, Meloni G, Mirto S, Specchia G, Valentini CG, Venditti A, Leone G, Foà R, Mandelli F, Pagano L |
| 2008 | 18508799 | 10.3324/haematol.12004 | Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemia. | Haematologica | Lo-Coco F, Cuneo A, Pane F, Cilloni D, Diverio D, Mancini M, Testoni N, Bardi A, Izzo B, Bolli N, La Starza R, Fazi P, Iacobelli S, Piciocchi A, Vignetti M, Amadori S, Mandelli F, Pelicci PG, Mecucci C, Falini B, Saglio G, |
| 2008 | 18421055 | 10.1200/JCO.2007.12.3117 | Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international study by the Chronotherapy Group of the European Organisation for Research and Treatment of Cancer. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | Efficace F, Innominato PF, Bjarnason G, Coens C, Humblet Y, Tumolo S, Genet D, Tampellini M, Bottomley A, Garufi C, Focan C, Giacchetti S, Lévi F, |
| 2008 | 18271064 | 10.1002/hon.846 | Heterogeneity in the therapeutic approach to relapsed elderly patients with acute myeloid leukaemia: a survey from the Gruppo Italiano Malattie Ematologiche dell' Adulto (GIMEMA) Acute Leukaemia Working Party. | Hematological oncology | Ferrara F, Fazi P, Venditti A, Pagano L, Amadori S, Mandelli F |
| 2008 | 18165644 | 10.1200/JCO.2007.13.2373 | Long-term outcome of complete cytogenetic responders after imatinib 400 mg in late chronic phase, philadelphia-positive chronic myeloid leukemia: the GIMEMA Working Party on CML. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | Palandri F, Iacobucci I, Martinelli G, Amabile M, Poerio A, Testoni N, Soverini S, Castagnetti F, De Vivo A, Breccia M, Specchia G, Abruzzese E, Martino B, Cilloni D, Saglio G, Pane F, Liberati AM, Rosti G, Baccarani M, |
| 2007 | 17213285 | | Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol. | Blood | Vignetti M, Fazi P, Cimino G, Martinelli G, Di Raimondo F, Ferrara F, Meloni G, Ambrosetti A, Quarta G, Pagano L, Rege-Cambrin G, Elia L, Bertieri R, Annino L, Foà R, Baccarani M, Mandelli F |
| 2007 | 17077333 | | Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience. | Blood | Mazzucconi MG, Fazi P, Bernasconi S, De Rossi G, Leone G, Gugliotta L, Vianelli N, Avvisati G, Rodeghiero F, Amendola A, Baronci C, Carbone C, Quattrin S, Fioritoni G, D'Alfonso G, Mandelli F, |
| 2007 | 17135723 | | Late relapses in acute promyelocytic leukaemia. | Acta haematologica | Latagliata R, Carmosino I, Breccia M, Minni A, Testi A, Iorio N, Lo-Coco F, Avvisati G, Petti MC, Mandelli F, Cimino G |
| 2007 | 17351113 | | ERK1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia. | Blood | Gregorj C, Ricciardi MR, Petrucci MT, Scerpa MC, De Cave F, Fazi P, Vignetti M, Vitale A, Mancini M, Cimino G, Palmieri S, Di Raimondo F, Specchia G, Fabbiano F, Cantore N, Mosna F, Camera A, Luppi M, Annino L, Miraglia E, Fioritoni G, Ronco F, Meloni G, Mandelli F, Andreeff M, Milella M, Foà R, Tafuri A, |
| 2007 | 17229641 | | Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party. | Haematologica | Rosti G, Iacobucci I, Bassi S, Castagnetti F, Amabile M, Cilloni D, Poerio A, Soverini S, Palandri F, Rege Cambrin G, Iuliano F, Alimena G, Latagliata R, Testoni N, Pane F, Saglio G, Baccarani M, Martinelli G |
| 2007 | 17339183 | | Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial. | Haematologica | Vitale A, Guarini A, Ariola C, Meloni G, Perbellini O, Pizzuti M, De Gregoris C, Mettivier V, Pastorini A, Pizzolo G, Vignetti M, Mandelli F, Foà R |
| 2007 | 17339189 | | Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study. | Haematologica | Thomas X, Suciu S, Rio B, Leone G, Broccia G, Fillet G, Jehn U, Feremans W, Meloni G, Vignetti M, de Witte T, Amadori S |
| 2007 | 17785703 | | Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma Network. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | Palumbo A, Falco P, Corradini P, Falcone A, Di Raimondo F, Giuliani N, Crippa C, Ciccone G, Omedè P, Ambrosini MT, Gay F, Bringhen S, Musto P, Foà R, Knight R, Zeldis JB, Boccadoro M, Petrucci MT, |
| 2006 | 16977651 | | Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions. | Cancer | Leibovici L, Paul M, Cullen M, Bucaneve G, Gafter-Gvili A, Fraser A, Kern WV |
| 2006 | 17189410 | | Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia. | Clinical cancer research : an official journal of the American Association for Cancer Research | Soverini S, Colarossi S, Gnani A, Rosti G, Castagnetti F, Poerio A, Iacobucci I, Amabile M, Abruzzese E, Orlandi E, Radaelli F, Ciccone F, Tiribelli M, di Lorenzo R, Caracciolo C, Izzo B, Pane F, Saglio G, Baccarani M, Martinelli G, |
| 2006 | 17145607 | | Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia. | Haematologica | Barcellini W, Capalbo S, Agostinelli RM, Mauro FR, Ambrosetti A, Calori R, Cortelezzi A, Laurenti L, Pogliani EM, Pedotti P, Liso V, Girelli G, Mandelli F, Zanella A, |
| 2006 | 18632496 | 10.3816/SCT.2006.n.018 | Role of prophylactic antibiotics in the prevention of infections after chemotherapy: a literature review. | Supportive cancer therapy | Moon S, Williams S, Cullen M |
| 2006 | 16720834 | | Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia. | Blood | Falini B, Martelli MP, Bolli N, Bonasso R, Ghia E, Pallotta MT, Diverio D, Nicoletti I, Pacini R, Tabarrini A, Galletti BV, Mannucci R, Roti G, Rosati R, Specchia G, Liso A, Tiacci E, Alcalay M, Luzi L, Volorio S, Bernard L, Guarini A, Amadori S, Mandelli F, Pane F, Lo-Coco F, Saglio G, Pelicci PG, Martelli MF, Mecucci C |
| 2006 | 16932345 | | Non-infusional vs intravenous consolidation chemotherapy in elderly patients with acute myeloid leukemia: final results of the EORTC-GIMEMA AML-13 randomized phase III trial. | Leukemia | Jehn U, Suciu S, Thomas X, Lefrère F, Muus P, Berneman Z, Marie JP, Adamo F, Fillet G, Nobile F, Ricciuti F, Leone G, Rizzoli V, Montanaro M, Beeldens F, Fazi P, Mandelli F, Willemze R, de Witte T, Amadori S |
| 2006 | 16179376 | | Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol. | Blood | Vitale A, Guarini A, Ariola C, Mancini M, Mecucci C, Cuneo A, Pane F, Saglio G, Cimino G, Tafuri A, Meloni G, Fabbiano F, Recchia A, Kropp MG, Krampera M, Cascavilla N, Ferrara F, Romano A, Mazza P, Fozza C, Paoloni F, Vignetti M, Foà R |
| 2006 | 16619048 | | Characterization of a recurrent translocation t(2;3)(p15-22;q26) occurring in acute myeloid leukaemia. | Leukemia | Trubia M, Albano F, Cavazzini F, Cambrin GR, Quarta G, Fabbiano F, Ciambelli F, Magro D, Hernandezo JM, Mancini M, Diverio D, Pelicci PG, Coco FL, Mecucci C, Specchia G, Rocchi M, Liso V, Castoldi G, Cuneo A |
| 2006 | 16531262 | | The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: a seven-year update of the GIMEMA 0496 trial. | Haematologica | Cimino G, Pane F, Elia L, Finolezzi E, Fazi P, Annino L, Meloni G, Mancini M, Tedeschi A, Di Raimondo F, Specchia G, Fioritoni G, Leoni P, Cuneo A, Mecucci C, Saglio G, Mandelli F, Foà R, |
| 2005 | 16019523 | | The use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemia. | Leukemia & lymphoma | Fassas A, Anagnostopoulos A |
| 2005 | 16243790 | | Gene expression profiles of B-lineage adult acute lymphocytic leukemia reveal genetic patterns that identify lineage derivation and distinct mechanisms of transformation. | Clinical cancer research : an official journal of the American Association for Cancer Research | Chiaretti S, Li X, Gentleman R, Vitale A, Wang KS, Mandelli F, Foà R, Ritz J |
| 2005 | 16032778 | | A gender-based score system predicts the clinical outcome of patients with early B-cell chronic lymphocytic leukemia. | Leukemia & lymphoma | Molica S, Mauro FR, Callea V, Gentile M, Giannarelli D, Lopez M, Lauria F, Rotoli B, Montanaro M, Cortelezzi A, Liso V, Mandelli F, Foa R, |
| 2005 | 15650057 | | A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol. | Blood | Mancini M, Scappaticci D, Cimino G, Nanni M, Derme V, Elia L, Tafuri A, Vignetti M, Vitale A, Cuneo A, Castoldi G, Saglio G, Pane F, Mecucci C, Camera A, Specchia G, Tedeschi A, Di Raimondo F, Fioritoni G, Fabbiano F, Marmont F, Ferrara F, Cascavilla N, Todeschini G, Nobile F, Kropp MG, Leoni P, Tabilio A, Luppi M, Annino L, Mandelli F, Foà R |
| 2005 | 15867198 | | ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | Soverini S, Martinelli G, Rosti G, Bassi S, Amabile M, Poerio A, Giannini B, Trabacchi E, Castagnetti F, Testoni N, Luatti S, de Vivo A, Cilloni D, Izzo B, Fava M, Abruzzese E, Alberti D, Pane F, Saglio G, Baccarani M |
| 2005 | 15621806 | | Comparison of two regimens for the treatment of elderly patients with acute lymphoblastic leukaemia (ALL). | Leukemia & lymphoma | Offidani M, Corvatta L, Malerba L, Marconi M, Catarini M, Centurioni R, Leoni F, Scortechini AR, Masia MC, Leoni P |
| 2005 | 15677559 | | GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. | Blood | Testi AM, Biondi A, Lo Coco F, Moleti ML, Giona F, Vignetti M, Menna G, Locatelli F, Pession A, Barisone E, De Rossi G, Diverio D, Micalizzi C, Aricò M, Basso G, Foa R, Mandelli F |
| 2005 | 15668275 | | Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trials. | Annals of oncology : official journal of the European Society for Medical Oncology | Pagano L, Pulsoni A, Vignetti M, Tosti ME, Falcucci P, Fazi P, Fianchi L, Levis A, Bosi A, Angelucci E, Bregni M, Gabbas A, Peta A, Coser P, Ricciuti F, Morselli M, Caira M, Foà R, Amadori S, Mandelli F, Leone G, |
| 2004 | 15003889 | | GIMEMA ALL - Rescue 97: a salvage strategy for primary refractory or relapsed adult acute lymphoblastic leukemia. | Haematologica | Camera A, Annino L, Chiurazzi F, Fazi P, Cascavilla N, Fabbiano F, Marmont F, Di Raimondo F, Recchia A, Vignetti M, Rotoli B, Mandelli F |
| 2004 | 15580686 | | Fourth International Workshop on Haploidentical Transplants, Naples, Italy, July 8-10, 2004. | Blood cells, molecules & diseases | Aversa F, Berneman ZN, Locatelli F, Martelli MF, Reisner Y, Tabilio A, Velardi A, Vuk-Pavlovic S |
| 2004 | 14749702 | | Second malignancy after treatment of adult acute myeloid leukemia: cohort study on adult patients enrolled in the GIMEMA trials. | Leukemia | Pagano L, Pulsoni A, Tosti ME, Caramatti C, Cerri R, Falcucci P, Fazi P, Fianchi L, Martino B, Mattei D, Offidani M, Pacilli L, Pogliani EM, Rotoli B, Specchia G, Visani G, Vignetti M, Voso MT, Leone G, Mandelli F, |
| 2004 | 15339678 | | Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups. | Haematologica | Amadori S, Suciu S, Willemze R, Mandelli F, Selleslag D, Stauder R, Ho A, Denzlinger C, Leone G, Fabris P, Muus P, Vignetti M, Hagemeijer A, Beeldens F, Anak O, De Witte T, , |
| 2004 | 15020267 | | Survival of elderly patients with acute myeloid leukemia. | Haematologica | Pulsoni A, Pagano L, Latagliata R, Casini M, Cerri R, Crugnola M, De Paoli L, Di Bona E, Invernizzi R, Marmont F, Petti MC, Rigolin G, Ronco F, Spadano A, Tosti ME, Visani G, Mele A, Mandelli F |
| 2004 | 15257938 | | Cryptococcosis in patients with hematologic malignancies. A report from GIMEMA-infection. | Haematologica | Pagano L, Fianchi L, Caramatti C, D'Antonio D, Melillo L, Caira M, Masini L, Todeschini G, Girmenia C, Martino B, Cinieri S, Martino P, Del Favero A, |
| 2004 | 15124706 | | Autologous versus allogeneic stem cell transplantation in acute myeloid leukemia. | Annals of hematology | Willemze R, Suciu S, Mandelli F, de Witte T, Amador S, |
| 2003 | 12750698 | | The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921). | Leukemia | Oosterveld M, Suciu S, Verhoef G, Labar B, Belhabri A, Aul C, Selleslag D, Ferrant A, Wijermans P, Mandelli F, Amadori S, Jehn U, Muus P, Zittoun R, Hess U, Anak O, Beeldens F, Willemze R, de Witte T |
| 2003 | 12801292 | | Clinical characteristics, prognostic factors and multidrug-resistance related protein expression in 36 adult patients with acute promyelocytic leukemia. | European journal of haematology | Candoni A, Damiani D, Michelutti A, Masolini P, Michieli M, Michelutti T, Geromin A, Fanin R |
| 2003 | 14576731 | | Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation. | Leukemia | Venditti A, Maurillo L, Buccisano F, Del Poeta G, Mazzone C, Tamburini A, Del Principe MI, Consalvo MI, De Fabritiis P, Cudillo L, Picardi A, Franchi A, Lo-Coco F, Amadori S |
| 2003 | 12810259 | | Trisomy 13 in a patient with common acute lymphoblastic leukemia: description of a case and review of the literature. | Cancer genetics and cytogenetics | Spirito FR, Mancini M, Derme V, Cimino G, Testi AM, Tafuri A, Vitale A, Foà R |
| 2003 | 12791662 | | Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study: absence of the ALL1/AF4 and of the BCR/ABL fusion genes correlates with a significantly better clinical outcome. | Blood | Cimino G, Elia L, Mancini M, Annino L, Anaclerico B, Fazi P, Vitale A, Specchia G, Di Raimondo F, Recchia A, Cuneo A, Mecucci C, Pane F, Saglio G, Foa R, Mandelli F, |
| 2003 | 12714526 | | Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial. | Blood | Suciu S, Mandelli F, de Witte T, Zittoun R, Gallo E, Labar B, De Rosa G, Belhabri A, Giustolisi R, Delarue R, Liso V, Mirto S, Leone G, Bourhis JH, Fioritoni G, Jehn U, Amadori S, Fazi P, Hagemeijer A, Willemze R, |
| 2003 | 12764372 | | Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols. | Leukemia | Mandelli F, Latagliata R, Avvisati G, Fazi P, Rodeghiero F, Leoni F, Gobbi M, Nobile F, Gallo E, Fanin R, Amadori S, Vignetti M, Fioritoni G, Ferrara F, Peta A, Giustolisi R, Broccia G, Petti MC, Lo-Coco F, |
| 2003 | 12707726 | | FLAG-IDA in the treatment of refractory/relapsed acute myeloid leukemia: single-center experience. | Annals of hematology | Pastore D, Specchia G, Carluccio P, Liso A, Mestice A, Rizzi R, Greco G, Buquicchio C, Liso V |
| 2003 | 12580965 | | E2A-PBX1 fusion in adult acute lymphoblastic leukaemia: biological and clinical features. | British journal of haematology | Foa R, Vitale A, Mancini M, Cuneo A, Mecucci C, Elia L, Lombardo R, Saglio G, Torelli G, Annino L, Specchia G, Damasio E, Recchia A, Di Raimondo F, Morra E, Volpe E, Tafuri A, Fazi P, Hunger SP, Mandelli F |
| 2003 | 12529661 | | The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial. | Leukemia | Keating S, Suciu S, de Witte T, Zittoun R, Mandelli F, Belhabri A, Amadori S, Fibbe W, Gallo E, Fillet G, Varet B, Meloni G, Hagemeijer A, Fazi P, Solbu G, Willemze R, , |
| 2003 | 12492579 | | Outcome prediction by immunophenotypic minimal residual disease detection in adult T-cell acute lymphoblastic leukaemia. | British journal of haematology | Krampera M, Vitale A, Vincenzi C, Perbellini O, Guarini A, Annino L, Todeschini G, Camera A, Fabbiano F, Fioritoni G, Nobile F, Szydlo R, Mandelli F, Foà R, Pizzolo G |
| 2003 | 12713812 | | Drug treatment in the development of mismatch repair defective acute leukemia and myelodysplastic syndrome. | DNA repair | Casorelli I, Offman J, Mele L, Pagano L, Sica S, D'Errico M, Giannini G, Leone G, Bignami M, Karran P |
| 2002 | 12357357 | | Partial deletions of long arm of chromosome 6: biologic and clinical implications in adult acute lymphoblastic leukemia. | Leukemia | Mancini M, Vegna ML, Castoldi GL, Mecucci C, Spirito F, Elia L, Tafuri A, Annino L, Pane F, Rege-Cambrin G, Gottardi M, Leoni P, Gallo E, Camera A, Luciano L, Specchia G, Torelli G, Sborgia M, Gabbas A, Tedeschi A, Della Starza I, Cascavilla N, Di Raimondo F, Mandelli F, Foà R |
| 2002 | 12200673 | | Acute megakaryoblastic leukemia: experience of GIMEMA trials. | Leukemia | Pagano L, Pulsoni A, Vignetti M, Mele L, Fianchi L, Petti MC, Mirto S, Falcucci P, Fazi P, Broccia G, Specchia G, Di Raimondo F, Pacilli L, Leoni P, Ladogana S, Gallo E, Venditti A, Avanzi G, Camera A, Liso V, Leone G, Mandelli F, |
| 2002 | 12391538 | | Acute lymphoblastic leukemia in the elderly. | The hematology journal : the official journal of the European Haematology Association | Annino L, Goekbuget N, Delannoy A |
| 2002 | 12384411 | | Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-up. | Blood | Avvisati G, Petti MC, Lo-Coco F, Vegna ML, Amadori S, Baccarani M, Cantore N, Di Bona E, Ferrara F, Fioritoni G, Gallo E, Invernizzi R, Lazzarino M, Liso V, Mariani G, Ricciuti F, Selleri C, Sica S, Veneri D, Mandelli F, |
| 2002 | 11806988 | | Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study. | Blood | Annino L, Vegna ML, Camera A, Specchia G, Visani G, Fioritoni G, Ferrara F, Peta A, Ciolli S, Deplano W, Fabbiano F, Sica S, Di Raimondo F, Cascavilla N, Tabilio A, Leoni P, Invernizzi R, Baccarani M, Rotoli B, Amadori S, Mandelli F, |
| 2002 | 12200354 | | Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience. | Blood | Pulsoni A, Pagano L, Lo Coco F, Avvisati G, Mele L, Di Bona E, Invernizzi R, Leoni F, Marmont F, Mele A, Melillo L, Nosari AM, Pogliani EM, Vignetti M, Visani G, Zagonel V, Leone G, Mandelli F |
| 2002 | 12130511 | | MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia. | Blood | Tafuri A, Gregorj C, Petrucci MT, Ricciardi MR, Mancini M, Cimino G, Mecucci C, Tedeschi A, Fioritoni G, Ferrara F, Di Raimondo F, Gallo E, Liso V, Fabbiano F, Cascavilla N, Pizzolo G, Camera A, Pane F, Lanza F, Cilloni D, Annino L, Vitale A, Vegna ML, Vignetti M, Foà R, Mandelli F, |
| 2002 | 11972521 | | Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres. | British journal of haematology | Pagano L, Fianchi L, Mele L, Girmenia C, Offidani M, Ricci P, Mitra ME, Picardi M, Caramatti C, Piccaluga P, Nosari A, Buelli M, Allione B, Cortelezzi A, Fabbiano F, Milone G, Invernizzi R, Martino B, Masini L, Todeschini G, Cappucci MA, Russo D, Corvatta L, Martino P, Del Favero A |
| 2002 | 11890999 | | Detection of minimal residual disease in peripheral blood stem cells from two acute myeloid leukemia patients with trisomy 8 predicts early relapse after autologous bone marrow transplantation. | Cancer genetics and cytogenetics | Scaravaglio P, Guglielmelli T, Giugliano E, Marmont F, Audisio E, Gallo E, Saglio G, Rege-Cambrin G |
| 2002 | 12184278 | | Second malignancy after treatment of acute promyelocytic leukemia: experience of GIMEMA trials. Gruppo Italiano Malattie Ematologiche dell'Adulto. | Blood | Pagano L, Pulsoni A |
| 2001 | 11522544 | | Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program. | Haematologica | Pagano L, Girmenia C, Mele L, Ricci P, Tosti ME, Nosari A, Buelli M, Picardi M, Allione B, Corvatta L, D'Antonio D, Montillo M, Melillo L, Chierichini A, Cenacchi A, Tonso A, Cudillo L, Candoni A, Savignano C, Bonini A, Martino P, Del Favero A, , |
| 2001 | 11484970 | | Cost of de novo acute myeloid leukemia induction therapy in adults: analysis of EORTC-GIMEMA AML10 and FLANG regimens. | Journal of experimental & clinical cancer research : CR | Clavio M, Quintino S, Masoudi B, Carrara S, Cerri R, Pierri I, Canepa L, Miglino M, Muner P, Damasio E, Gobbi M |
| 2001 | 11300325 | | Acute myeloid leukemia in patients previously diagnosed with breast cancer: experience of the GIMEMA group. | Annals of oncology : official journal of the European Society for Medical Oncology | Pagano L, Pulsoni A, Mele L, Tosti ME, Cerri R, Visani G, Melillo L, Candoni A, Clavio M, Nosari A, Petti MC, Martino B, Mele A, Levis A, Allione B, Almici C, Equitani F, Leone G, Mandelli F, |
| 2001 | 11225603 | | Clinical and biological features of acute myeloid leukaemia occurring as second malignancy: GIMEMA archive of adult acute leukaemia. | British journal of haematology | Pagana L, Pulsoni A, Tosti ME, Avvisati G, Mele L, Mele M, Martino B, Visani G, Cerri R, Di Bona E, Invernizzi R, Nosari A, Clavio M, Allione B, Coser P, Candoni A, Levis A, Camera A, Melillo L, Leone G, Mandelli F, |
| 2000 | 11920210 | | Acute leukemia following a previous malignancy: do acute lymphoid leukemia and acute myeloid leukemia have common risk factors? | The hematology journal : the official journal of the European Haematology Association | Pagano L, Pulsoni A, Tosti ME, Mele A, Mele L, Corvatta L, Miraglia E, Almici C, Manna A, Del Poeta G, Lanza F, Masini L, Recchia A, Equitani F, Leone G, Mandelli F, |
| 2000 | 11091211 | | The epidemiology of fusariosis in patients with haematological diseases. Gimema Infection Programme. | British journal of haematology | Girmenia C, Pagano L, Corvatta L, Mele L, del Favero A, Martino P |
| 2000 | 11187562 | | Is workflow technology suitable to represent and manage clinical trials? | Studies in health technology and informatics | Fazi P, Grifoni P, Luzi D, Ricci FL, Vignetti M |
| 2000 | 11091221 | | Feasibility of peripheral blood stem cell rescue as intensification in elderly patients with acute myelocytic leukaemia: a pilot study from the Gimema Group. Gruppo Italiano Malattie Ematologiche Maligne Dell'Adulto. | British journal of haematology | Montillo M, Tedeschi A, Pagano L, Venditti A, Ferrara F, Fabris P, Martino B, Musso M, De Rosa G, Specchia G, Monaco M, Sparaventi G, Spadea A, Palmas A, Deplano W, Manna A, Melillo L, Miraglia E, Mirto S, Mandelli F |
| 2000 | 10721774 | | Minimally differentiated acute myeloid leukemia (AML M0): clinico-biological findings of 29 cases. | Leukemia & lymphoma | Cascavilla N, Melillo L, D'Arena G, Greco MM, Carella AM, Sajeva MR, Perla G, Matera R, Minervini MM, Carotenuto M |
| 2000 | 10965736 | | [Retinoic acid syndrome. Severe respiratory insufficiency treated with CPAP]. | Minerva anestesiologica | Tommasino C, De Felice L, Colombo S, Salaris D, Capocasa T, Giudici D |
| 2000 | 10792270 | | Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia. | British journal of haematology | Di Bona E, Avvisati G, Castaman G, Luce Vegna M, De Sanctis V, Rodeghiero F, Mandelli F |
| 2000 | 10942364 | | Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. | Blood | Sanz MA, Lo Coco F, Martín G, Avvisati G, Rayón C, Barbui T, Díaz-Mediavilla J, Fioritoni G, González JD, Liso V, Esteve J, Ferrara F, Bolufer P, Bernasconi C, Gonzalez M, Rodeghiero F, Colomer D, Petti MC, Ribera JM, Mandelli F |
| 2000 | 10929031 | | t(4;11)(q21;p15) translocation involving NUP98 and RAP1GDS1 genes: characterization of a new subset of T acute lymphoblastic leukaemia. | British journal of haematology | Mecucci C, La Starza R, Negrini M, Sabbioni S, Crescenzi B, Leoni P, Di Raimondo F, Krampera M, Cimino G, Tafuri A, Cuneo A, Vitale A, Foà R |
| 1999 | 10064240 | | Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche dell' Adulto. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | Menichetti F, Del Favero A, Martino P, Bucaneve G, Micozzi A, Girmenia C, Barbabietola G, Pagańo L, Leoni P, Specchia G, Caiozzo A, Raimondi R, Mandelli F |
| 1999 | 10362124 | | Human herpes virus-6 seroprevalence and leukaemias: a case-control study. GIMEMA (Gruppo Italiano Malattie Ematologiche dell' Adulto). | British journal of cancer | Gentile G, Mele A, Ragona G, Faggioni A, Zompetta C, Tosti ME, Visani G, Castelli G, Pulsoni A, Monarca B, Martino P, Mandelli F |
| 1999 | 10456442 | | Autologous transplantation with peripheral blood stem cells in chronic lymphocytic leukemia. A phase III, randomized, multicenter study. GIMEMA. Gruppo Italiano per le Malattie Ematologiche dell'Adulto. GITMO-Gruppo Italiano Trapianto di Midollo Osseo. | Hematology and cell therapy | |
| 1999 | 10477455 | | Out-patient management of acute myeloid leukemia after consolidation chemotherapy. Role of a hematologic emergency unit. | Haematologica | Girmenia C, Alimena G, Latagliata R, Morano SG, Celesti F, Coppola L, Spadea A, Tosti S, Mecarocci S, D'Elia GM, Tafuri A, Cimino G, Mandelli F |
| 1999 | 10509043 | | The incidence of secondary leukemias. | Haematologica | Leone G, Mele L, Pulsoni A, Equitani F, Pagano L |
| 1999 | 10520009 | | Acute lymphoblastic leukaemia occurring as second malignancy: report of the GIMEMA archive of adult acute leukaemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. | British journal of haematology | Pagano L, Pulsoni A, Tosti ME, Annino L, Mele A, Camera A, Martino B, Guglielmi C, Cerri R, Di Bona E, Invernizzi R, Castagnola C, Bassan R, Mele L, Todeschini G, Leone G, Mandelli F |
| 1999 | 10673975 | | Centre effect on treatment outcome for patients with untreated acute myelogenous leukaemia? An analysis of the AML 8A Study of the Leukemia Cooperative Group of the EORTC and GIMEMA. European Organization for Research and Treatment of Cancer (EORTC) Leukemia Cooperative Group and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA). | European journal of cancer (Oxford, England : 1990) | Keating S, de Witte T, Suciu S, Mandelli F, Damasio E, Willemze R, Morra E, Amadori S, Dardenne M, Vegna ML, Zittoun RA |
| 1998 | 9753069 | | The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA. European Organization for Research and Treatment of Cancer. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. | British journal of haematology | Keating S, de Witte T, Suciu S, Willemze R, Hayat M, Labar B, Resegotti L, Ferrini PR, Caronia F, Dardenne M, Solbu G, Petti MC, Vegna ML, Mandelli F, Zittoun RA |
| 1998 | 9531332 | | Secondary haematological neoplasm after treatment of adult acute lymphoblastic leukemia: analysis of 1170 adult ALL patients enrolled in the GIMEMA trials. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. | British journal of haematology | Pagano L, Annino L, Ferrari A, Camera A, Martino B, Montillo M, Tosti ME, Mele A, Pulsoni A, Vegna ML, Leone G, Mandelli F |
| 1998 | 9680345 | | Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. GIMEMA-AIEOP Multicenter "AIDA" Trial. | Blood | Diverio D, Rossi V, Avvisati G, De Santis S, Pistilli A, Pane F, Saglio G, Martinelli G, Petti MC, Santoro A, Pelicci PG, Mandelli F, Biondi A, Lo Coco F |
| 1998 | 9855248 | | Acute promyelocytic leukaemia: epidemiology and risk factors. A report of the GIMEMA Italian archive of adult acute leukaemia. GIMEMA Cooperative Group. | European journal of haematology | Pulsoni A, Stazi A, Cotichini R, Allione B, Cerri R, Di Bona E, Nosari AM, Pagano L, Recchia A, Ribersani M, Rocchi L, Veneri D, Visani G, Mandelli F, Mele A |
| 1998 | 10037004 | | Management of advanced acute lymphoblastic leukemia in children and adults: results of the ALL R-87 protocol. AIEOP and GIMEMA Cooperative Groups. | Leukemia & lymphoma | Giona F, Annino L, Testi AM, Rondelli R, Arcese W, Meloni G, Moleti ML, Mandelli F |
| 1998 | 9864917 | | Disappearance of PML/RAR alpha acute promyelocytic leukemia-associated transcript during consolidation chemotherapy. | Haematologica | Martinelli G, Ottaviani E, Testoni N, Visani G, Diverio D, D'Elia G, Mandelli F, Tura S |
| 1997 | 9242531 | | Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups. | Blood | Mandelli F, Diverio D, Avvisati G, Luciano A, Barbui T, Bernasconi C, Broccia G, Cerri R, Falda M, Fioritoni G, Leoni F, Liso V, Petti MC, Rodeghiero F, Saglio G, Vegna ML, Visani G, Jehn U, Willemze R, Muus P, Pelicci PG, Biondi A, Lo Coco F |
| 1997 | 9350178 | | New strategies for the treatment of acute promyelocytic leukaemia. | Journal of internal medicine. Supplement | Mandelli F |
| 1997 | 9217194 | | Treatment of adults with acute lymphoblastic leukaemia in first bone marrow relapse: results of the ALL R-87 protocol. | British journal of haematology | Giona F, Annino L, Rondelli R, Arcese W, Meloni G, Testi AM, Moleti ML, Amadori S, Resegotti L, Tabilio A, Ladogana S, Fioritoni G, Camera A, Liso V, Leoni P, Mandelli F |
| 1997 | 9285546 | | Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial. | Bone marrow transplantation | Zittoun R, Suciu S, Watson M, Solbu G, Muus P, Mandelli F, Stryckmans P, Peetermans M, Thaler J, Resegotti L, Dardenne M, Willemze R |
| 1997 | 9313879 | | Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors. | Bone marrow transplantation | Carlo-Stella C, Tabilio A, Regazzi E, Garau D, La Tagliata R, Trasarti S, Andrizzi C, Vignetti M, Meloni G |
| 1997 | 9375750 | | Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto). | British journal of haematology | Pagano L, Ricci P, Tonso A, Nosari A, Cudillo L, Montillo M, Cenacchi A, Pacilli L, Fabbiano F, Del Favero A |
| 1997 | 9457393 | | Interleukin-2 therapy in relapsed acute myelogenous leukemia. | The cancer journal from Scientific American | Meloni G, Vignetti M, Pogliani E, Invernizzi R, Allione B, Mirto S, Sica S, Leoni F, Selleri C, Mandelli F |
| 1996 | 8751460 | | Outcome of patients with acute myeloid leukemia who failed to respond to a single course of first-line induction therapy: a GIMEMA study of 218 unselected consecutive patients. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. | Leukemia | Liso V, Iacopino P, Avvisati G, Petti MC, Broccia G, Carotenuto M, Falda M, Fazi P, Lazzarino M, Leoni P, Mirto S, Pucci G, Nobile F, Nosari AM, Specchia G, Stasi R, Tabilio A, Mandelli F |
| 1996 | 8695858 | | AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study. | Blood | Avvisati G, Lo Coco F, Diverio D, Falda M, Ferrara F, Lazzarino M, Russo D, Petti MC, Mandelli F |
| 1996 | 8858693 | | Empirical treatment of fever in neutropenic children: the role of the carbapenems. International Antimicrobial Therapy Cooperative Group of the European Organisation for Research and Treatment of Cancer and the Gimema Infection Program. | The Pediatric infectious disease journal | Cometta A, Viscoli C, Castagnola E, Massimo L, Giacchino R, Gibson B, Giacchino M, Balbo L, Engelhard D, Shapiro M, Amsallem D, Estavoyer JM, Ferster A, Glauser MP |
| 1996 | 8974788 | | The EORTC trials for acute myelogenous leukemia. EORTC Leukemia Cooperative Group. European Organisation of Research and Treatment of Cancer. | Hematology and cell therapy | Zittoun R |
| 1996 | 8807105 | | Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups. | Bone marrow transplantation | Keating S, Suciu S, de Witte T, Mandelli F, Willemze R, Resegotti L, Broccia G, Thaler J, Labar B, Damasio E, Bizzi B, Rotoli B, Vekhoff A, Muus P, Petti MC, Dardenne M, Solbu G, Vegna ML, Zittoun RA |
| 1996 | 8616033 | | The GIMEMA ALL 0183 trial: analysis of 10-year follow-up. GIMEMA Cooperative Group, Italy. | British journal of haematology | Mandelli F, Annino L, Rotoli B |
| 1996 | 8901362 | | A modular questionnaire for the assessment of longterm quality of life in leukaemia patients: the MRC/EORTC QLQ-LEU. | Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation | Watson M, Zittoun R, Hall E, Solbu G, Wheatley K |
| 1995 | 7496348 | | Proceedings of the 3rd GIMEMA Conference on Recent Advances in the Cytobiology of Acute Leukemias. Bari, Italy, 13-14 May 1994. | Leukemia & lymphoma | |
| 1995 | 7808487 | | Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. | The New England journal of medicine | Zittoun RA, Mandelli F, Willemze R, de Witte T, Labar B, Resegotti L, Leoni F, Damasio E, Visani G, Papa G |
| 1995 | 7734347 | | Fatal haemoptysis in pulmonary filamentous mycosis: an underevaluated cause of death in patients with acute leukaemia in haematological complete remission. A retrospective study and review of the literature. Gimema Infection Program (Gruppo Italiano Malattie Ematologiche dell'Adulto). | British journal of haematology | Pagano L, Ricci P, Nosari A, Tonso A, Buelli M, Montillo M, Cudillo L, Cenacchi A, Savignana C, Melillo L |
| 1994 | 7811016 | | Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program. | Antimicrobial agents and chemotherapy | Menichetti F, Martino P, Bucaneve G, Gentile G, D'Antonio D, Liso V, Ricci P, Nosari AM, Buelli M, Carotenuto M |
| 1994 | 7514043 | | Antithrombin III infusion suppresses the hypercoagulable state in adult acute lymphoblastic leukaemia patients treated with a low dose of Escherichia coli L-asparaginase. A GIMEMA study. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis | Mazzucconi MG, Gugliotta L, Leone G, Dragoni F, Belmonte MM, De Stefano V, Chistolini A, Tura S, Mandelli F |
| 1994 | 8075572 | | EORTC-GIMEMA AML8 protocol. A phase III study on autologous bone-marrow transplantation in acute myelogenous leukemia (AML). | Leukemia & lymphoma | Zittoun R, Mandelli F, Willemze R, De Witte T, Labar B, Resegotti L, Ferrini PR, Visani G, Caronia F, Stryckmans P |
| 1994 | 8011548 | | Treatment of primary refractory and relapsed acute lymphoblastic leukaemia in children and adults: the GIMEMA/AIEOP experience. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Associazione Italiana Ematologìa ed Ocologia Pediatrica. | British journal of haematology | Giona F, Testi AM, Annino L, Amadori S, Arcese W, Camera A, Di Montezemolo LC, Ladogana S, Liso V, Meloni G |
| 1994 | 7815837 | | Treatment of patients with acute promyelocytic leukemia. The EORTC-LCG experience. EORTC Leukemia Cooperative Group. | Leukemia | Willemze R, Suciu S, Mandelli F, de Witte T, Cadiou M, Castoldi GL, Liso V, Dardenne M, Solbu G, Zittoun R |
| 1993 | 8485204 | | Reproducibility of the morphological diagnostic criteria for acute myeloid leukemia: the GIMEMA group experience. | Annals of hematology | Castoldi GL, Liso V, Fenu S, Vegna ML, Mandelli F |
| 1993 | 8471981 | | Immunophenotype of acute lymphoblastic leukemia cells: the experience of the Italian Cooperative Group (Gimema). | Leukemia & lymphoma | De Rossi G, Grossi C, Foà R, Tabilio A, Vègna L, Lo Coco F, Annino L, Camera A, Cascavilla N, Ciolli S |
| 1993 | 8426473 | | Idarubicin in combination with intermediate-dose cytarabine and VP-16 in the treatment of refractory or rapidly relapsed patients with acute myeloid leukemia. The GIMEMA Cooperative Group. | Leukemia | Carella AM, Carlier P, Pungolino E, Resegotti L, Liso V, Stasi R, Montillo M, Iacopino P, Mirto S, Pagano L |
| 1993 | 8446931 | | Evidence of a hypercoagulable state in patients with acute lymphoblastic leukemia treated with low dose of E. coli L-asparaginase: a GIMEMA study. | Thrombosis and haemostasis | Leone G, Gugliotta L, Mazzucconi MG, De Stefano V, Belmonte MM, Dragoni F, Specchia G, Centra A, Gamba G, Camera A |
| 1993 | 8427721 | | The new fluorinated quinolones for antimicrobial prophylaxis in neutropenic cancer patients. | European journal of cancer (Oxford, England : 1990) | Del Favero A, Menichetti F |
| 1992 | 1578948 | | Treatment of acute non lymphoid leukemia (ANLL) in elderly patients. The GIMEMA experience. | Leukemia | Resegotti L |
| 1992 | 1578909 | | Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A). The EORTC Leukemia Cooperative Group and the GIMEMA Group. | Leukemia | Zittoun R, Mandelli F, Willemze R, de Witte T, Tura S, Ferrini PR, Stryckmans P, Gattringer C, Petti MC, Solbu G |
| 1992 | 1578928 | | GIMEMA ALL 0288: a multicentric study on adult acute lymphoblastic leukemia. Preliminary results. | Leukemia | Mandelli F, Annino L, Vegna ML, Camera A, Ciolli S, Deplano W, Fabiano F, Ferrara F, Ladogana S, Muti G |
| 1992 | 1578949 | | Intensive consolidation chemotherapy versus standard consolidation maintenance in acute myelogenous leukemia (AML) in first remission. An EORTC/GIMEMA phase III trial (AML8 B). The EORTC Leukemia Cooperative Group and the GIMEMA Group. | Leukemia | Zittoun R, Liso V, Mandelli F, Rotoli B, de Witte T, Gattringer C, Resegotti L, Caronia F, Leoni P, Petti MC |
| 1992 | 1581404 | | A randomized study of the efficacy of postconsolidation therapy in adult acute nonlymphocytic leukemia: a report of the Italian Cooperative Group GIMEMA. | Annals of hematology | Mandelli F, Vegna ML, Avvisati G, Amadori S, Spadea A, Cacciola E, Cantore N, De Laurenzi A, De Rosa C, Fioritoni G |
| 1992 | 1317727 | | Identification of DNA rearrangements at the retinoic acid receptor-alpha (RAR-alpha) locus in all patients with acute promyelocytic leukemia (APL) and mapping of APL breakpoints within the RAR-alpha second intron. Italian Cooperative Study Group "GIMEMA". | Blood | Diverio D, Lo Coco F, D'Adamo F, Biondi A, Fagioli M, Grignani F, Rambaldi A, Rossi V, Avvisati G, Petti MC |
| 1992 | 1397242 | | Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving L-asparaginase during induction therapy: a retrospective study. The GIMEMA Group. | European journal of haematology | Gugliotta L, Mazzucconi MG, Leone G, Mattioli-Belmonte M, Defazio D, Annino L, Tura S, Mandelli F |
| 1991 | 1681308 | | Detection of Ph1-positive acute lymphoblastic leukaemia by PCR. GIMEMA Cooperative Study Group. | Lancet (London, England) | Saglio G, Guerrasio A, Rosso C, Lo Coco F, Frontani M, Annino L, Mandelli F |
| 1991 | 2048868 | | Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. | Annals of internal medicine | |
| 1991 | 1780745 | | Allogeneic or autologous bone marrow transplantation for intensification of salvage therapy in patients with high-risk advanced acute lymphoblastic leukemia. The AIEOP/GIMEMA Groups. | Seminars in hematology | Arcese W, Amadori S, Meloni G, Giona F, Vegna ML, Testi AM, Annino L, Carotenuto M, Resegotti L, Madon E |
| 1991 | 1878707 | | Methodology of evaluation in EORTC trials including BMT in acute myelogenous leukemia (AML) in first complete remission (CR). EORTC Leukemia Cooperative Group (LCG) and GIMEMA. | Bone marrow transplantation | Suciu S, Solbu G, Zittoun R, Hayat M, Willemze R, de Witte T, Mandelli F |
| 1991 | 1829918 | | A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia. A multicentric study from the Italian Co-operative Group GIMEMA. | European journal of cancer (Oxford, England : 1990) | Mandelli F, Petti MC, Ardia A, Di Pietro N, Di Raimondo F, Ganzina F, Falconi E, Geraci E, Ladogana S, Latagliata R |
| 1990 | 2188854 | | Idarubicin (4-demethoxydaunorubicin) as single agent for remission induction of previously untreated acute promyelocytic leukemia: a pilot study of the Italian cooperative group GIMEMA. | European journal of haematology | Avvisati G, Mandelli F, Petti MC, Vegna ML, Spadea A, Liso V, Specchia G, Bernasconi C, Alessandrino EP, Piatti C |
| 1990 | 2202470 | | Relative value of allogeneic BMT, autologous BMT and intensive chemotherapy during the first complete remission (CR) of acute myelogenous leukemia (AML). An interim analysis of the AML8 EORTC-GIMEMA protocol. | Bone marrow transplantation | Zittoun R, Mandelli F, De Witte T, Willemze R, Tura S |
| 1990 | 2189506 | | Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients. | Blood | Rodeghiero F, Avvisati G, Castaman G, Barbui T, Mandelli F |
| 1990 | 2098299 | | Thrombotic complications during L-asparaginase treatment for acute lymphocytic leukemia. | Haematologica | Castaman G, Rodeghiero F, Dini E |
| 1989 | 2697401 | | Idarubicin in acute leukaemia. GIMEMA Group. | Bone marrow transplantation | Mandelli F, Annino L, Avvisati G, Giona F, Meloni G, Petti MC, Testi AM, Carella AM, Caronia F, Carotenuto M |
| 1989 | 2649141 | | GIMEMA ALL 0183: a multicentric study on adult acute lymphoblastic leukaemia in Italy. GIMEMA Cooperative Group. | British journal of haematology | |
| 1989 | 2928805 | | Idarubicin in acute leukemias: experience of the Italian Cooperative Group GIMEMA. | Seminars in oncology | Petti MC, Mandelli F |
| 1989 | 2653497 | | Prognosis in chronic lymphocytic leukemia (CLL): experience of the Italian cooperative group (GIMEMA). | Bone marrow transplantation | De Rossi G |
| 1989 | 2653486 | | A randomized comparison of post-consolidation therapy in acute non-lymphoid leukaemia: a study of the Italian cooperative group GIMEMA. | Bone marrow transplantation | Petti MC, Mandelli F, Vegna ML, Broccia G, Carotenuto M, De Rosa F, Di Marco P, Di Raimondo F, Fioritoni G, Leone G |
| 1989 | 2644129 | | High-dose Ara-C (HiDAC) plus asparaginase in elderly patients with acute non-lymphocytic leukemia: a pilot multicentric study by the Italian Cooperative Group GIMEMA. | European journal of haematology | Petti MC, Mandelli F, Avvisati G, Covelli A, Amadori S, Liso V, Leone G, De Laurenzi A, Leoni P, Neri A |
| 1987 | 3819805 | | Prognosis in chronic lymphocytic leukemia: a retrospective multicentric study from the GIMEMA group. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | Mandelli F, De Rossi G, Mancini P, Alberti A, Cajozzo A, Grignani F, Leoni P, Liso V, Martelli M, Neri A |
